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resumo 
 
 
Os vidros e vitrocerâmicos bioactivos fazem parte da chamada terceira 
geração de biomateriais, i.e., materiais que estimulam uma resposta especial 
quando em contacto com fluidos biológicos, capaz de conduzir ao 
estabelecimento de ligações fortes entre a sua superfície e os tecidos vivos. O 
presente estudo visou o estudo e desenvolvimento de vidros bioactivos à base 
de diópsido e isentos de metais alcalinos que apresentem um bom 
comportamento na sinterização, elevados índices de bioactividade, e taxas de 
dissolução / degradação compatíveis com as almejadas aplicações em 
regeneração óssea e em engenharia de tecidos. Procurou-se ainda entender 
as relações entre a estrutura e as propriedades dos vidros bioactivos 
estudados. De acordo com esta perspectiva, estudaram-se várias 
composições de vidros bioactivos pertencentes ao sistema Diópsido 
(CaMgSi2O6) – Fluorapatite (Ca5(PO4)3F) – Fosfato de tricálcico (3CaO•P2O5). 
Todas as composições vítreas foram preparados por fusão, seguida de 
fritagem em água fria, e caracterizados através de um conjunto de técnicas 
complementares de caracterização. Os vitrocerâmicos foram obtidos por 
sinterização das fritas de vidro moídas e compactadas, seguida de tratamento 
térmico adequado para promover os fenómenos de nucleação e cristalização. 
Além disso, algumas composições vítreas seleccionadas foram dopadas com 
vários iões funcionais e os seus efeitos na estrutura vítrea, na sua propensão 
para a sinterização, e nos comportamentos in vitro em termos de bio-
degradação e bio-mineralização foram avaliados. Os efeitos das mesmas 
variáveis no processo de devitrificação (nucleação e cristalização) dos vidros e 
formação de materiais vitrocerâmicos foram também investigados. Algumas 
composições de vítreas apresentaram taxas de bio-mineralização elevadas, 
expressas através da formação de camadas superficiais de hidroxiapatite após 
1-12 h de imersão num fluido fisiológico simulado (SBF).  
Todas as composições vítreas apresentaram taxas de degradação mais baixas 
quando comparadas com a do 45S5 Bioglass
®
. Alguns vidros bioactivos 
revelaram comportamentos in vitro excelentes, sendo a taxa de bio-
mineralização dos co-dopados com zinco e estrôncio dependente da dose 
incorporada de dopantes. Os materiais estudados demostraram boa aptidão 
para aplicações em regeneração óssea e para o fabrico de estruturas de 
suporte em engenharia de tecidos. 
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abstract 
 
Bioactive glasses and glass-ceramics are a class of third generation 
biomaterials which elicit a special response on their surface when in contact 
with biological fluids, leading to strong bonding to living tissues. The purpose of 
the present study was to develop diopside based alkali-free bioactive glasses in 
order to achieve good sintering behaviour, high bioactivity, and a dissolution/ 
degradation rates compatible with the target applications in bone regeneration 
and tissue engineering. Another aim was to understand the structure-property 
relationships in the investigated bioactive glasses. In this quest, various glass 
compositions within the Diopside (CaMgSi2O6) – Fluorapatite (Ca5(PO4)3F) – 
Tricalcium phosphate (3CaO•P2O5) system have been investigated. All the 
glasses were prepared by melt-quenching technique and characterized by a 
wide array of complementary characterization techniques. The glass-ceramics 
were produced by sintering of glass powders compacts followed by a suitable 
heat treatment to promote the nucleation and crystallization phenomena. 
Furthermore, selected parent glass compositions were doped with several 
functional ions and an attempt to understand their effects on the glass 
structure, sintering ability and on the in vitro bio-degradation and bio-
mineralization behaviours of the glasses was made. The effects of the same 
variables on the devitrification (nucleation and crystallization) behaviour of 
glasses to form bioactive glass-ceramics were also investigated. Some of the 
glasses exhibited high bio-mineralization rates, expressed by the formation of a 
surface hydroxyapatite layer within 1–12 h of immersion in a simulated body 
fluid (SBF) solution. All the glasses showed relatively lower degradation rates in 
comparison to that of 45S5 Bioglass
®
. Some of the glasses showed very good 
in vitro behaviour and the glasses co-doped with zinc and strontium showed an 
in vitro dose dependent behaviour. The as-designed bioactive glasses and 
glass–ceramic materials are excellent candidates for applications in bone 
regeneration and for the fabrication of scaffolds for tissue engineering.  
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1. Introduction 
A glass can be defined as an amorphous solid completely lacking in long range, 
periodic atomic structure, and exhibiting a region of glass transformation behaviour. Any 
material, inorganic, organic, or metallic formed by any technique, which exhibits glass 
transformation behaviour is considered to be a glass [1]. 
Humans have been using glass for thousands of years, from the first uses of natural 
glass (e.g. obsidian, a volcanic glass) for tools and arrow heads, to the early man-made glass 
beads and drinking vessels of the Egyptians. Since then, glass has fascinated and attracted 
much interest both scientifically and technologically. The multiple forms and uses of glasses 
are becoming increasingly important in science, industry and in general daily life. During the 
last century, glasses and glass-ceramics became widely used for decorative articles, optics, 
architectural purposes (from windows to whole glass facades), and glassware for chemical 
reactions or fibres for telecommunication applications. The major advantage of glasses and 
glass-ceramics among its ceramic counterparts is their ability to accommodate various 
functional ions in their amorphous or crystalline phase, thus providing the flexibility to tailor 
and optimize their compositions with respect to different technological applications. 
In particular bioactive glasses have been a relatively young group of materials 
discovered in 1970´s by Larry Hench. Bioactive glasses and glass-ceramics constitute a class 
of bioactive materials, i.e. “Materials which elicit a special response on their surface when in 
contact with biological fluids, leading to strong bonding to living tissue”. Since its discovery, 
45S5 Bioglass
®
 has been used in >650,000 human patients and is being marketed for various 
dental and orthopaedic applications under different commercial brand names [2-4]. Due to 
number of attractive properties for bone regeneration and tissue engineering (TE), increasing 
efforts have been made towards expanding the range of potential applications and 
understanding the fundamental science governing the physical, chemical and thermal 
properties of bioactive glasses in order to develop novel compositions with superior set of 
properties for biomedical applications [5-10]. Irrespective of this huge success, high alkali-
containing glasses face some drawbacks which do restrict their application in some of the 
most advanced areas of human biomedicine. High alkali-content in glasses increase their 
crystallization tendency upon sintering, hindering the densification process and limiting the 
mechanical strength of sintered materials. Further, the relatively high chemical dissolution 
rates of such glasses in aqueous media decrease their in vitro and in vivo efficacy [11]. All 
these features constitute serious drawbacks in terms of fabrication of porous scaffolds or 
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porous coatings, and mitigate the potential benefits that could be drawn from their usage as 
biomedical devices for bone regeneration and TE.  
Despite many comprehensive studies leading to the development of bioactive glasses 
from different systems, the majority of these studies were based on 45S5 Bioglass
®
 or 
compositions inspired by it. Therefore, this work aims at designing new alkali-free bioactive 
glasses in the Diopside (Hereafter referred as Di) – Tricalcium phosphate (Hereafter referred 
as TCP) – Fluorapatite (Hereafter referred as FA) system having good bioactive properties 
and to understand the structure–property relationships in the as designed glasses.  
In the light of the above mentioned perspective, this dissertation comprises of five 
chapters. The first chapter, i.e., the Introduction, provides an outlook of the content of each 
chapter; the second chapter will focus on the literature survey in the field of bioactive glasses 
for biomedical applications, with special emphasis on alkali-free silicate systems. The second 
chapter has been divided into different subsections; the first section aims at providing a 
historical background on the development and evolution of bioactive glasses in general, while 
the second section outlines the motivations and purpose behind the present work. The third 
chapter deals with the description of the general experimental procedures and methodologies 
used along the thesis. It provides details about all the experimental techniques and procedures 
employed in order to synthesise, characterize and test our samples. Chapter four is the most 
important part of this work as it presents all the experimental results obtained on alkali-free 
glasses and glass-ceramics during past 3 years along with the pertaining discussions. In 
chapter five we have tried to conclude all the results and achievements obtained during this 
work and chapter six provides future directions in this field of research.  
Several experimental techniques were used throughout this investigation aiming at a 
better understanding of the glass structure, biodegradation behaviour and the sintering and 
crystallization behaviour of the corresponding glass powder compacts. Some properties of 
glasses and glass-ceramics such as density, mechanical strength, were also evaluated to 
achieve a better understanding concerning the structure-properties relations. 
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2. State of the art 
2.1 Need for Biomaterials for bone regeneration 
Human bone is a dynamic, highly vascularised connective tissue which provides 
structural support and act as a protective casing for the delicate internal organs of the body 
[12]. It is a tissue that is constantly remodelling to adapt to mechanical stresses imposed and 
repair minor injuries occurring during the lifetime. However, if the injuries suffered are 
extensive leading to very large bone defects, the use of bone grafts is required in order to 
repair the damaged part.  
Worldwide, millions of people are affected by degenerative and inflammatory 
problems related to bone and joint. In fact, they account for half of all chronic diseases in 
people over 50 years of age in developed countries. Further, every year there are roughly 8.9 
million cases of fractures, which occur due to osteoporosis only [13]. Also, approximately 1.6 
million hip fractures occur worldwide each year, by 2050 this number could reach between 
4.5 million [14] and 6.3 million [15]. Current treatments for filling bone defects and 
subsequent repair are based on autograft and allografts. Autologous grafts are the ones which 
contain essential elements for bone regeneration (osteogenic cells, osteoinductive growth 
factors and a matrix that supports adhesion and bone growth), are collected from the 
individual, minimizing the risk of rejection. Although autograft present relatively good 
percentages of success, however the range of applications is restricted, mainly due to the 
limited availability of living tissues and due to donor site morbidity [16]. Further, allograft 
bone introduces the possibilities of immune rejection and of pathogen transmission from 
donor to host. Although infrequent, infections could occur in the recipient’s body after the 
transplantation [16]. Therefore there is a severe need to search for new bone regeneration 
strategies in order to meet the increasing medical and socioeconomic challenge of our aging 
population. Hence, materials that enhance bone regeneration have a wealth of potential 
clinical applications from the treatment of non-union fractures to spinal fusion. Synthetic 
biomaterials, developed in an effort to overcome the inherent limitations of autograft and 
allograft, represents an alternative strategy. 
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2.2 Biomaterials for bone repair 
A biomaterial according to the American National Institute of Health is “Any 
substance (other than a drug) or combination of substances, synthetic or natural in origin, 
which can be used for any period of time, as a whole or as a part of a system which treats, 
augments, or replaces any tissue, organ, or function of the body”. The development of 
novel biomaterials is an iterative process that involves the creation of increasingly safer, more 
reliable, less expensive and more physiologically appropriate replacements for damaged or 
diseased human tissues. In the last 60 years, biomaterials for orthopaedic applications have 
evolved from materials available from different industrial applications into the materials with 
inherent capabilities to interact with the biological environment and to elicit specific 
biological responses. Most of the problems that orthopaedic surgery has to face have not 
basically changed, and are practically the same that orthopaedics had to face 50 years ago; 
however, the choice of possible solutions has been greatly expanded because new materials  
have allowed the design of innovative devices. Based on the evolution of biomaterials, these 
can be roughly divided into three broad categories depending upon the interaction 
mechanisms of the materials; namely inert materials (first generation biomaterials). Bioactive 
and biodegradable materials (second generation), and materials designed to stimulate specific 
cellular responses at the molecular level (third generation) [17]. This division represent the 
development in the field of biomaterials based on the requirements and properties of the 
materials involved. The present research is still devoted to the first or the second generation 
depending upon their properties and application. This means that the materials that each new 
generation brings in do not necessarily outweigh the existing materials. 
 
First generation biomaterials: Developed in the early 1950s [18], the principle 
underlying the development of first generation biomaterials was that they should be as 
chemically inert as possible in order to minimize the immune response to the foreign body  
[17]. Initially, the first generation of biomaterials consisted of already functional materials 
which were being applied in industrial applications (for e.g. aerospace) where mechanical 
properties were the main benchmark for the selection of candidate materials for implant 
manufacture. These biomaterials are mainly metallic or alloys (Co–Cr–Mo alloys, Ti6Al4V, 
etc.), ceramics (alumina, zirconia, etc.) and polymers (silicone rubber, acrylic resins) [19]. 
Though bio-inert in nature, these tend to form a thin non-adherent fibrous capsule over their 
surface with the passage of time after implantation which inhibits further interaction with 
tissue [20]. The thickness of the layer developed is a function of the level of reactivity of the 
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implant. Formation of this thin layer is attributed to the absorption of unspecific proteins that 
results in unspecific signalling to the cellular environment. This thin layer leads to loosening 
and deterioration of the mechanical fit. Eventually, surgical removal of the device is required. 
Therefore the development of bioactive interfaces eliciting a specific biological response and 
avoiding any fibrous layer was one of the main driving forces behind the development of 
second generation biomaterials. 
 
Second generation of biomaterials: Developed between the years 1970-1980. These 
biomaterials mainly include ceramics (bioactive glasses, glass-ceramics and calcium 
phosphates), biodegradable polymers (polylactic acid (PLA) and polyglycolic acid (PGA) 
etc.) [20]. Bioactive glasses discovered by Larry Hench in 1969-1971 [21] provided an 
alternative to the bio-inert materials used in orthopaedic applications. These second 
generation biomaterials were defined by their ability to interact with the biological 
environment in a controlled manner to enhance the biological response and the tissue/surface 
bonding. Further progress of the second generation biomaterials was the development of 
bioresorbable or bio-absorbable materials with the ability to undergo a progressive 
degradation while new tissue regenerates and heals [20, 22]. Bioactivity is defined as the 
ability of the material to bond to bone tissue via the formation of a bone-like hydroxyapatite 
(HA) layer on its surface [23]. The HA phase that forms on bioactive implants is equivalent 
chemically and structurally to the mineral phase in the bone, and is responsible for strong 
interfacial bonding, allowing for bone regeneration rather than replacement.  
 Second generation biomaterials have been in clinical use since 1980 in many 
orthopaedics and dental applications, including various compositions of bioactive glasses, 
ceramics, glass-ceramics, and composites. Synthetic calcium phosphate ceramics have been 
routinely used as bone cements and coatings over metallic prosthesis to facilitate bioactive 
fixation [20]. Different phases of calcium phosphate ceramics are used depending upon 
whether a bioresorbable or bioactive material is desired. Bioactive glasses and glass-ceramics 
are used as middle-ear prostheses to restore the ossicular chain and treat conductive hearing 
loss and as oral implants to preserve the alveolar ridge from the bone resorption that follows 
tooth extraction [20, 24, 25]. In comparison to the bioactive glasses and glass-ceramics, 
calcium phosphate based cements have been used in many orthopaedic applications such as 
bone substitution, repair of bone fractures (including ligament fixation), cartilage, meniscus 
and intervertebral disc. 
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Third generation of biomaterials: Developed in the 21
st
 century, third generation of 
biomaterials brought together separate concepts of bioresorbable and bioactive materials of 
second generation. The motive behind the design and development of these materials was to 
enhance the self-healing capabilities of the body, by the systematic stimulation of specific 
cellular responses at the molecular level [20]. Primarily, third generation biomaterials were 
developed by interchanging and intermixing of the properties of bioresorbable and bioactive 
materials. Consequently, these tailored biomaterials with new levels of bio-functionality have 
led to new approaches for the treatment of bone defects. Two main strategies have been 
followed during the last two decades with respect to tissue regeneration are TE and in situ 
tissue regeneration. 
TE is one of the approaches in which cells planted in the scaffolds are made to 
proliferate and differentiate in vitro. These tissue-engineered constructs are then implanted 
into the patients to replace diseased or damaged tissues. Clinical applications include repair 
of articular cartilage, skin, and the vascular system, although stability of the repaired tissues 
needs improvement. Another method was in situ tissue regeneration which involved the use 
of biomaterials directly implanted into the body in the form of powders, solutions, or doped 
micro-particles to stimulate local tissue repair. These materials release controlled amount of 
ionic dissolution products or growth factors such as bone morphogenic protein (BMP) by 
diffusion or network breakdown.  
 
2.3 Bioactive glasses  
Bioactive glasses are amorphous materials, compatible with the human body; bond to 
bone and can stimulate new bone growth while dissolving over time. They therefore have the 
potential to restore diseased or damaged bone to its original state and function (bone 
regeneration). Bioactive glasses belong to class A of bioactive materials which are osteogenic 
and osteoconductive materials. The first bioactive glass (silicate based) was discovered by 
Larry Hench and colleagues in 1969 using melt-quench method, at the University of Florida 
[26]. The glass composition of the first bioactive glass was 46.1% SiO2, 24.4% NaO, 26.9% 
CaO and 2.6% P2O5 (mol%), termed 45S5 Bioglass
®
, which is now a trademarked name 
(Figure 2.1).  
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Figure 2.1 Compositional dependence of bioactivity in Na2O-CaO-SiO2-P2O5 glass system 
[2].  
  
When in contact with a physiological fluid, bioactive glasses undergo a specific set of 
reactions, leading to the formation of an amorphous calcium phosphate (ACP) or crystalline 
HA phase on the surface of the glass, which is responsible for their strong bonding with the 
surrounding tissue [20]. Further, ionic dissolution products released from bioactive glasses 
(e.g. Si, Ca, P) are also reported to activate osteogenic gene expression [27, 28] and to 
stimulate angiogenesis [29, 30]. In addition to it, bioactive glasses offer remarkable 
advantages such as the ease of controlling chemical composition and, thus, the rate of 
degradation which make them attractive materials for orthopaedic applications. The structure 
and chemistry of glasses can be tailored over a wide range by changing either composition, or 
thermal or environmental processing history. Therefore, it is possible to design bioactive 
glasses with variable degradation rates to match that of bone ingrowth and remodelling.  
Based on the type of glass former, there are mainly three types of bioactive glasses: 
the conventional silicate-based glasses; phosphate-based glasses; and borate-based glasses. 
Recently, there has been an increase in interest in borate based bioactive glasses [31, 32], 
largely due its potential ability to heal chronic wounds that would not heal under 
conventional treatment [33]. The soft tissue response may be due to their lower chemical 
durability (faster dissolution) in comparison to the silica-based counterparts [31]. Also 
phosphate-based glasses have shown great potential in regenerative medicine [31], as the 
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solubility of these glasses can be controlled by modifying their composition; therefore these 
glasses show additional clinical potential as resorbable materials. Thus, benefits of phosphate 
glasses are probably related to their very rapid solubility which is strongly composition 
dependent rather than bioactivity [34].  
Oxide glasses are conventionally produced by melting the precursors (inorganic 
oxides, carbonates, fluorides and others) in precious metal or ceramic crucibles at high 
temperatures (for bioactive glasses typically above 1000 ºC, depending on the composition). 
If the cooling is rapid enough (with the necessary cooling rates depending, again, on the 
composition) crystallization will be inhibited and an amorphous material, a glass, will result. 
Another common way of preparing bioactive glasses is by a polycondensation reaction from 
organic precursors, alkoxides such as tetraethyl orthosilicate [35]. Synthesized in the early 
1990s [35], this new class of bioactive glasses displays higher compositional range of 
bioactivity: bioactive sol-gel glass compositions have been synthesized within the ternary 
SiO2:CaO:P2O5 or even within the binary SiO2:CaO systems, and might contain between 60 
and 90 mol% of silica [36, 37]. As the synthesis of glasses is highly dependent on 
composition and external conditions, sol-gel method gives better control over the surface and 
structural properties (such as surface area and porosity) of the resultant glass in comparison to 
melt-quenching method. The introduction of sol-gel synthesis technique has opened the 
research to new types of biomaterials. Many possible dopants can be introduced in a material 
synthesized via sol-gel. For example, it has been shown that sol-gel derived glasses 
containing 5 mol% ZnO resulted in increased alkaline phosphatase activity (ALP) activity 
and osteoblast proliferation [38].  
However, in the frame of the present thesis, melt-quenching was used to prepare 
glasses and sol-gel derived glasses are beyond the scope of this PhD work program. Hence, 
the subsequent discussion will solely be based on the silicate based glasses prepared by melt-
quenching. 
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2.4 Glass structure and bioactivity 
Within the glass structure, three different components are usually described. Network 
formers are able to form amorphous materials without the need for additional components. 
The basic building unit of silicate glasses is the SiO4 tetrahedron, which can be connected to 
neighbouring SiO4 tetrahedra via Si—O—Si bonds, known as bridging oxygens (BO). 
Silicon possess a charge of 4
+
 thus in the glasses when SiO4 tetrahedral forms a network these 
building units can share all their four oxygen atoms to give the stoichiometry (SiO4/2 or SiO2 
which is charge-balanced (assuming a charge of 2
– 
on the oxygen). 
 
Figure 2.2 2-dimensional representation of structure of silica glass [1].  
 
Each oxygen atom is shared between two silicon atoms, which occupy the centres of 
linked tetrahedra. Randomness in the structure is facilitated by the variability in the Si–O–Si 
angle connecting adjacent tetrahedra. Further rotation of adjacent tetrahedra around the point 
occupied by the oxygen atom linking the tetrahedra, and by rotation of the tetrahedra around 
the line connecting the linking oxygen with one of the silicon atoms results in augmentation 
in disorder in the structure. These tetrahedra are commonly referred to as Q
n
 (n = 1, 2, 3, 4) 
units, where n describes the number of BO connected to the tetrahedron. Silica glass therefore 
consists of Q
4
 units only. A 2-dimensional representation of such a structure is shown in 
Figure 2.2, where the fourth oxygen, which would sit directly above the small silicon ion, is 
not shown.  
Network modifiers, on the other hand, alter the glass structure by turning BO’s 
(predominantly covalent in character) into non-bridging oxygens (NBO’s) (Si—O- M+ 
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linkages, predominantly ionic in character, where M
+
 is a modifier cation). Typical modifiers 
include the oxides of alkali or alkaline-earth metals having co-ordination number 6 or more. 
The more modifiers we have in the glass composition, lower is the average number of SiO4 
tetrahedra each tetrahedron is linked to. At the same time, the number of NBO’s in the glass 
structure increases. In conventional silicate glasses, we find large concentrations of Q
4
 and Q
3
 
units, i.e. SiO4 tetrahedra connected to neighbouring ones in four or three directions, forming 
a silicate network. The relative concentrations of BO’s and NBO’s have an important 
influence on the structure and properties of the glasses. The rigidity of the glass network 
decreases gradually by replacing bridging atoms by non-bridging atoms. 
Intermediates on the other hand can either act like typical network modifiers or enter 
the backbone of the glass structure, acting more like a network former. These have a co-
ordination ranging from 4 to 6. 
Bioactive glasses, by contrast, contain larger concentrations of network modifiers and 
smaller amounts of silica than conventional soda-lime silicate glasses, and they therefore 
consist of a more disrupted silicate network of mostly Q
2
 units. According to Tilocca [5] 
maximum bioactivity for bioactive glasses is achieved if the structure is dominated by chains 
of Q
2
 metasilicates, which are occasionally cross-linked through Q
3
 units, whereas the Q
1
 
species terminate the chain. Further, the structure of glass can also be estimated based on the 
glass composition. Different parameters have been suggested for describing the glass 
structure in the literature [39-41]. Strnad [40] introduced the concept of network connectivity 
(NC) model to describe the average number of bridging oxygens per network forming 
element and to correlate the molecular structure of silicate glasses with their bioactivity 
(apatite forming ability). In a pure silica glass (containing no network modifiers) we have 
only Q
4
 units, thus has a NC = 4. With the introduction of the network modifiers the NC 
decreases as the BO’s are converted into NBO’s. Bioactive glasses with NC value in the 
range of 2 and 3 are believed to show good bioactive properties (45S5 Bioglass
®
 has a NC of 
1.90 [39], corresponding to a structure consisting of silicate).  
However, while NC may be a useful as a qualitative and a preliminary tool to predict 
the bioactivity of glasses, its predictive power rapidly decreases when: (i) a wider range of 
glass compositions are considered; (ii) cations of similar charge are partially substituted in 
the glass compositions. It has been shown that there is no straightforward correlation between 
the NC and the degradation behaviour bioactive glasses. For example, glass compositions 
with NC similar to that of 45S5 Bioglass
®
 (NC = ~1.95) have been shown to exhibit slower 
chemical dissolution behaviour in aqueous solutions than the latter while partial substitution 
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of Zn
2+
 in bioactive glasses at the expense of  Mg
2+
 retards the apatite forming ability of 
bioactive glasses despite their NC being unchanged [42]. 
 
2.5 Mechanism of HCA layer deposition 
Even though all the composition of silicate based bioactive glasses synthesized till 
date are quite different, the mechanism of HA or HCA (hydroxycarbonate apatite) formation 
are analogous for all of them. The apatite layer forms following solution-mediated dissolution 
of the glass with a mechanism very similar to conventional glass corrosion [43]. 
Accumulation of dissolution products causes both the chemical composition and the pH of 
the solution to change, providing surface sites and a pH conducive to apatite nucleation. 
There are five proposed stages for apatite formation in body fluid in vivo or in SBF in vitro 
[20].  
STEP 1 – Reactions for the rapid exchange of ions between the modifiers in the glass 
network (Na
+
 and Ca
2+
) with H
+
 ions or H3O
+
 in solution , leading to hydrolysis of the groups 
of silica and creating silanol groups (Si–OH ) on the glass surface. This process results in a 
net increase of pH of the solution due to the increasing OH ions. 
Si − O − Na+ +  H+ → Si − OH+ +  Na+  (1) 
STEP 2 – The increase of pH leads to attack on the glass network, breaking Si–O–Si bonds. 
Soluble silica is lost in the form of Si–OH to the solution, leaving more Si–OH (silanols) at 
the glass–solution interface. These silanol groups play a vital role as the nucleation centres of 
the apatite formation.  
Si − O − Si + H2O → Si − OH + OH − Si  (2)   
 
STEP 3 – Condensation and repolymerization of SiO2-rich layer on the glass surface depleted 
in alkali and alkaline earth cations. 
 
STEP 4 – Migration of Ca2+ and PO4
3–
 groups to the surface through the silica-rich layer, 
forming a film rich in amorphous CaO–P2O5 on the silica-rich layer. 
Si O 
O 
O 
H O Si OH 
O 
O 
O H 2 O + + Si 
O 
O 
O Si 
O 
O 
O O   (3) 
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STEP 5 – Incorporation of hydroxyls and carbonate from solution and crystallization of the 
CaO–P2O5 film to form apatite. After the apatite layer is formed the adsorption of growth 
factors, attachment, proliferation and differentiation of osteoprogenitor cells are the 
biological mechanisms of bonding to bone. In addition to this, adsorption of adhesion 
proteins (e.g., fibronectin, vitronectin, etc.) is necessary condition for cellular attachment.  
 
2.6 Role of various functional ions  
The processes of bone formation and bone resorption (bone remodelling) are 
regulated by variety of systematic and local regulated agents including growth factors and 
hormones. Single inorganic ions are known to be involved in the bone formation and bone 
resorption (bone remodelling) and play a physiological role in angiogenesis, growth and 
mineralization of bone tissues. In particular, some metal ions act as enzyme co-factors and 
therefore influence signalling pathways and stimulate metabolic effects during tissue 
formation [44]. These properties make metal ions attractive for use as therapeutic agents in 
the fields of hard and soft TE. 
Further, bioactive glasses have the ability to exhibit surface reactivity when in contact 
with body fluids leading to the release of ionic dissolution products (example: Si, Ca, P, Mg, 
F) which further stimulate the various vital mechanisms in human body like gene expression, 
osteoblast proliferation, angiogenesis and also provide anti-bacterial as well as anti-
inflammatory effects [28, 30, 45]. In fact, it has been well established that ionic dissolution 
products are key to understand the behaviour of parent inorganic materials in vitro and in 
vivo, especially in context of TE applications [46].  
 
2.6.1 Silicon 
Silicon (Si) is a non-metallic element with an atomic weight of 28. It is the second 
most abundant element in the Earth's crust at 28 wt%. Si is known to be an essential element 
for metabolic processes related with the formation and calcification of bone tissue [44]. 
Silicon is present in all body tissues, but the tissues with the highest concentrations of silicon 
are bone and other connective tissue including skin, hair, arteries, and nails [47]. Silicon 
plays an important role in the formation of cross-links between collagen and proteoglycans 
[48-50]. In vitro studies have demonstrated that silicon stimulates type I collagen synthesis 
and osteoblast differentiation [51]. Studies in rats have demonstrated that silicon at 
physiological levels improves calcium incorporation in bone when compared to rats that are 
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deficient in silicon [52-54]. Additionally, dietary Si intake was shown to increase the bone 
mineral density (BMD) in men and premenopausal women. Further Si intake has shown to 
improve BMD by bone resorption in case of calcium deficiency in rats [55]. Moreover, it has 
been reported that Si has a biochemical function in bone growth processes affecting bone 
collagen turn over and sialic acid-containing ECM proteins like osteopontin. Moreover, 
orthosilicate acid (Si(OH)4) at physiological concentration of 10 mmol has been shown to 
stimulate collagen I formation in human osteoblast cells (HOC) and to stimulate osteoblastic 
differentiation [44].  
 
2.6.2 Strontium 
Strontium (Sr) is an abundant and widely distributed element in the geosphere, natural 
water and human tissues. The amount of Sr in the skeleton is only 0.335% of its Ca content 
[56]. The biological properties of strontium are related to its chemical similarity to calcium. 
Sr can accumulate in bone by exchanging with Ca in the HA crystal lattice Thus strontium 
accumulates to a high degree in bone, can displace calcium in hard tissue metabolic processes 
and at high concentrations interferes with normal bone development. Low levels of Sr have 
been known to be associated with low energy fracture sites. Presence of strontium lactate 
enhances Ca deposition in the bone and reduces bone pain in osteoporosis patients. Sr ions 
have been shown to stimulate osteoblastic bone formation and to inhibit osteoclastic bone 
resorption both in vitro and in vivo [56, 57]. Sr drew attention as a drug for the management 
of osteoporosis in the 1950s. Indeed, strontium ranelate (Protelos) is a drug approved for 
treatment and prevention of osteoporosis.  Owing to the above-mentioned beneficial aspects 
of Sr in bone regeneration and considering the ion releasing ability of glasses in aqueous 
medium, bioactive glasses incorporated with Sr have gained considerable attention in the 
recent past for various orthopaedic applications. Sr-containing bioactive glasses were shown 
to combine the known bone regenerative properties of bioactive glasses with the anabolic and 
anti-catabolic effects of Sr cations in vitro [58]. 
 
2.6.3 Zinc 
Zinc (Zn) plays a vital role in bone formation, resorption and TE as it directly 
activates aminoacyl–tRNAsynthetase (a rate-limiting enzyme at translational process of 
protein synthesis) in osteoblastic cells and stimulates cellular protein synthesis [42]. Zn has 
also been shown to stimulate gene expression of the transcription factors: runt-related 
transcription factor 2 (Runx2) that is related to differentiation into osteoblastic cells. 
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Moreover, Zn inhibits osteoclastic bone resorption by inhibiting osteoclast–like cell 
formation from bone marrow cells and stimulating apoptotic cell death of mature osteoclasts 
[42].  
In case of soft tissue regeneration, Zn has been proved to be an essential element for 
wound healing [30, 44, 45]. It is an essential trace mineral for DNA synthesis, cell division 
and protein synthesis during the proliferative phase of wound healing [42]. Zn deficiency has 
been associated with poor wound healing and decreased breaking strength of animal wounds 
[44] which can result from decreased protein and collagen synthesis during healing found in 
Zn deficient animals. Agren et al [59] demonstrated the beneficial aspect of topically applied 
Zn on leg ulcer healing and wound healing in animal models. It was shown that topical zinc 
oxide promotes cleansing, re–epithelialisation and inhibits bacterial growth. 
 
2.6.4 Magnesium 
Magnesium (Mg) is the fourth most abundant cation in human body with 
approximately half of the total physiological Mg stored in bone tissue [60]. It is essential to 
bone metabolism and has been shown to have stimulating effects on new bone formation 
[61]. Mg is a co-factor for many enzymes, and stabilizes the structures of DNA and RNA. 
Depelition of Mg in body results in impaired bone growth, increased bone resorption and loss 
in trabecular bone [62, 63]. The level of Mg in the extracellular fluid ranges between 17 ppm 
and 25.5 ppm, where homeostasis is maintained by the kidneys and intestine [60, 64]. 
Although Mg levels exceeding 25.5 ppm can lead to muscular paralysis, hypotension and 
respiratory distress and cardiac arrest occurs for severely high serum levels of 145–170 ppm, 
the incidence of hyper- Mg is rare due to the efficient excretion of the element in the urine 
[60, 64, 65].  
 
2.6.5 Calcium 
Calcium (Ca) accounts for 1-2 % of the adult human body weight [66], and a major 
component of mineralized tissues, approximately 99% of body Ca is found in bone, where it 
serves a key role as a component of HA. Ca plays an important role in osteoblast proliferation 
and bone remodelling by directly activating intracellular mechanisms by affecting Ca-sensing 
receptors in osteoblastic cells. The influence of Ca in the body is highly concentration 
dependent. Maeno et al. [67] found that Ca concentrations in blood varying within the range 
of 48 mmol are suitable for osteoblast proliferation, differentiation and extracellular matrix 
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(ECM) mineralization, whereas higher Ca concentrations (>10 mmol) are cytotoxic. 
Extracellular Ca also plays an important role in the control of bone remodelling by directly 
regulating parathyroid cells through activation of the seven-transmembrane-spanning 
extracellular calcium-sensing receptor (CaSR), a member of the G-protein coupled receptor 
(GPCR) family [68]. Similar results were observed by Valério et al. [69], who found that 
extracellular Ca increases the glutamate release of osteoblastic cells. Since glutamate 
signalling pathways are known to play an important role for bone mechano sensitivity [70], 
extracellular Ca concentration must be considered as an important regulating agent in bone 
metabolism 
 
2.6.6 Phosphorus 
Phosphorus (P) is an essential nutrient for human and animal life. It is fundamental to 
growth, maintenance, and repair of all body tissues, and is necessary, along with calcium and 
magnesium, for proper growth and formation of bones in infants and children. P being a 
major component of the inorganic phase of human bone plays an important role in bone 
formation as it stimulates expression of matrix Gla protein (MGP), a key regulator for bone 
formation, in osteoblastic cells when added (10 mmol) to cell culture medium in 
concentration of <30 ppm [71, 72]. This release in controlled amounts has been shown to 
favour biomineralisation and induce expression of osteogenic messenger RNA transcripts 
while an increase in concentration of P beyond 30 ppm results in decrease in cell viability 
[72].  
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2.7 Introduction to the present work 
Since the discovery of 45S5 Bioglass
®
 in 1971 there has been a heightened interest in 
the science and biomedical application of bioactive glass over the last two decades, as 
evidenced by the growing number of publications in the field (Figure 2.3). Many artificial 
biomaterials based on, or inspired by Hench’s glass have been developed and successfully 
employed in clinical applications for repairing and replacing parts of a human body 
Figure 2.3 Number of papers published per year in the field of ‘‘bioactive glass’’ (compiled 
from a literature search SCOPUS carried out in November 2014). 
 
. This field is continuously expanding: new processing routes have extended the range 
of applications towards new exciting directions in biomedicine [17], many of which still rely 
on the original Hench’s base formulation, which is now considered a benchmark for the 
bioactive materials. Table 2.1 lists some bioactive glass compositions compiled from 
literature. Although the use of 45S5 Bioglass
®
 in numerous clinical programs has exhibited 
favourable healing capability, one of the main problems associated with this glass is its high 
dissolution rate [73], mainly owing to its high alkali content. Our recent studies have shown 
that alkali-incorporation in bioactive glasses decreased their apatite forming ability during 
initial 72 hours of reaction with body fluids due to excessive release of sodium from the 
glasses [74], thus leading to apoptosis.  
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Table 2.1 Selected bioactive glass compositions (mol%). 
 
With reference to the use of 45S5 Bioglass
®
 in vivo, Vogel et al. [81] showed that this 
glass has good biological efficacy in cases where shorter healing periods are required (~1 
month). However, this glass may not be a good option for serious injuries requiring 
prolonged treatment. Similarly, most of the bioactive glass compositions investigated so far 
and reported in papers [75-80, 82-87] and registered in a number of patents [75, 88-92] 
contain significant amounts of alkali oxides (Na2O, K2O). Although the incorporation of 
alkali oxides in bioactive glass is advantageous for their production, as they reduce their 
melting temperature, their presence in bioactive glass can reduce the usefulness of the glass 
in vivo. Often bioactive glasses for certain biomedical applications require heat treatments 
(coatings, sintering of porous scaffolds). When intended for coatings metal prosthesis the 
coefficient of thermal expansion has to match that of the metallic substrate. On the other 
hand, a good sintering ability is essential for achieving the required mechanical stability. 
These essential requirements are not fulfilled by alkali-rich bioactive glass compositions. As 
a matter of fact, high alkali contents degrade the working range of bioactive glasses by 
increasing the crystallization tendency of glass, thus rendering them unfit for use as bioactive 
porous scaffolds or porous coatings [93]. For example, in the case of 45S5 Bioglass
®
, owing 
to its poor sintering ability, there have been problems with the manufacture of highly porous 
scaffolds possessing good mechanical. Hence, these drawbacks related to the alkali content of 
the bioactive glasses can be overcome by reducing the alkali contents or even by adopting 
alkali-free bioactive glass compositions.  
 SiO2 P2O5 Na2O CaO K2O MgO CaF2 
45S5 [26] 46.1 2.6 24.4 26.9 
   
45S5F [75] 46.1 2.6 24.4 16.9 
  
10 
S53P4 [76] 53.9 1.7 22.7 21.8 
   
13-93 [77] 54.6 1.7 6.0 22.1 7.9 7.7  
6P61 [78] 61 2.5 10 13.5 2.4 10.7  
6P55 [78] 54.1 2.5 11.5 15.9 3.4 12.6  
A-W [79] 35.4 7.2 - 49.9 - 7.1 0.4 
ICIE1[80] 49.46 1.07 26.38 23.08 
  
 
ICIE16 [80] 49.46 1.07 6.6 36.27 6.6 
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The initial work for the development of alkali-free bioactive was made by Kukubo et 
al. in the year 1982, who designed a series of alkali-free glasses in the 3CaO•P2O5 – 
CaO•SiO2 – MgO•CaO•2SiO2 system [79]. The Apatite-Wollastonite (A-W) glass-ceramics 
designed by Kukubo et al. [94, 95] exhibit excellent mechanical properties as well as good in 
vitro and in vivo behaviour. Kasuga et al. [96] studied the effect of magnesium and 
aluminium on the bioactivity of the alkali-free glasses. Results indicated that Al2O3 tends to 
inhibit the apatite forming ability of the glasses and magnesium tends to slow down (but not 
hinder) the apatite forming ability of glasses when immersed in SBF solution. K. Ohura et al. 
[97] incorporated various ions into CaO-SiO2 based glasses and studied their effect on the in 
vivo performance. The formation of a calcium phosphate layer was achieved in the all the 
glasses except for the ones containing Fe2O3. In the mid 1990 Galliano et al. [98] investigated 
the influence of Mg
2+
 and Sr
2+
 on the structure and thermal behaviour of glasses in the 
CaOSiO2P2O5CaF2 system. To the best of our knowledge, this is one of the foremost 
studies on Sr-containing bioactive glasses. 
In another study, Salinas et al. [99] reported on the influence of Mg on the in vitro 
bioactivity of slightly modified A-W glasses and glass-ceramics. The results showed 
negligible changes in bioactivity of glasses; however, presence of Mg led to the appearance 
of new crystalline phases in the glass-ceramics which were able to suppress the in vitro 
bioactivity. Further, an extensive work has been done by Oliveira et al. [100-102] using 
29
Si 
and 
31
P MAS-NMR to investigate the structure versus bioactivity (assessed through 
immersing the glass samples in SBF) relationship of bioactive glasses compositions without 
alkali content. In 2006 Kamitakahara et al. [103] designed alkali-free Di based glass-ceramics 
and investigated their mechanical strength and bioactivity. They found that the flexural 
strength of an eutectic glass–ceramic composition 38 TCP–62 Di (wt.%) was higher than 200 
MPa. However, no further studies dealing with this system have been reported since that, and 
our attempts to reproduce these results were unsuccessful. Recently, Kansal et al. [104-106] 
investigated the structure, thermal and dissolution behaviours of alkali-free glasses and glass-
ceramics in Di-based glasses using MAS-NMR and ICP-AES. The as developed glasses 
exhibited better sintering ability than 45S5 Bioglass
®
 and good in vitro bioactive properties.  
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2.7.1 Aim of the thesis 
Despite of extensive amount of work done by scientists all over the world, literature 
survey reveals that since the earnest 1970s, most of the work in the field of bioactive glasses 
has been mainly focused upon understanding the compositional dependence of glass 
dissolution for 45S5 Bioglass
®
 (46.1% SiO2, 24.4% Na2O, 26.9% CaO and 2.6% P2O5 in 
mole percent) or other silicate glasses with similar compositions [77, 107-109]. Further, last 
few years have witnessed a consistent upsurge of studies attempting correlating the atomic 
and molecular structure of silicate glasses with their chemical dissolution and bioactivity 
behaviours [5, 80, 110-112]. Simultaneously, significant efforts have been made either to 
unearth the influence of functional ions on the structure of bioactive glasses [113-118] or to 
study their influence on the chemical dissolution behaviour of glasses [119-125]. However, 
few attempts have been made to elucidate about the correlation between the structural role of 
these functional ions and the chemical degradation and bioactivity of glasses [23, 42, 87, 104, 
126] especially in case of alkali-free bioactive glasses. Despite significant progress made in 
the pursuit of establishing relationships between chemical composition, molecular structure 
and bioactivity of silicate glasses, we are still not in a position to develop scientifically robust 
and statistically accurate models to predict the chemical dissolution and bioactivity of glasses 
mainly because most of the studies available in scientific literature still revolve around 
structure-property relationships of glasses based on or inspired by 45S5 Bioglass
®
 [5, 110, 
111, 127-129].  
 Therefore, in the present doctoral work we have tried to design and characterize 
glasses covering far from region of high alkali-content in an attempt to find a possible 
solution for the above discussed long-standing problem of alkali-containing glasses. 
Accordingly, the work reported in this dissertation has been directed towards fulfilment of the 
following aims: 
1. To design alkali-free bioactive glasses having high bioactivity, lower dissolution rate and 
good sintering behaviour so as to prove their efficacy for bone regeneration and TE 
applications.  
2. To understand on the structure-property relationships in alkali-free bioactive glasses  
3. To understand effect of various functional ions on the structure and its implications on 
the biodegradation behaviour of the glasses and its impact on in vitro behaviour of 
glasses. 
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4. To understand the effect of these functional ions on sintering, crystallization behaviour 
of bioactive glasses and glass-ceramic. 
 
We hope that the work reported in this dissertation will be a good contribution to the growing 
literature in the field of bioactive glasses, that will enable us to create a succinct database 
which can be further used to develop models for designing bioactive glasses with controlled 
chemical degradation rate and high bioactivity with novel applications in the field of human 
biomedicine.    
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Chapter 3 
Experimental 
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3. Experimental 
3.1 Glass synthesis 
High purity powders of SiO2 (BDH Chemicals Ltd., UK, purity >99.0%), CaCO3 
(BDH Chemicals Ltd., UK, purity >99.0%), MgCO3 (BDH Chemicals Ltd., UK, purity 
>99.0%), NH6PO4 (Sigma Aldrich, Germany, >99.0%), ZnO (Sigma Aldrich, Germany, 
>99.9%), SrCO3 (Sigma Aldrich, Germany, >99.9%) and CaF2 (Sigma Aldrich, Germany, 
325 mesh, >99.9%) were used. All the glass compositions have been prepared by melt-
quenching technique. Homogeneous mixtures of batches (~100 g) obtained by ball milling, 
were preheated at 900 ºC for 1 h for calcinations and then melted in platinum (Pt) crucibles at 
1570-1590 ºC for 1 h. The glasses were obtained in bulk form by casting the glass melt on a 
metallic mould and then annealing the glass at 500-700 ºC for 1 h. The glasses were obtained 
in frit form by quenching of glass melts in cold water. The frits were dried and then milled in 
a high-speed agate mill resulting in fine glass powders with mean particle sizes of ~ 10–20 
μm (determined by light scattering technique; Coulter LS 230, Beckman Coulter, Fullerton 
CA; Fraunhofer optical model). The amorphous/crystalline nature of frits was confirmed by 
X-ray diffraction (XRD) analysis (Rigaku GeigerflexD/Max, Tokyo, Japan; C Series; Cu Kα 
radiation; 2θ angle range 10º–60º; step 0.02º s−1. 
 
3.2 Density and Molar volume 
Archimedes’ method [i.e. immersion in diethyl phthalate (C12H14O4) (molar mass: 
222.24 g mol
–1
; density: 1.12 g cm
–3
)] was employed to measure the apparent density of the 
bulk annealed glasses and glass-ceramics. Molar volume (Vm), was calculated using the 
density data for the bulk glasses using following relations: 
𝑉𝑚 =  
𝑀
𝜌
 
Where M is the molar mass of the glass and  is the apparent density of the bulk glasses. 
 
3.3 Structural characterization of glasses 
3.3.1 Magic angle spinning (MAS) – Nuclear magnetic resonance (NMR) spectroscopy 
The 
29
Si MAS-NMR spectra were recorded on a Bruker ASX 400 spectrometer 
operating at 79.52 MHz (9.4 T) using a 7 mm probe at a spinning rate of 5 kHz and 60 
seconds delay time was used. Kaolinite was used as the chemical shift reference. The 
31
P 
MAS-NMR spectra of glasses were recorded using 4 mm probe on a Bruker ASX 400 
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spectrometer operating at 161.97 MHz with 45º pulses, spinning rates of 12 kHz, a 60 s 
recycle delay and the chemical shift was quoted in ppm from phosphoric acid (85%). 
 3.3.2 Infra-red spectroscopy.  
Fourier transform infrared (FTIR) spectra of the glasses (before and after immersion 
in SBF) were obtained using an Infrared Fourier spectrometer (FTIR, model Mattson Galaxy 
S-7000, USA). For this purpose glass powders were mixed with KBr in the proportion of 
1/150 (by weight) and pressed into a pellet using a hand press. 64 scans for background and  
64 scans per sample were made with signal gain 1. The resolution was 4 cm
–1
. The bands 
were assighned as per the Table 3.1 [119, 208]. 
 
Table 3.1 Infrared bands of functional groups of bioactive glasses.  
Vibration mode Wavenumber (cm
˗1
) 
Si-O-Si 415-540 
P-O bend crystal 515-530 
P-O bend crystal 550-560 
P-O bend amorphous 570-600 
P-O bend crystal 600-610 
C-O stretch 800-890 
Si-O-Si tetraedral 860-1175 
Si-O stretch 1000-1100 
P-O stretch 910-1040 
P=O stretch 1180-1350 
 
 
3.4 Biodegradation of glasses 
The in vitro bioactivity of glasses, reflected in their capability of inducing HA-
formation onto their surfaces, was investigated by immersion of glass powders in simulated 
body fluids (SBF) (0.10 g glass powder in 50 ml SBF solution) at 37 ºC. SBF had an ionic 
concentration (Na
+
 142.0, K
+ 
5.0, Ca
2+
 2.5, Mg
2+
 1.5, Cl
−
 125.0, HPO4
−
 1.0, HCO3
2− 
27.0, 
SO4
2− 
0.5 mmol l
−1
) nearly equivalent to human plasma, as discussed by Tas [130]. The 
powder–SBF mixtures were immediately sealed into sterilized plastic flasks and were placed 
in an oven at 37 ºC (± 0.5 ºC). The SBF solution was replaced every 48 h and sampling took 
place at variable times ranging from days to weeks. The experiments were performed in 
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duplicate in order to ensure the accuracy of results. The apatite forming ability on glass 
powders was followed by XRD and FTIR analysis.  
The degradation tests were performed according to the standard ISO 10993–14 
“Biological evaluation of medical devices – Part 14: Identification and quantification of 
degradation products from ceramics”. The test simulates the more frequently encountered in 
vivo pH (7.4 ± 0.1) and therefore investigates the degradation of glasses/ceramics in freshly 
prepared Tris–HCl buffered solution. The glass powder with particle size varying between 
300 – 400 μm was added to the Tris–HCl solution (2.5 g glass powder in 50ml Tris–HCl 
solution). The tests were carried out without solution replacement at 37 ºC and with a mixing 
speed of 120 rpm. The sampling was done after 120 h, when the solid and liquid phases were 
separated by filtering (0.22 μm, Millex GP, Millipore Corporation, USA). The solid samples 
were then washed in deionised water and dried in an oven to a constant weight. The structural 
changes (if any) in the glasses after immersion in Tris–HCl were analysed by XRD and FTIR 
analysis. The pH and elemental concentrations (Ca
2+
, Sr
2+
, Mg
2+
, PO5
5-
, SiO4
4+
) (ICP-AES; 
JobinYvon, JY 70 plus, France) of the soaking solutions were measured. The relative weight 
loss percentage (WL) of the glass samples after 120 h of immersion in the solutions was 
calculated from the following equation: 
100
0
0 




 

W
WW
W tL  
Where W0 refers to the weight of the glasses before immersion and Wt refers to their weight 
after immersion in Tris-HCl. 
 
3.5 Thermal analysis 
3.5.1 Sintering behaviour- hot stage microscope (HSM) 
 The sintering behaviour of the glass powders was investigated using a side-view hot 
stage microscope (HSM) EM 201 equipped with image analysis system and 1750/15 Leica 
electrical furnace. The cylindrical shaped samples with height and diameter of ~3 mm were 
prepared by cold-pressing the glass powders. The cylindrical samples were placed on a 10 × 
15 × 1 mm alumina (>99.5 wt% Al2O3) support. The temperature was measured with a Pt/Rh 
(6/30) thermocouple contacted under the alumina support. The microscope projects the image 
of the sample through a quartz window and onto the recording device. The computerized 
image analysis system automatically records and analyses the geometry changes of the 
sample during heating. The image analyser takes into account the thermal expansion of the 
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alumina substrate while measuring the height of the sample during firing, with the base as a 
reference. The HSM software calculates the percentage of decrease in height, width and area 
of the sample images. The measurements were conducted in air with a heating rate (β) of 5 K 
min
–1
.  
 
3.5.2 Differential thermal analysis 
 The values of the glass transition temperature (Tg), crystallization onset temperature 
(Tc) and peak temperature of crystallization (Tp) were obtained by differential thermal 
analysis (DTA)  using a Setaram LabSys TG–DTA16 instrument (Setaram Instrumentation, 
France) calibrated in the temperature range 25–1000 ºC. The measurements were performed 
using powdered glass samples (50 mg) in an alumina crucible and –alumina powder as 
reference at a heating rate (β) of 5 K min–1 and 20 K min–1. 
 
3.6 Preparation of glass-ceramics 
Glass-ceramics can be prepared either by nucleation and crystallization through 
suitable heat treatments given to monolithic glasses, or by sintering and crystallization of 
glass powder compacts. Rectangular bars with dimensions 4 × 5 × 50 mm
3
 and circular disc 
shaped pellets with diameter 20 mm and thickness ~3 mm were prepared from fine glass 
powders by uniaxial pressing (80 MPa). The glass powder compacts were sintered under 
isothermal conditions for 1 h at the different temperatures. A slow heating rate (β) of 5 K 
min
–1
 was maintained in order to prevent deformation of the samples. 
 
3.7 Characterization of glass-ceramics 
3.7.1 Mechanical Properties of sintered glass-ceramics 
The mechanical properties were evaluated by measuring the three-point bending 
strength of rectified parallelepiped bars (3 × 4 × 50 mm
3
) of sintered glass-ceramics 
(Shimadzu Autograph AG 25 TA, Columbia, MD; 0.5 mm min
–1
 displacement). The mean 
values and the standard deviation presented for shrinkage and density were obtained from (at 
least) ten different samples. 
 
3.7.2 Microstructural characterization- SEM and EDS 
 Microstructural observations were made on polished surfaces of the sintered and heat 
treated glass powder compacts (chemically etched by immersion in 2 vol% HF solution for 
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duration of 2 min) by scanning electron microscopy (SEM; SU–70, Hitachi). In addition, 
energy dispersive spectroscopy (EDS; Bruker Quantax, Germany) has been utilized to study 
the distribution of elements.  
 
3.8 In vitro studies 
3.8.1 Alkali-free glasses for bone tissue engineering: A preliminary investigation 
3.8.1.1 Mesenchymal stem cell proliferation  
The biological performance of the as developed glass-ceramics was addressed by the 
in vitro cellular responses, including cell proliferation and osteoblastic differentiation. The 
results were compared with the tissue culture plastic used as a control. For the cellular study, 
mesenchymal stem cells (MSCs) derived from rat bone marrow were used. MSCs have been  
a potential source for the regenerative therapy of tissues including bone, because of their 
multipotent and self-renewal capacity without the concern of ethical issues. The experimental 
procedures were based on their previous work [28] and followed by the guidelines approved 
by the Animal Ethics Committee of Dankook University. MSCs gathered from the bone 
marrow of rats were maintained in a normal culture medium containing -minimal essential 
medium (MEM) supplemented with 10% foetal bovine serum (FBS), 100 U ml
–1
 penicillin 
and 100 mg ml
–1
 streptomycin in a humidified atmosphere of 5% CO2 in air at 37 ºC.  
MSCs maintained up to 3-4 passages were used for cellular study. The glass-ceramics 
were sterilized with 70% ethanol for 1 h prior to seeding cells. For the cell growth study, 
MSCs were seeded on each sample (15 mm × 2 mm disc type) and then cultured in the 
normal culture medium condition as described above. After culture for 3, 7 and 14 days, the 
cell growth level was analysed by the cell counting kit (CCK) assay. At each time of 
culturing (3 and 7 days), the CCK-8 reagent was added to each sample and incubated for 3 h 
at 37 ºC. The absorbance was measured at a wavelength of 450 nm using a microplate reader 
(Molecular Devices, USA). The cell growth morphology was observed by SEM (Hitachi) 
after fixation the cells with 2.5% glutaraldehyde, dehydration with a graded series of ethanol 
(50, 70, 90 and 100%) and coating with gold.  
 
3.8.1.2 Alkaline phosphatase activity 
The osteoblastic differentiation of the MSCs on the glass-ceramics was determined 
by measuring the ALP activity. Cells were seeded on each sample (15 mm × 2 mm disc type), 
and cultured in the osteogenic medium containing 50 μg ml−1 sodium ascorbate, 10 mM β-
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glycerol phosphate, and 10 nM dexamethasone. After culture for 7 and 14 days, cellular 
samples were gathered and added to the ALP reaction media to allow an enzymatic reaction 
according to the manufacturer’s instruction (Sigma). The quantity of samples used for the 
reaction was determined based on the total protein content which was determined by using a 
commercial DC protein assay kit (BioRad). As a result of the reaction, the product p-
nitrophenol appears as the colour change which was then measured at an absorbance of 405 
nm using a spectrophotometer.  
The CCK and ALP assays were performed on three replicate samples (n = 3). Data 
were represented as means ± standard deviations. Statistical analysis was carried out by 
analysis of variance (ANOVA) and significance level was considered at p < 0.05.  
 
3.8.2 Influence of ZnO/MgO substitution on sintering, crystallization, and bio-activity of 
alkali-free glass-ceramics 
Similar procedure as mention in section 3.8.1 was used.  
 
3.8.3 Role of glass structure in defining the chemical dissolution behaviour, bioactivity 
and antioxidant properties of zinc- and strontium- co-doped alkali-free phosphosilicate 
glasses 
3.8.3.1 In vitro cellular tests  
For investigating the cellular responses and antioxidative effect for the developed 
glass compositions (ZS–2 to ZS–8), thin slices of glasses measuring ~1 mm of thickness were 
prepared by cutting and polishing the bulk annealed glasses. Tissue culture plastic was used 
as a control.  
 
3.8.3.1 Cell Culture studies   
Human osteosarcoma cell line MG63 was obtained from National Centre for Cell 
Science (NCCS), Pune, India and maintained on Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with streptomycin (100 U ml
1), gentamycin (100 μg ml1), 10% 
FBS (Sigma-Aldrich) at 37 ºC and humid environment containing 5% CO2. MTT was used to 
assess cell integrity and potential cytotoxicity of the plant extract by monitoring the uptake of 
the vital mitochondrial dye, 3-[4,5-dimethylthiazol-2-yl]- 2,5-diphenyl tetrazolium bromide 
(MTT) by cell mitochondria. 
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Binding of MG63 cells to glass samples was carried out in 24 well plates. Rectangular 
shaped, sterilized glass slices were kept in triplicates in the 24 well plates. The wells without 
glass samples were considered as control. 500 µl of lymphocyte suspension at a concentration 
of 2×10
4 
cells ml
1 
was added to each well. The plate was then incubated at 37 ºC, 5% CO2 in 
air and 90% relative humidity in CO2 incubator for 96 h. Four hours before the termination of 
cultures, 500 l of MTT (2 mg ml1) prepared in serum free medium was added to each well. 
After 4 h, 500 l of DMSO (Dimethyl sulfoxide) was added to each well. The blue colored 
formazan formed was read at 570 nm with Labsystems Multiskan EX ELISA reader against a 
reagent blank. 
The cells on disks were fixed with freshly prepared Karnovsky’s fixative (2% 
paraformaldehyde; 2.5% glutaraldehyde in 0.1 M phosphate buffer pH 7.4.) at 4 ºC for 90 
min. After fixation, the fixative was removed and cells were washed for 2 min with 0.1 M 
phosphate buffer. Further, cells were fixed in 1% buffered osmium tetroxide (prepared in 
phosphate buffer) for 90 min at 4 ºC. The cells were further dehydrated with various 
concentrations of ethanol starting with 30% for 5 min twice and repeating the same with 50, 
75, 95% and absolute ethanol. After critical point drying, cells were photographed with 
EVO
®
 LS10 Life Science SEM. 
 
3.8.3.2 Cytoprotective assay 
Cytoprotective effect of bioactive glasses was carried out on hydrogen peroxide 
(H2O2) induced oxidative stress in human MG63 cells. The H2O2 dose (LD50) for 
cytoprotection studies was calculated by treating cells at 50% confluency with H2O2 (7.5 µM 
to 1000 µM diluted in medium) for 12 h in serum free medium. The glass slices were kept in 
triplicates in the 24 well plates. The wells without glass samples and H2O2 were considered as 
negative control and cells with H2O2 along with glass samples were kept as positive controls. 
500 µl of cell suspension at a concentration of 2×10
4 
cells ml
1 
was added to each well. The 
plate was then incubated at 37
 
ºC, 5% CO2 in air and 90% relative humidity in CO2 incubator 
for 72 h. The LD50 dose of H2O2 was given at this point to induce the oxidative stress for 12 
h in the wells with and without glass samples except negative control. Four hours before the 
termination of cultures, 500 l of MTT (2 mg ml1) prepared in serum free medium was 
added to each well. After 4 h, 500 l of DMSO was added to each well. The blue colored 
formazan formed was read at 570 nm with Labsystems Multiskan EX ELISA reader against a 
reagent blank. 
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3.8.4 An experimental approach towards understanding the composition-structure-
bioactivity relationships in silicate glasses 
3.8.4.1 Cell Culture Studies 
Human mesenchymal stem cells (hMSC, Lonza) were thawed and then cultured in 
175 cm
2
 tissue culture flasks containing DMEM (Gibco), supplemented with 10% v/v 
inactivated FBS (Gibco), and 1% v/v penicillin/streptomycin (P/S, Gibco). Cells were 
maintained at 37 ºC under a 5% CO2 humidified atmosphere. The medium was changed every 
third day until confluence, when cells were be sub-cultured in order to prevent cell death. In 
order to sub-culture, the cell monolayer was washed with phosphate buffered saline (PBS) 
(Sigma) and incubated with a trypsin/ethylene diamine tetra acetic acid (EDTA) solution for 
8 min at 37 ºC to detach the cells. The effect of trypsin was then inhibited by adding culture 
medium at room temperature. Cells were used in the passage six. 
The glass samples were autoclaved (120 ºC, 20 min) and placed in untreated 48-well 
plates (~ 1 cm
2
 surface area) (Cellstar
®
) to avoid cell adhesion to the bottom of the wells. The 
controls were wells treated with poly-D-lysine. The cells were seeded at 2×10
4
 cells per well 
and fresh medium was added, followed by incubation at 37 ºC for 4 h to allow cell adhesion. 
Afterwards, fresh medium was added until it reached a final volume of 400 µl per well. To 
induce the hMSCs differentiation along the osteoblastic lineage, cells were also cultured with 
osteogenic medium: basal medium supplemented with 10 µl ml
1
 glycerophosphate (Sigma), 
10 µl ml
1
 dexamethasone (Sigma), and 10 μl ml1 ascorbic acid (1.61 mg ml1) (Fluka). 
hMSCs were cultured on samples of the glass for periods of 1, 3, 7, 14 and 21 days. At each 
time point, the samples were evaluated for cell metabolic activity, viability, morphology and 
differentiation. 
 
3.8.4.2 Cell metabolic activity 
A resazurin method was used to assess metabolic activity at days 1, 3, 7, 14 and 21. A 
resazurin solution (Sigma) was added to fresh medium at a final concentration of 10% (v/v). 
Cells were incubated in this solution at 37 ºC for 3 h, after which, 100 µl per well were 
transferred to a 96-well black plate and fluorescence was measured (530 nmEx/590 nmEm) 
in a Spectra Max Gemini XS (Molecular Devices). 
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4 Results and Discussion 
4.1 Alkali-free glasses for bone tissue engineering: A preliminary investigation  
4.1.1 Introduction 
The present chapter reports on a preliminary attempt to find a feasible solution for the 
above discussed long-standing problem of designing alkali-free bioactive glasses. In this 
pursuit, the alkali-free glass compositions have been designed in the system Di–FA–TCP 
with a general formula (Di) (90x)–(FA)10–(TCP)x (x = 10–40 wt%). Table 4.1.1 presents 
the detailed compositions of the glasses. The present composition has been selected due to 
following reasons:  
 
Table 4.1.1 Nominal composition of the as-designed glasses (mol%).  
 
Glass SiO2 P2O5 CaO MgO CaF2 
TCP-10 42.57 3.57 32 21.29 0.57 
TCP-20 38.49 5.61 36.07 19.24 0.59 
TCP-30 34.12 7.79 40.42 17.06 0.61 
TCP-40 29.44 10.12 45.08 14.73 0.63 
 
Di belongs to the group of inosilicates and is an important member of clinopyroxene 
group with composition CaMgSi2O6. The structure of amorphous Di is dominated by Q
2
 unit 
which is a positive attribute for bioactivity in glasses. Also, it has been demonstrated that Di-
based ceramics and glass-ceramics have no general toxicity in cell cultures and help in bone 
regeneration [131, 132]. Nakajima et al. [133, 134] found that Di possessed ability to form 
apatite in SBF and could closely bond to bone tissue when implanted in rabbits. Aza et al. 
[132] investigated the reactivity of the material in a natural medium of high protein content 
by soaking Di based ceramic pellets in human parotid saliva (HPS) over various time 
intervals. Also Yoganand et al. [135] synthesized bioactive glass-ceramics with the help of 
transferred arc plasma technique in the system CaOMgOSiO2 with Di as the major 
crystalline phase.  
In addition to the biocompatibility aspect of Di based ceramics and glass-ceramics; 
they are known to exhibit superior mechanical properties in comparison to many of their 
ceramic counterparts. Nonami et al. [131] reported significantly improved fracture toughness 
values for pure sintered HA with added Di.  It was reported that the bending strength and 
fracture toughness of Di-HA composite was 2 to 3 times higher in comparison to that of 
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sintered HA. Therefore, owing to the presence of Di, we can expect superior mechanical 
properties for the glass-ceramics without compromising their biomedical characteristics. 
Further, the presence of hydroxy-, oxy- or fluoro- apatite is highly favourable for 
biomedical applications. In particular, FA based glasses and glass-ceramics have gained 
attention [104, 105, 136, 137] due to their structural and chemical similarities with bone 
forming mineral, HA [87]. Also, fluoride is known to increase bone density and also has anti-
carcinogenic properties [104]. Further, intracellular or plaque-associated enzymes have been 
reported to be affected by fluoride ions [104]. Alkali-free Di-FA-W bioactive glass-ceramics 
for replacement materials for tooth roots, dental crowns were developed by Shibuya et al. 
[88], while Tulyaganov et al. [138] developed glass-ceramics in ternary system tetrasilicic 
mica-FA-Di. Recently Kansal et al. [104, 105] reported the biodegradation behaviour of the 
Di-FA based glasses.  
Similar to Di-FA join, glass-ceramics along Di-TCP join have been a subject of 
interest due to their potential biomedical applications. TCP is a typical bioresorbable material 
which is widely used in bone repair [139]. Also TCP ceramics bear excellent properties for 
bone marrow stromal cells culture towards osteogenic differentiation [140]. Therefore, the 
addition of TCP at the expense of Di in the glass compositions is expected to enhance their 
solubility as well as their bioactivity in physiological fluids. Also, the addition of TCP to Di 
is expected to improve its sintering ability as it has been reported that the flexural strength of 
eutectic glass-ceramic composition 38TCP-62Di (wt%) is higher than 200 MPa [103]. 
Kamitakahara et al. [103] studied the bioactivity and mechanical properties of bioactive 
scaffolds. Also,  Ashizuka et al. [141] reported on the mechanical properties of Di-TCP based 
glass-ceramics. Thus it’s expected that the combination of Di, FA and TCP phases is 
expected to result in the development of glasses with excellent bioactive properties, low 
chemical degradation and good sintering ability.   
 
4.1.2 Results and discussions 
4.1.2.1 Glass forming ability 
For all the investigated glass compositions (x = 10  40 wt%), melting at 1570 ºC for 
1 h was sufficient to obtain bubble-free, transparent and amorphous glasses (Figure 4.1.1). 
The glass forming ability diminished with further increase in TCP content in glasses (x > 40 
wt%) as resultant glass frits were prone to spontaneous crystallization even after super-
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cooling in cold water thus, resulting in white, opaque material with FA as the only crystalline 
phase, as revealed by XRD analysis (not shown).  
 
 
 Figure 4.1.1 X-ray diffractograms of as-quenched glass frits. 
 
4.1.2.2 Structure of glasses (MAS – NMR spectroscopy) 
The molecular structure of glasses plays a crucial role in deciding their bioactivity. 
Therefore, understanding their structural features allows designing new glasses with 
improved chemical durability and tailored biodegradability for specific applications. In the 
present study, MAS-NMR results are presented in Figure 4.1.2, the 
29
Si spectra (Figure 
4.1.2a) for all the investigated glasses depict the dominance of Q
2
 (Si) structural units in the 
glasses. In particular, the broad 
29
Si spectra centred around –81 to –82 ppm indicative of Q2 
as predominant silicate species [188]. Further, with decrease in the amount of SiO2 no change 
in structure was observed (TCP: 10  40 wt%), however a slight chemical peak shift towards 
more negative ppm was observed. 
 Further, we could not observe any significant change in peak maxima for spectra of 
31
P nucleus with predominance of an orthophosphate-type environment (Figure 4.1.2b). In 
fact, the observed chemical shifts, 1–2 ppm, are close to that of the calcium orthophosphate 
(3.1 ppm) and that of the amorphous magnesium orthophosphate (ca. 0.5 ppm) [137]. 
However, it should be noticed that bioactivity is not solely a function of glass structure and 
also depends on their chemical nature [142].
  
According to Tilocca and Cormack [143], low 
contents of P2O5 in glasses (~ 10 mol%) enhance their bioactivity while further increase in 
P2O5 amount affects the bioactive nature of glasses in a negative manner.  
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Figure 4.1.2 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
4.1.2.3 Apatite formation and chemical degradation of glasses 
 Immersing the materials in SBF is a relatively simple technique to evaluate the 
biomineralization activity and this method can be regarded as a first approach to assess 
bioactivity in vitro. However, even the preparation conditions of the SBF solution are tricky 
and there exist a lack of consensus regarding the usefulness of SBF tests in the literature 
[144]. But there are a large number of evidences about the good correlation between the bio-
mineralization ability a given bioactive material (understood as the ability to form a 
carbonated apatite layer onto its surface) in SBF and its performance in vivo [145, 146]. 
The in vitro bioactivity analysis by immersion in SBF solution revealed the presence 
of apatite formation in all the glass powders. The results presented here have been mainly 
explained with an emphasis on glasses TCP-20 and TCP-40 due to their high potential for use 
in human biomedicine. The XRD patterns observed for all as-quenched glasses (Figure 4.1.1) 
exhibit an amorphous halo, thus depicting the absence of any crystallinity. However, the X-
ray diffractograms of investigated glasses (including 45S5 Bioglass
®
) after soaking in SBF 
solution for time durations varying between 1  12 h (Figure 4.1.3) showed considerable 
differences in comparison to the diffractograms of their respective parent glasses. A small X-
ray peak at 2q = 31.77º corresponding to the formation of crystalline HA [(Ca5(PO4)3OH; 
ICDD: 00-09-0432] can be seen for glass TCP-40 after immersion in SBF for 1 h, while 45S5 
Bioglass
®
 suggests that calcite (CaCO3; ICDD: 01-083-0577) formation under similar 
conditions (Figure 4.1.3a). The XRD pattern for glass TCP-20 depicted a broad amorphous 
halo after 1 h immersion in SBF (Fig. 4.1.3a) while the infrared spectra of this glass (Figure 
4.1.4) 
-200-150-100-50050
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Figure 4.1.3 X-ray diffractograms of glass powders after immersion in SBF solution for (a) 1 h; (c) 3 h; 
(c) 12 h, (d) 3 days and (e) 7 days. C refers to calcite while HA refers to hydroxyapatite. 
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exhibited significant structural differences before and after immersion in SBF. As is 
evident from Figure 4.1.4, a strong low frequency band centred at ~ 480 cm
1
, ascribed to a 
deformation mode of silica layer that develops on the dissolving glass particles could be seen 
in glass TCP-20 after immersion in SBF solution for 1 h [83]. The main IR band now occurs 
at 1080 cm
1
 and a nearby shoulder, centred at ~1235 cm
1
 attributed to Si-O-Si vibration  
can be observed [147], owing to the interfacial formation of high-area silica gel layer, as 
postulated in Hench’s inorganic reaction set [20]. These features were common for all the 
glasses investigated in present study. Further, band at ~ 1440 cm
1
 along with another one at 
~880 cm
1
 present in all glasses corresponds to incorporation of carbonate into the apatite, 
resulting in hydroxyl carbonated apatite, rather than stoichiometric HA [83].  
Furthermore, a small broad band was observed in case of glass TCP-20 (Figure 4.1.4) 
at ~565 cm
1
 after immersion in SBF solution for 1 h. This is the most characteristic region 
for apatite and other phosphates as it corresponds to PO bending vibrations in a PO4
3
 
tetrahedron. A single peak in this region suggests the presence of non-apatitic or ACP, which 
is usually taken as an indication of presence of precursors to HA. Apatitic PO4
3
 groups have 
characteristic split bands at ~560 and 600 cm
1
, with a third signal at ~575 cm
1
 observed for 
crystallites of small size [83, 87]. However, apart from a band at ~565 cm
1
 as is evident in 
Figure 4.1.4, no other bands in this region could be observed for glass TCP-20 even after 12 h 
of immersion in SBF solution while the XRD data of the same sample as presented in Figure 
4.1.3c reveals the presence of sharp peak corresponding to formation of HA along with minor 
amounts of calcite. It is noteworthy that no HA formation could be observed instead a small 
X-ray peak at 2q = 29.41º corresponding to the presence of calcite was observed in 45S5 
Bioglass
®
 even after 12 h of immersion in SBF solution (Fig. 4.1.3c) 
The increasing tendency towards development of ACP rich layer leading to formation 
of crystalline HA with increasing TCP content in glasses may be explained on the basis of 
decreasing Mg concentration in glasses. It has been reported that Mg tends to associate 
preferentially with phosphorus at glass surface, which consequently leads to the decrease in 
concentration of apatite like-calcium phosphate domains on the glass surface that are 
supposed to act as nucleation centres for apatite formation [148]. Also, glass compositions 
containing phosphorus are known to be more soluble and exhibit faster release of silica in 
solution. Further, isolated orthophosphate groups can be directly released without breaking 
any chemical bond; thus high rate of formation of HA in TCP containing glasses is likely 
related to the high availability of this species [149].  
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Figure 4.1.4 FTIR spectra of glass powder (TCP-20) before and after immersion in SBF 
solution for time durations varying between 1 h – 12 h. 
 
The XRD data after 3 days of immersion in SBF solution (Figure 4.1.3d) depicts the 
highly amorphous character of glasses with a small phase reflection corresponding to HA in 
composition TCP-20 and TCP-40. Similar structural features could be observed in all the 
investigated glasses. Since intense ionic exchanges occur at the bioactive glass surface that 
cause major changes in the degree of super-saturation for HA formation in biological fluids, 
the potential for each glass to form an apatite layer can be extrapolated from the 
corresponding evolution of the degree of super-saturation. According to Lao et al. [122], the 
degree of super-saturation may be defined as: SD = Q/Ksp, where Ksp is the solubility product 
of HA in aqueous solution while Q is the ionic activity product for the formation of HA. 
Therefore, the solution and HA mineral phase reach equilibrium when SD = 1. For SD < 1, 
the dissolution of HA mineral phase is favoured, while the solution is supersaturated with 
respect to HA mineral and its precipitation is favoured when SD > 1. In the present scenario, 
during the initial hours of immersion of the glass in SBF, the SD increases because of 
dealkalinization of the glass surface, while the formation of a silica-rich layer provides 
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regions of low interfacial energy, thus providing favourable sites for the nucleation of HA. 
However, the decreasing intensity of the XRD phase reflections for the HA phase in 
investigated glasses after 72 h of immersion in SBF may be attributed to the changing degree 
of super-saturation owing to the refreshing of the SBF solution after every 48 h. 
An increase in immersion time of glasses in SBF solution led to complete 
disappearance of calcite from the investigated glasses and depicted the formation of HA as 
the only crystalline phase as shown in Figure 4.1.3d. However, calcite still persisted in 45S5 
glass as a minor phase along with HA even after 7 days of immersion in SBF.  According to 
Jones et al. [150], the in vitro apatite forming ability of 45S5 glass decreases with increasing 
glass powder / SBF ratio beyond 0.002 g ml
1
 as further increase in this value will favour the 
formation of calcite at the expense of HA on the glass surface. In the present study, the 
calcite formation in 45S5 glass may be attributed to the fact that we are exactly at this 
threshold value of glass powder / SBF ratio. It is noteworthy that Ca-carbonate phases present 
a higher solubility product (Kps calcite = 1.7 × 10
−8
) with respect to HA 
(Kps HA = 1.6 × 10
−58
) at pH 7.4 [83] and this should favour the precipitation of the latter. 
Nevertheless, Ca-carbonate phases are likely to present a higher rate of crystallization 
because of the presence of basic surface species (for instance: O
2
 ions, OH

 ions or 
coordinatively unsaturated cation-anion pairs), which can coordinate with CO2, thus giving 
rise to many possible types of carbonate like species. According to Cerruti and Morterra 
[147], the carbonate formation in silica-based bioactive glasses occurs only if both CO2 and 
an excess of water are present at the same time as it is believed that the gas-phase admission 
of both CO2 and an excess of water mimics the long-lasting process of carbonate formation.  
One of the relevant parameters in the study of glass dissolution is the kind of medium 
used. The pH and ionic strength of the medium play an important role in the rate at which the 
glasses dissolve. The variation in pH of Tris–HCl with respect to TCP content in glasses is 
presented in Figure 4.1.5. A slight increase in pH from 7.4 to 8.4 was observed in case of 
Tris-HCl with increasing TCP content in glasses while highest pH value of 9.7 was observed 
for the 45S5 glass, which exhibited higher dissolution rate than the investigated glasses. In 
the present study, an increasing pH of simulated solution with increasing TCP content in the 
glasses may be attributed to the increasing dissolution of Ca and Mg ions from glasses due to 
the dissolution of charged ion pairs (Ca-F)
+
 or (Mg-F)
+
. 45S5 glass exhibited the highest 
weight loss in Tris-HCl (3.7%).  
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Figure 4.1.5 Graph depicting changes in pH of solution and weight loss of glass powders 
after immersion in Tris-HCl for 120 h. 
 
Among all the investigated glasses, an increment in TCP content in glasses did not 
affect the weight loss significantly as it varied between 1.6–1.7% (Fig. 4.1.5). 
  
4.1.2.4 Differential thermal analysis  
The DTA plots of fine powders with a heating rate (β) of 20 K min−1, shown in Figure 
4.1.6, feature an endothermic dip in the temperature interval of 750 – 755 ºC corresponding 
to Tg before Tc followed by a well-defined single exothermic crystallization curve for glasses 
TCP-10, TCP-20 and TCP-30. We could not observe any significant differences in the 
variation of Tg values with varying Di/TCP ratio in the glasses. 
Further, the presence of a single crystallization exothermic peak in TCP-10 and TCP-
20 samples anticipates that the resulting glass-ceramics are formed either by single crystalline 
phase, or derived from an almost simultaneous precipitation of different crystalline phases 
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(TCP-30); while the appearance of two distinct crystallization peaks (Tp1 and Tp2) in glass 
TCP-40 points towards the formation of two different crystalline phases. The Tp values for 
glasses TCP-10 and TCP-20 are almost similar (i.e. 932 ºC) while further decrease in Di/TCP 
ratio resulted in shifting of Tp to 907 ºC for glass TCP-30 and 843 ºC (Tp1) for glass TCP-
40. 
  
Figure 4.1.6 DTA thermographs of glasses at a heating rate of 20 K min
−1
. 
 
This decrease in Tp values with increasing TCP content in glasses may be attributed to 
their increasing crystallization tendency as will be shown further in section 4.1.6.  
 
4.1.2.5 Sintering and crystallization behaviour of glasses 
The prerequisite for optimizing the fabrication of glass-ceramics scaffolds is to 
understand the sintering conditions of glass powders and the interaction between sintering 
and crystallization of the material. By knowing the structural transformations which occur 
during the heat treatment of glasses, the scaffold fabrication process can be tailored, like in 
terms of achieving the highest possible density of the sintered scaffolds and the required 
crystallinity which itself controls the material´s bioactivity. It is due to this reason that a 
comparison between DTA and HSM thermographs obtained under the same heating 
conditions can reveal a great deal of information in this regard. In general, two different 
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trends can be observed related to the sintering and crystallization behaviours of the glasses: 
(i) Tc occur after the final sintering stage. Therefore, under such circumstances, sintering and 
crystallization are independent processes. This is the required trait to obtain well sintered 
glass-ceramic scaffolds with good mechanical properties; (ii) Tc appears before maximum 
density has been reached. In this case, the crystallization process starts before complete 
densification, thus, preventing sintering.  
In the present study both of the above mentioned trends related with sintering and 
crystallization behaviour of glasses have been observed depending on the glass compositions. 
Figure 4.1.7 presents the DTA and HSM thermographs of glasses TCP-20 (Figure 4.1.7a) and 
TCP-40 (Figure 4.1.7b), respectively at b = 5 K min1 depicting a single stage sintering 
behaviour for the investigated glass compositions while Figure 4.1.7c presents the changes in 
different thermal parameters with respect to variation in TCP content in glasses. As is evident 
from Figure 4.1.7c, the values for temperature of first shrinkage (TFS; log  = 9.1 ± 0.1, 
where  is viscosity; dPa.s) and temperature of maximum shrinkage (TMS; log  = 7.8 ± 0.1) 
exhibited a slight decrease with increasing TCP content in glasses while values for Tc showed 
an initial increase and then a steep decrease with decreasing Di/TCP ratio.  
With respect to TMS and Tc, different trends were observed for the investigated glass 
compositions which can be explained with the aid of sinterability parameter (Sc), where Sc = 
Tc - TMS. The parameter Sc is the measure of ability of sintering versus crystallization: the 
greater this difference, the more independent are the kinetics of both processes [151]. The 
estimated error for data points is smaller than ± 10%, approximately equal to the size of the 
data symbols. As can be seen from Figure 4.1.7c, the value of parameter Sc increased with 
increasing TCP content in the glasses until 20 wt%.  However, further decrease in Di/TCP 
ratio led to a gradual decrease in the value of Sc with glass TCP-40 (Sc = - 24 ºC) exhibiting 
the lowest value for Sc. These results imply that sintering precedes crystallization in glass 
compositions TCP-10, TCP-20 and TCP-30 with glass composition TCP-20 exhibiting better 
sintering ability in comparison to the other investigated compositions. 
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Figure 4.1.7 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions (a) TCP-20 and (b) TCP-40 at the heating rate of 5 K min
1
; (c) influence of 
TCP content on different thermal parameters of glasses obtained from DTA and HSM, 
respectively 
 
Therefore, we can expect well sintered, dense and mechanically stronger glass-
ceramics from composition TCP-20 in comparison to its counterparts. On the other hand, 
crystallization precedes sintering in glass TCP-40 which should result in a poorly sintered 
and mechanically weak glass-ceramic material. The decreasing/poor sintering ability for 
glasses TCP-30 and TCP-40 is mainly due to predominance of FA in these glasses (as has 
been presented ahead in XRD results) which masks the influence of Di which is a crystalline 
phase with good mechanical strength. 
Figure 4.1.8 presents the SEM images of the glass powder compacts after sintering in 
temperature interval of 800900 ºC for 1 h. In agreement with HSM and DTA results, the 
sintering of glass powder compacts at 800 ºC resulted in well sintered and dense glass-
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powder compacts for compositions TCP-10 (Figure 4.1.8a), TCP-20 (Figure 4.1.8b) and 
TCP-30 (Figure 4.1.8c), respectively, while TCP-40 resulted in a poorly sintered and 
mechanically weak glass powder compact.  
 
  
  
 
Figure 4.1.8. SEM images of glass powder compacts (a) TCP-10, (b) TCP-20, (c) 
TCP-30, after sintering at 800 ºC for 1 h, respectively while (d) and (e) represent 
glass composition TCP-10 after sintering at 900 ºC for 1 h. 
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Figure 4.1.9 X-ray diffractograms of glass compositions after sintering at (a) 800 ºC; (b) 900 
ºC and 1000 ºC, respectively. 
 
The flexural strength values as obtained for composition TCP-20 sintered at 800 and 
850 ºC are 85 ± 6 MPa and 135 ± 9 MPa, respectively. The qualitative crystalline phase 
analysis of sintered glass powders as presented in Figure 4.1.9 revealed that compositions 
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TCP-10 and TCP-20 were completely amorphous after sintering at 800 ºC while FA (ICDD 
card: 71-880) precipitated as the major crystalline phase in compositions TCP-30 and TCP-40 
along with Di (ICDD card: 78-1390) and the intensity of XRD peaks increased with 
increasing TCP content in glasses, thus, indicating an increase in crystallinity (Figure 4.1.9a). 
These results are in co-relation with the microstructural evolution of sintered glass-ceramics 
as studied through SEM. Figure 4.1.8c depicts the formation of crystals beneath the 
amorphous layer in composition TCP-30, thus depicting the presence of crystallinity. Further 
increase in sintering temperature to 850 ºC (Figure 4.1.9b) and 900 ºC (Figure 4.1.9c) 
resulted in appearance of crystallinity in all the investigated glass compositions with Di as the 
major crystalline phase in compositions TCP-10 and TCP-20, thus rendering them good 
sintering ability while FA dominated the crystalline phase assemblage in compositions TCP-
30 and TCP-40, thus leading to their poor sintering ability. The SEM images (Figure 4.1.8d 
and 4.1.8e) obtained from glass-ceramics TCP-10 after sintering at 900 ºC depict the presence 
of thin lamellar crystals typical for Di intermixed with needle like FA crystals (Figure 
4.1.8e). The results obtained in the present study are different from those obtained by 
Kamitakahara et al. [103] in their study related with synthesis of glass-ceramics in Di-TCP 
binary system and also from the results of Magallanes-Perdomo et al. [152] where they 
investigated the devitrification behaviour of a eutectic glass-ceramic composition in 
wollastonite-TCP binary system as in both the earlier studies, TCP crystallized in glass-
ceramics the form of -TCP [152]  or b-TCP [103] along with other crystalline phases. 
However, in the present study, no trace of crystallization of TCP has been observed as its 
growth seems to be masked by FA. 
 
4.1.2.6 Cellular response to sintered glass powder compacts 
The cell proliferation on the sintered glass powder compacts and control during 
culture for 3, 7 and 14 days is shown in Figure 4.1.10. For the control, cells proliferated 
actively for up to 7 days and showed a plateau with prolonged culture for 14 days. 
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Figure 4.1.10 Proliferation behaviour of the MSCs cultured on the glass compacts 
(TCP-10 and TCP-20) and the tissue culture plastic used as a control during the periods 
for 3, 7 and 14 days. MSCs derived from rat bone marrow were used for the assay. 
Statistically significance difference was noticed between the groups; control vs. TCP-10 
at day 3; control vs. TCP-10 or TCP-20 at day 7 (p < 0.05, ANOVA, n = 3) 
 
On the other hand, the cell proliferation appeared to be relatively slower for 
investigated glass compositions in the culture for up to 7 days. However, cells continued to 
grow with prolonged culture period reaching to the proliferation level of the control at 14 
days, featuring good proliferative potential of cells upon the glass disc substrates. The 
morphologies of cells grown on the glass disks for 7 days are shown in Figure 4.1.11. 
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Figure 4.1.11 SEM images of the MSCs grown on the sintered glass powder compacts 
(TCP-10 and TCP-20) during culture for 7 days. Cells spread well on both glass 
samples in intimate contacts with the underlying substrates and have active cytoskeleton 
processes with highly elongated filopodia. Some surface cracks associated with the 
sample treatment for SEM are observed. 
 
 As is evident from the images, cells spread well on both the glass compositions in 
intimate contacts with the underlying substrates and have active cytoskeleton processes with 
highly elongated filopodia. The results on cell proliferation and growth morphology suggest 
that the developed glasses provide suitable substrate conditions for the MSCs to adhere and 
proliferate.  
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Figure 4.1.12 Alkaline phosphatase activity of the MSCs during culture for 7 and 14 
days on the glass compacts (TCP-10 and TCP-20) and tissue culture plastic control. 
Statistically significant higher level was noticed on the glass samples with respect to 
control at both periods; *p < 0.05, ANOVA, n = 3.  
 
The effect of the osteogenic differentiation was further investigated by the ALP 
activity of cells grown on the glass disks for 7 and 14 days. The data plotted in Figure 4.1.12 
shows that ALP activity level was significantly higher on both types of glass compositions 
with respect to that on the control at all culture periods. In particular, the increase in the ALP 
level from 7 to 14 days was much higher in the glasses than in the control. ALP is known as 
one of the essential osteogenic markers of cells including MSCs, particularly at an early stage 
of osteogenic differentiation. Therefore, the significantly stimulated ALP level observed in 
the MSCs cultured on the glass-ceramics samples indicates that the materials developed 
herein are effective in modulating the functions of MSCs into the lineage of bone cells, 
consequently highlighting their potential usefulness for bone regeneration.  
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4.2.2 Conclusions 
We have tried to shed some light e influence of varying Di/TCP ratio on the structure, 
biodegradation, and sintering-crystallization behaviour of glasses in the Di-FA-TCP system 
has been presented. The as obtained results depict the potential of investigated glass 
compositions for their application in human biomedicine. The structure of the investigated 
glasses is dominated by Q2 (Si) units while phosphorus is predominantly in orthophosphate 
type environment. Some of the investigated glasses exhibited higher rate of bioactivity in 
vitro in comparison to 45S5 Bioglass® during initial 12 h of immersion in SBF solution. The 
glass with nominal composition Di50 – FA10 – TCP40 (wt%) (Labelled as TCP-40) 
exhibited hydroxyapatite formation on its surface within 1 h of its immersion in SBF while 
glass TCP-20 with composition Di70 – FA10 – TCP20 (wt%) exhibited apatite formation 
after 12 h of its immersion in SBF. All the glasses exhibited considerably lower weight loss 
in comparison to 45S5 Bioglass® in Tris-HCl. Sintering preceded crystallization in glass 
composition with TCP content varying between 10 – 30 wt.%. Further increase in TCP 
content in glasses deteriorated the sintering ability of glass powders considerably. The glass 
composition TCP-20 exhibited superior sintering ability in comparison to other investigated 
glasses. The resultant glass powder compacts were completely amorphous after sintering at 
800 ºC with a three-point flexural strength of ~85 MPa. Di crystallized as primary crystalline 
phase in compositions with TCP content 10 and 20 wt.%, respectively after sintering at 850 
ºC, while further increase in TCP content in glasses suppressed the formation of Di with FA 
being crystallized as the major phase. The sintered (but amorphous) glass powder compacts 
(TCP-10 and TCP-20) significantly increased the osteogenic differentiation of MSCs with 
respect to the culture plastic control, as assessed by the alkaline phosphatase activity. 
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4.2 Structural role of zinc in biodegradation of alkali-free bioactive glasses 
4.2.1. Introduction 
Zinc is an important element that plays a vital role in bone formation and resorption, 
which should be considered in the design of bone graft compositions aimed at bone 
regeneration and TE applications. Owing to the above-mentioned beneficial aspects of zinc in 
human metabolism in section 2.5.3, and considering the ion releasing ability of glasses in 
aqueous medium, bioactive glasses incorporated with zinc have gained considerable attention 
in the recent years for various TE applications. The increasing interest in Zn-containing 
bioactive glasses has resulted in a multiple-fold increase in the number of scientific 
publications in this area during last decade [82, 125, 153-160].  
Despite the interesting studies, there exists a significant disparity among the results 
reported in literature with respect to influence of Zn
2+
 and its content on biodegradation, 
apatite forming ability, osteoblast activity, anti-inflammatory response and angiogenic 
behaviour in bioactive glasses [25, 161]. All these issues have been recently reviewed by 
Hoppe et al. [44] and therefore, will not be discussed in the present section. Apart from that, 
another major concern with most of the zinc-containing bioactive glass compositions studied 
until now is that they are either based on- or inspired by 45S5 Bioglass
®
 [82, 120, 157, 162, 
163] which contain significant amounts of alkali content.  
In the light of above mentioned facts, it becomes necessary to investigate the 
influence of Zn
2+
 on different properties of bioactive glasses but with their chemical 
compositions completely different from that of 45S5 Bioglass
®
 in order to obtain a 
comprehensive database highlighting the precise function and mechanism of zinc in 
regulating various biological processes in human body. Such an attempt has been made by 
Bini et al. [164] and Saino et al. [165] but on alkali-free sol-gel derived glass in the system 
SiO2P2O5CaO. It is usually difficult to compare the results obtained on sol-gel glasses with 
those from melt-quenched glasses due to the high specific surface area and moisture content 
of the former along with the heterogeneous chemical environment of network modifier 
species in comparison to melt-quenched glasses [166]. 
The very promising glass composition TCP-20 discussed in section 4.1 was adopted 
as the starting point for synthesis new series of glasses and was developed by partial 
substitution ZnO for MgO in the same composition with the aim to study the effect of zinc on 
structure and biodegradation of melt-quenched alkali-free glasses designed in 
CaOMgOSiO2P2O5CaF2 glass system. 
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4.2.2 Results and discussion 
4.2.2.1 Glass forming ability 
For all the investigated glass compositions (mol%): 36.07 CaO – (19.24 – x) MgO – x 
ZnO – 5.61 P2O5 – 38.49 SiO2 – 0.59 CaF2, (x = 2–10) (Table 4.2.1), melting at 1570 ºC for 1 
h was sufficient to obtain bubble-free, transparent and XRD-amorphous glasses (Figure 
4.2.1). 
 
Table 4.2.1 Nominal composition of the as-designed glasses (mol%). 
 
 
Figure 4.2.1 X-ray diffractograms of as-quenched glasses. 
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Zn–0 36.07 19.24 38.49 5.61   0.00 0.59 
Zn–2 36.07 17.24 38.49 5.61   2.00 0.59 
Zn–4 36.07 15.24 38.49 5.61   4.00 0.59 
Zn–6 36.07 13.24 38.49 5.61   6.00 0.59 
Zn–8 36.07 11.24 38.49 5.61   8.00 0.59 
Zn–10 36.07 9.24 38.49 5.61 10.00 0.59 
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4.2.2.2 Glass structure 
The MAS-NMR spectrum (Figure 4.2.2) shows that ZnO substitution for MgO does 
not affect the silicate network connectivity of these glasses. The 
29
Si MAS-NMR results of all 
the glasses as presented in Figure 4.2.2a depict the dominance of Q
2
 (Si) structural units in 
the glasses. Further, only slight shift in the peak positions of spectra could be observed and 
all the spectra are centred between –81 ppm and –82 ppm, thus depicting no significant 
changes in the silicon coordination in glass structure. The findings are further supported by 
the MD simulation studies performed on the glasses which show a predominance of Q
2
 units 
ranging from 47 to 51 % from Zn-0 to Zn-10 [42]. 
  
Figure 4.2.2 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
The 
31
P MAS-NMR spectra of all the glasses show a predominance of an 
orthophosphate-type environment (Figure 4.2.2b), again in agreement with the MD results 
[42]. In fact, the observed chemical shifts, 1–3 ppm, are close to that of the calcium 
orthophosphate (3.1 ppm) and that of the amorphous magnesium orthophosphate (ca. 0.5 
ppm) [137]. The phosphate environment is therefore similar to that of 45S5 Bioglass
®
 [127, 
167].  
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4.2.2.3 Apatite forming ability of glasses 
 The X-ray diffractograms of investigated glasses after soaking in SBF solution for 
time durations varying between 1 h  7 days (Figure 4.2.3) showed considerable differences 
in comparison to the diffractograms of their respective parent glasses. A phase reflection at 
2q = 31.77º corresponding to the formation of crystalline hydroxyapatite [HA; 
(Ca5(PO4)3OH; ICDD: 00-09-0432] is evident in the X-ray diffractograms of glasses with 
ZnO concentration varying between 4 – 10 mol% after their immersion in SBF for 1 h 
(Figure 4.2.3a). It should be noted that the HA formed in such experiments in carbonated HA 
and not stoichiometric crystalline HA. With further prolonging the immersion time, the 
intensity of the main XRD peak of HA increased particularly for the Zn-6 composition, while 
showed a fading trend for the other bioactive glasses (Figure 4.2.3b – 4.2.3d). Interestingly, at 
the conclusion of 7 days, HA formation was observed only for parent glass Zn-0 while no Zn-
containing glass exhibited clear evidences for the formation of HA. Various reasons may be 
cited for such a trend observed from XRD data for bioactive glass dissolution and HA 
formation in SBF solution. The two main plausible factors behind this behaviour may 
include:  
1. Influence of ZnO/MgO ratio on HA formation in bioactive glasses: Magnesium is 
known to delay the HA formation in vitro as well as in vivo. According to Pariente et 
al. [148], during in vitro SBF tests, magnesium tends to associate with phosphorus on 
the glass surface due to which apatite-like calcium phosphate domains are barely 
detected in magnesium containing glasses. Further, both Mg
2+
 and Zn
2+
 when present 
together also inhibit HA crystal growth. 
2. Solution pH and degree of saturation: The pH of the SBF solution and its degree of 
saturation play crucial roles in deciding the nature of crystalline products as has been 
discussed in our study [23]. In the present study, the initial pH of SBF solution was 
7.28 while the pH of SBF solution after 24 h of glass powder immersion varied 
between 7.7 – 7.95, irrespective of the ZnO concentration in glasses. It is now 
generally agreed that, both in vitro and in vivo, precipitation reactions at sufficiently 
high supersaturation and pH result in the initial formation of ACP with molar 
calcium/phosphate ratio of about 1.18 – 2.50 [168, 169]. The chemical composition of 
ACP is strongly dependent on the solution pH: ACP phases with Ca/P ratios in the 
range of 1.18:1 precipitated at pH 6.6 to 1.53:1 at pH 11.7 and even as high as 2.5:1 
[170].   
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Figure 4.2.3 X-ray diffractograms of glass powders before and after immersion in SBF 
solution for (a) as quenched glasses (b) 1 h (c) 6 h (d) 3 days and (e) 7 days. HA refers to 
hydroxyapatite. 
 
The FTIR spectra of glasses after immersion in SBF solution for 1 h (Figure 4.2.4a) 
depicts several changes in the glass structure that occurred due to the reaction between glass 
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powder and SBF. The strong low frequency band in the region 350 – 650 cm−1 has been split 
into small bands at ~480 cm
−1
, ~570 cm
−1
 and ~620 cm
−1
 as is evident from Figure 4.2.4a. 
The band centred at 480 cm
−1
 can be ascribed to a deformation mode of silica layer that 
develops on the dissolving glass particles while small broad bands at 570 cm
−1
 and 620 cm
−1
 
are characteristic for apatite and other phosphates as it corresponds to P–O bending vibrations 
in a PO4
3−
 tetrahedron. A single peak in this region (570 cm
−1
) suggests the presence of non-
apatitic or ACP, which is usually taken as an indication of presence of precursors to HA. It is 
noteworthy that apatitic PO4
3−
 groups have characteristic split bands at ~560 and 600 cm
−1
, 
with a third signal at ~575 cm
−1
 observed for crystallites of small size [83, 87].  
Figure 4.2.4 FTIR spectra of glass powders after immersion in SBF solution for (a) 1 h and 
(b) 24 h. 
 
Further, a small band at ~1440 cm
−1
 along with a broad but intense band at ~850 cm
−1
 
present in all glasses corresponds to incorporation of carbonate into the apatite, resulting in 
hydroxy carbonated apatite, rather than stoichiometric HA [83]. The most interesting feature 
of the FTIR data on zinc-containing glasses obtained after 1 h of immersion in SBF solution 
is the complete absence of the SiOSi vibration band in the region 12001270 cm−1 which 
corresponds to the formation of silica gel layer, as postulated in Hench’s inorganic reaction 
set [20]. It is interesting due to the fact that this band is highly evident in the FTIR spectra of 
zinc-free parent glass, Zn-0. An increase in SBF immersion time to 24 h did lead to the 
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appearance of an absorption band at ~1220 cm
−1
 in glasses with lower ZnO content (26 
mol%) but this band was still absent in glasses with ZnO content varying between 8 and 10 
mol% as shown in Figure 4.2.4b. Consequently, the increase in immersion time resulted in 
either sporadic or minimal apatite formation on glass surface during 7 days of immersion in 
SBF solution (Figure 4.2.3c – 4.2.3e). Similar observations regarding the absence of silica gel 
layer in bioactive glasses have been reported in zinc containing glasses by Oudadesse et al. 
[162], Kamitakahara et al. [158], Lusvardi et al. [82] and Ebisawa et al. [171].  
 
4.2.2.4 Chemical degradation of glasses in Tris-HCl 
The variation in pH of Tris–HCl with respect to ZnO content in glasses is presented in 
Figure 4.2.5. A slight decrease in pH from 7.4 to 7.2 was observed with increasing ZnO 
content in glasses. It is noteworthy that pH value of 9.7 has been reported for Tris-HCl during 
chemical degradation of 45S5 Bioglass
®
 as reported in the section 4.1, thus exhibiting higher 
dissolution than the investigated glasses. The pH results are in good agreement with the 
weight loss data obtained for the investigated glasses as incorporation of ZnO in glasses 
reduced their dissolution which is evident from their weight loss (Figure 4.2.5). 
All the glasses were amorphous after immersion in Tris-HCl for 120 h as shown in 
Figure 4.2.6, thus negating the possibility of any chemical reaction between the dissolution 
products 
  
 
Figure 4.2.5 Graphs depicting the change in solution pH and weight loss of glass 
powders after immersion in Tris–HCl.  
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The decrease in pH value of Tris-HCl with incorporation of ZnO is due to the low 
leaching of Mg and Ca ions from glasses as shown in Figure 4.2.7. The slower Ca release 
from the bioactive glasses with increasing ZnO content may be one of the reasons for slow 
HA formation on bioactive glass surface. The concentration of zinc ions leached out from 
glasses after 120 h of immersion in Tris-HCl increased with increase in ZnO content in 
glasses and varied between 0.06 ppm (for Zn-0) to 8 ppm (Zn-8). The zinc release profile of 
glasses is important from the fact that the role of major functional ions (Ca, Mg, Si, P) in 
bone regeneration and soft TE has been well established and documented [28, 104, 125, 172]. 
However, the influence of different functional ions which although present in trace quantities 
in human body are essential for good metabolism is still ambiguous. In particular case of 
zinc, its role in human metabolism has been shown to depend on its ionic release profile in 
body fluids and is therefore dose dependent [120, 157]. 
 
 
Figure 4.2.6 X-ray diffractograms of glass powder after 120 days of immersion in 
TRIS-HCL 
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Figure 4.2.7 ICP-AES plots of elemental concentrations of Ca, Mg, P, Si and Zn in Tris–HCl 
after 120 h of immersion of glass powder. It should be noted that Si refers to SiO4
4
 and P 
refers to PO4
3
 species. 
 
4.2.2.5 Discussion  
  The role of zinc on structure and bioactivity of glasses has been extensively studied 
in literature. For example, Aina et al. [120, 173] studied the influence of zinc on surface 
reactivity and cytotoxicity of 45S5-based glasses while Courthéoux et al. [174] investigated 
the influence of Zn
2+
 on alkali-free glasses in the CaOP2O5SiO2 and CaOSiO2 systems, 
respectively. However, all the above mentioned studies have been focused upon sol-gel 
derived glass compositions which have high surface area due to inherent porosity, different 
surface chemistry in comparison to melt-quenched glasses. Therefore, a comparison between 
the results obtained on sol-gel derived and melt-quenched glasses is not plausible.  
Some studies have also been reported on the influence of Zn
2+
 on the surface 
reactivity and biological activity of melt-quenched glasses. However, most of the results 
obtained in these studies are in contradiction with each other. For example: according to Aina 
et al. [120] and Lusvardi et al. [82], the incorporation of ZnO in 45S5 glass reduces its 
solubility but still apatite formation (when immersed in simulated body fluids) takes place 
within few hours to few days of time span. Also, they reported that ZnO enhances the 
biological activity of glasses in vitro as well as in vivo. On the other hand, according to Haimi 
et al. [175], zinc addition in bioactive glasses has no significant effect on the DNA content, 
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ALP activity and osteopontin concentration of human adipose stem cells. Similar results have 
also been reported by Popp et al. [176], who studied the influence of soluble zinc from ACP’s 
on the proliferation of rat bone marrow stromal cells. 
Despite the significant disparity in the results related with the biological behaviour of 
zinc, one result that is coherent among almost all the glass compositions reported in literature 
irrespective of their synthesis route is their decreasing solubility with increasing zinc content. 
A similar behaviour has been observed in the present investigation, as chemical degradation 
of glasses in Tris-HCl decreases with their increasing Zn
2+
 concentration. The implications of 
decreasing solubility with increasing zinc content in glasses may be interpreted on the basis 
of the solubility of parent glass, for example, according to Aina et al. [120], incorporation of 
Zn
2+
 in 45S5 glass is beneficial owing to the high solubility of the latter which leads to a 
significant increase in the pH of physiological fluid, thus affecting the proliferation of 
endothelial cells. However, the precise reason for decreasing solubility with zinc 
incorporation in glasses is still ambiguous as some studies explain it on the basis of influence 
of zinc on glass structure [162, 173] while others discuss it as a function of chemical 
composition and surface chemistry of glasses [177]. According to Aina et al. [173], the zinc 
species in alkali-free bioactive glasses are found in a tetrahedral environment, and can 
enhance the glass reticulation by forming SiOZn inter-tetrahedral links. Similar results on 
the role of Zn in bioactive glasses irrespective of its concentration have also been reported by 
Linati et al. [110] on zinc-doped 45S5 Bioglass
®
. For the present compositions, the MD 
simulations studies [42] have shown that both Zn
2+
 and Mg
2+
 are primarily present in five-
fold coordination, which appears reasonable considering the similar ionic radii of Mg
2+
 (0.65 
Å) and Zn
2+
 (0.74 Å) [178]. The intermediate role of zinc is well documented in literature, 
and therefore depending on the glass composition and its local environment, Zn
2+
 can be a 
four-coordinated weak network former as has been suggested for traditional bioactive glasses 
or five-coordinated as has been observed in the present study [179]. In general, zinc has been 
shown to exhibit a marked preference for tetrahedral coordination in simple alkali silicate 
glasses [180] which has been the case with most of the studies based on Zn-doped 45S5 
Bioglass
®
 or its alkali-containing derivatives. However, with increasing Zn/modifier ratio, the 
ratio of six – to fourfold coordinate Zn species is reported to increase due to the availability 
of charge compensating modifier cations [180, 181]. Further lack of any significant changes 
in the silicate network connectivity glass by varying the Zn
2+
/Mg
2+
 ratio indicates towards the 
similar co-ordination of Zinc to magnesium.  
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The decreasing glass degradation and reduced HA formation in the present case may 
be attributed to the ability of zinc to promote enhanced inter-tetrahedral cross-links as 
observed in MD simulations [42] which in combination with constant silicate network 
connectivity enhances the chemical durability of the glasses. The way in which a modifier or 
intermediate cation involved in inter-tetrahedral cross-links between adjacent silicate 
fragments can result in a more stable glass network (with a higher resistance to dissolution) 
even without actual changes in the silicate network connectivity has been recently discussed 
[110].  
The importance of the silica-rich gel layer is usually attributed to the fact that its 
presence on the glass surface in SBF helps in inducing apatite formation while no apatite 
formation can be induced by silica glass or quartz crystal [182]. However, although 
carbonated-HA formation on glass surface during their immersion in biological fluids is 
considered to be a marker of bioactivity, recent evidence has indicated that formation of this 
HA layer is not critical for bone generation. The ionic dissolution products from bioactive 
glasses appear to stimulate the growth and differentiation of cells at the genetic level, an 
effect which has been considered to be dose dependent [28]. For example: Zn concentrations 
in the range of 2 – 8 ppm have been reported to cause damage to human osteoblasts via 
oxidative stress [157]. Similar results have been reported for endothelial cells where decrease 
in cell proliferation was observed due to toxic Zn concentration of 2.7 ppm released in the 
culture medium from a Zn-doped bioactive glass [120]. Therefore, special consideration 
should be given to the ZnO content in bioactive glasses and their release profile in body 
fluids while designing the compositions. 
 
4.2.3 Conclusions 
The effects of zinc in the biodegradation of alkali-free phosphosilicate glasses have 
been studied through a combination of MAS-NMR, FTIR, XRD and chemical degradation 
experiments An increase in the Zn
2+
/Mg
2+ 
ratio did not induce any significant change in Q
n
 
speciation and network connectivity, as revealed by MAS-NMR; however it did improve the 
chemical durability of investigated glasses (as observed from Tris-HCl studies) which 
consequently suppressed the apatite (carbonated) forming ability of glasses in simulated body 
fluid. The influence of zinc on suppressing the apatite forming ability of glasses has been 
explained on the basis of the constant silicate network connectivity of the combined with the 
previously suggested ability of Zn to strengthen the glass network through non-covalent 
SiO---Zn---O-Si links. This results in a glass structure more resistant to dissolution in a 
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biological medium. An additional factor discussed is the potential influence of zinc on the 
surface chemistry of glasses when immersed in physiological fluids.    
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4.3 Influence of ZnO/MgO substitution on sintering, crystallization and bio-activity of 
alkali-free glass-ceramics 
4.3.1 Introduction 
 Bioactive glasses and glass-ceramics are used in a wide range of applications: bulk 
implants to replace bones or teeth, coatings to anchor orthopaedic or dental devices, or in the 
form of powders, as bone grafts, to fill various types of bone defects [4, 183, 184]. The 
successful development of bioactive glasses for such applications requires suitable 
densification and crystallization behaviours along the heat treatment step. Such requirements 
are also of paramount importance in other advanced applications of bioactive glasses 
involving heat treatments aiming at obtaining products such as glass fibres.  
The aim of the present section is to elucidate the effect of partial substitution of MgO 
by ZnO on the evolution of the glass structure and of the crystalline phases developed along 
the heat treatments using MAS-NMR and X-ray powder diffraction as complementary 
techniques and to study the sintering and crystallization behaviours of glass powders using 
hot-stage microscopy and differential thermal analysis, respectively. Understanding the 
sintering behaviour of the glass powders and the interactions between the sintering and 
crystallization events is of utmost importance for successfully fabricating porous scaffolds or 
coatings on metallic implants from bioactive glasses. Further, cell-culture tests using 
mesenchymal stem cells from rat bone marrow were used to investigate the in vitro behaviour 
of as designed glass-ceramics. 
 
4.3.2 Results and discussion  
4.3.2.1 Glass-forming ability 
For all the investigated glass compositions presented in Table 4.2.1, melting at 1570 
ºC for 1 h was sufficient to obtain bubble-free, transparent and XRD-amorphous glasses. 
4.3.2.2 Thermal analysis  
The DTA thermographs of fine glass powders with b= 20 K min−1 are shown in 
Figure 4.3.1. All the glass compositions feature a single endothermic dip before the Tc 
corresponding to Tg, which is followed by the exothermic crystallization effect. The 
characteristic parameters obtained from DTA thermographs are summarized in the Table 
4.3.1. In general, addition of ZnO resulted in gradually lowering Tg from 752 ºC to 718 ºC. 
The decrease in Tg can be attributed to the lower bond strength of Zn–O bond in comparison 
to the Mg–O bonds [185], which in turn reduces the rigidity of the glass network at high 
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temperature in comparison to magnesium, even though both possess similarities in size and 
charge. Further, structural rigidity of a glass network also depends on the field strength thus, 
the weak bond strength of ZnO bond than MgO can be attributed to the weaker cation field 
strength of Zn in comparison to Mg [186]. This in turn translates in lowering the viscosity of 
the glasses [187] thus, decreasing their Tc values. Such changes could be observed in glass 
powder compacts sintered at 800 ºC (not shown here) which remained amorphous for the 
lower zinc contents, and visible XRD peaks only appeared in the glasses with higher zinc 
contents. Hence, the results obtained in the present work for zinc-containing glass-ceramics 
are in good agreement with other literature reports [158, 186, 187]. 
  
Figure 4.3.1 DTA thermographs of glasses at a heating rate of 20 K min
−1
. 
 
4.3.2.3 Sintering and Crystallization behaviour  
A comparison between DTA and HSM results under the same heating conditions can 
be useful in investigating the effect of glass composition on sintering and devitrification 
phenomena. Figure 4.3.2 presents variation in the relative area and heat flow with respect to 
temperature as obtained from HSM and DTA, respectively, for all the investigated glasses at 
a similar heating rate of 5 K min
−1
. Table 4.3.2 summarizes the values of the temperature of 
first shrinkage (TFS; log  = 9.1 ± 0.1,  is viscosity in dPa s), temperature for maximum 
shrinkage (TMS; log = 7.8 ± 0.1) and ratio of the final area/initial area of the glass powder 
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compact (A/A0) at TMS1, as obtained from the HSM along with temperature for Tc and Tp, as 
obtained from the DTA of the glasses. 
(i) In general, TFS values show a decreasing tendency with increasing content of ZnO.  
(ii) Two stage sintering was observed in glasses Zn–2, Zn–4 while a gradual shift to single 
stage shrinkage was observed for glasses thereafter (Figure 4.3.2). The conclusion of 
first sintering stage is characterized at TMS1 while end of second sintering stage is 
characterized by TMS2. Interestingly, in all the glass compositions TMS1 was observed at 
temperatures lower than Tc (i.e., TMS1< Tc). Thus sintering precedes crystallization in 
all the glasses. Therefore one can expect well sintered and mechanically strong glass 
powder compacts.  
(iii) The value for TMS2 was higher than Tc in the glasses exhibiting two stage sintering 
behaviour. Thus depicting that shrinkage continued in the glass powders even after 
onset of crystallization, probably due to the existence of residual glassy phase in the 
glass-ceramics.  
(iv) Table 4.3.1 lists the values of sinterability parameter (Sc), where Sc = Tc –TMS. The 
parameter Sc is the measure of ability of sintering vs. crystallization: the greater this 
difference, the more independent are the kinetics of both processes. However, in the 
present study no particular trend could be observed for the variation of Sc. 
Nevertheless, all the investigated glasses show larger values of Sc (greater than 25 ºC) 
(26 ºC – 48 ºC) indicating good sintering behaviour.  
(v) The values of Tp varied between 895 ºC – 861 ºC. As evident from Table 4.3.1, the 
highest Tp value was observed for Zn–0. Adding increasing amounts of ZnO to the 
parent glass at the expanses of MgO resulted in gradual decreases in Tp. 
(vi) Values of A/A0 ranged from 0.63 to 0.67 (Table 4.3.1) for all the glasses implying 
towards good densification levels of 95–98%.  
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Figure 4.3.2 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions: (a) Zn2, (b) Zn4, (c) Zn6, (d) Zn8 and (e) Zn10. 
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Table 4.3.1 Thermal parameters measured from DTA and HSM at 5 K min
1
 *β = 20 K min–
1
. 
 
4.3.2.4 Effect of heat treatment of the structure 
4.3.2.4.1 Crystalline phase evolution by XRD 
The exact nature of the phases produced during the heat treatment is of great interest 
in bioactive glasses as they are intended to be often exposed to high temperature when it is 
sintered for different biomedical application. Based on DTA thermographs, Tc was 
established for all the compositions and used as a criterion for selecting the heat treatment 
temperature to induce crystallization. In agreement with HSM and DTA, well sintered and 
dense glass-ceramics were obtained after heat treating the glass–powder compacts at 850 ºC 
for 1 h. Figure 4.3.3 presents the qualitative crystalline phase analysis of the sintered glass-
ceramics as depicted by XRD data. Thus heat treating at 850 ºC for 1 h resulted in well-
defined XRD phase reflections in all the compositions indicating their crystalline nature 
(Figure 4.3.3). Di (CaMgSi2O6; ICSD: 10223) and FA (Ca5(PO4)3F; ICSD: 163790) were the 
two the primary crystalline phases formed in all the glass-ceramics, followed by rankinite 
(Ca3Si2O7; ICSD: 2282) as secondary phase. Another phase named petedunnite (CaZnSi2O6; 
ICSD: 158143) crystallized in glass-ceramics with ZnO contents > 4 mol%. Consequently, 
with the addition of ZnO for MgO, Zn
2+
 replaced Mg
2+
 in the Di, thus forming the major 
crystalline phase with higher intensity than FA. The presence of FA phase is highly desirable 
as FA is more stable than HA. Therefore, materials containing FA would be recommended 
when coatings having low dissolution rate are required [136]. 
 Zn0 Zn2 Zn4 Zn6 Zn8 Zn10 
TFS  (±5 ºC) 757 753 748 766 747 750 
TMS1 (±5 ºC) 820 809 797 817 797 795 
TMS2 (±5 ºC) – 883 888 – – 850 
Tg
*
 (±2 ºC) 752 737 733 725 722 718 
Tc (±2 ºC) 850 843 852 843 837 822 
Tp (±2 ºC) 895 881 878 870 868 861 
Sc (=Tc–TMS1) 30 48 55 26 41 27 
A/A0 at TMS1 0.66 0.67 0.66 0.63 0.65 0.67 
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Figure 4.3.3 X-ray diffractograms of glass-ceramics heat treated at 850 ºC for 1 h.  
 
Hence, with the addition of ZnO to the parent composition the intensity of XRD peaks 
corresponding to Di increased whereas the intensity of FA peaks remained almost constant 
throughout the series.  
 
4.3.2.4.2 MAS-NMR of glass-ceramics  
The XRD data was further supported by MAS-NMR studies (Figure 4.3.4). The full 
width half maximum has reduced considerably in comparison to the original glasses (Figure 
4.2.1). Further, as shown in Figure 4.3.4a, all the spectra have a sharp peak centred ~ –84.4 
ppm and a small shoulder at –74.5 ppm, which becomes more pronounced with increase of 
zinc content in glasses, where the former is close to the pure Di [188] while the latter 
corresponds to the presence of minor phase rankinite [188]. In our study of XRD, a total of 
two silicate phases pertaining to chain silicates were observed in the glass-ceramics. 
However, discrimination between these phases is difficult due to the similarity in their silica 
connectivity. Therefore the resonance around –84 ppm can be due to the contribution from Di 
and petedunnite (inosilicates).  
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Figure 4.3.4 (a) 
29
Si MAS-NMR and (b) 
31
P MAS-NMR spectra of glass-ceramics heat 
treated at 850 ºC for 1 h. 
 
Figure 4.3.4b shows 
31
P NMR spectra of glass-ceramics heat treated at 850 ºC for 1 h. 
All the spectra have a sharp peak at 3.3 – 3.5 ppm corresponding to an orthophosphate 
environment and a small shoulder at around –5.3 and –14.6 ppm indicating the presence of 
pyrophosphate units. The band at 3.5 ppm is close to that reported for FA [136]. Further, the 
formation of pyrophosphate phase around –5.3 and –14.6 ppm may be due to the reduction in 
the charge balancing cations, which migrated towards their respective crystalline phases upon 
heat treatment. Further, Di being a mechanically strong phase renders high mechanical 
strength to the resultant glass-ceramics. It is worth noting that the presence of petedunnite as 
a minor phase indicates that zinc predominantly remains in the residual glassy phase. 
 
4.3.2.5 Density and molar volume 
The experimental results showed that substitution of MgO by ZnO caused an increase 
in the density (Table 4.3.2) of the glasses due to the higher density of ZnO (5.6 g cm
−3
) in 
respect to MgO (3.6 g cm
−3
). The molar volume of the glasses increased with increase in Zn 
content in glasses. The increase in molar volume can attributed to the small bond strength of 
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Zn–O bond in comparison to Mg–O bond which results in higher bond lengths thus causing 
an expansion in the network. 
 
Table 4.3.2 Density and molar volume of the investigated glasses. 
Glasses Density (g cm
3
) Molar volume (cm
3
 mol
1
) 
Zn0 2.92 20.40 
Zn2 2.95 20.47 
Zn4 2.98 20.51 
Zn6 3.02 20.55 
Zn8 3.05 20.59 
Zn10 3.08 20.66 
 
4.3.2.6 Mechanical Behaviour 
Evaluating the mechanical strength of a biomaterial is very important while judging 
its suitability for a given intended application, such as scaffolds for bone regeneration. It is 
likely that mechanical strength of a given glass-ceramic will be dependent on the mechanical 
properties of the constituting crystalline phases, their volume fractions, the size/shape of the 
crystals formed, and on the interfacial bonding between the amorphous and crystalline 
phases.  The flexural strength was calculated for powder compacts sintered at 850 ºC. High 
flexural strength values were obtained for glass powder compacts, which can be attributed 
the predominance of Di in all glass-ceramics (Figure 4.3.5). In general, an increase in 
mechanical strength with increasing Zn contents in glasses was observed, with the highest 
mechanical strength being measured for the GC Zn–8. As deduced from HSM and DTA 
analysis, this enhancement can be attributed to two complementary reasons: (i) an improved 
sintering ability due to a decrease in the viscosity of glasses translated by decreasing Tg 
values; (ii) a more extensive subsequent crystallization promoted by the enhanced diffusivity 
of ionic species in the glassy matrix.  
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Figure 4.3.5 Flexural strength of the glass-ceramics heat treated at 850 ºC for 1 h 
 
4.3.2.7 Apatite forming ability of glass-ceramics 
The SEM-EDS results of the glass-ceramic samples before and after immersion in 
SBF solution for different time periods are shown in Figure 4.3.6. The surface morphology of 
Zn-0, Zn-4 and Zn-8 samples before immersion in SBF (Figure 4.3.6a) is similar, a situation 
that was altered for the samples immersed in SBF (Figure 4.3.6b). The EDS data was 
gathered over the entire areas shown in the SEM micrographs to assure reliable averaging of 
the signals and the scale of all EDS spectra was always kept constant to enable a direct 
comparison. Although all the spectra reveal the presence of all glass-constituting elements, 
their relative intensities changed significantly after immersing the samples in SBF. It can be 
seen that the EDS spectrum of Zn-0 sample (Figure 4.3.6a) significantly differs from those 
obtained after immersing in SBF (Figure 4.3.6b). Namely, the intensities of Ca and P became 
more and more predominant with increasing immersion time. This constitutes an obvious 
evidence of apatite formation at the surface of the samples.  
The formation of HA at the surface of ZnO-containing glass-ceramics is less obvious. 
Various reasons can be cited for this delayed bio-mineralization process in ZnO-containing 
glass-ceramics: 
1. Presence of ZnO: The delayed formation of HA can be due to inter-tetrahedral 
non-covalent linkages in the residual glassy phase. Similar results have been 
reported in our previous section. Further, the concomitant presence of Mg
2+
 and 
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Zn
2+
 inhibits HA crystal growth. Literature reports suggest a Langmuir-type 
adsorption of these ionic species at active growth sites on the HA crystals [169] 
2. Low residual glassy phase: The enhanced crystallization of ZnO-containing glass-
ceramics (lower Tc values) and the consequent lower amount of residual glassy 
phase is also expected to decrease the apatite forming ability [189]. 
 
  
Zn-0 Zn-4 
 
Zn-8 
 
Figure 4.3.6a SEM/EDS micrographs images of unpolished and non-etched glass-ceramics 
samples before soaking in SBF:  Zn-0, Zn-4,and Zn-8. 
  
 
10 µm 5 µm 
5 µm 
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Figure 4.3.6b SEM/EDS micrographs images of unpolished and non-etched glass-ceramics 
samples after soaking in SBF for 7 and 14 days: (a) Zn0, (b) Zn4, and (c) Zn8. 
 
4.3.2.8 Mesenchymal cell activity and alkaline phosphatase activity 
Figure 4.3.7 shows the cell viability on the glass-ceramics and control during culture 
for up to 7 days, as assessed by a CCK method. Apparently, the growth kinetics of glass-
ceramics with 4 mol.% ZnO was significantly higher with respect to that of tissue culture 
plastic control as well as to that of other investigated glass-ceramics. Interestingly, all other 
zinc containing glass-ceramics showed lower cell viability in comparison to that for tissue 
culture plastic.  
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Figure 4.3.7 Influence of ZnO content in glass-ceramics on cell viability during culture for 
up to 7 days, as assessed by CCK method. Glass-ceramics with 4 mol% ZnO showed highest 
growth with respect to tissue culture plastic control as well as to that of other investigated 
glass-ceramics.  
 
The representative cell growth images at day 3 and day 7 on the glass-ceramics 
samples are presented in Figure 4.3.8. The cells were not readily noticed on the Zn0 glass-
ceramic after 3 days while the cell proliferation was comparatively better on glass-ceramic 
Zn8. On the other hand, when grown on Zn4, the cells were readily observed covering the 
surface almost completely with active cytoskeletal processes and elongated filopodia 
indicating that glass-ceramic Zn4 provides favourable conditions for adherence, spreading 
and proliferation of MSCs. After 7 days, although the cell proliferation on glass-ceramics 
other than Zn4 was better in comparison to that observed after day 3 but still the glass-
ceramic Zn4 exhibited the highest rate of cell proliferation. The lower cell viability in the 
absence of zinc can be explained by the fact that after iron, zinc is the most abundant trace 
metal in human organisms and is essential for various metabolic activities as has been 
discussed above 
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Figure 4.3.8 SEM images of the MSCs grown on the sintered glass powder compacts (Zn0, 
Zn4 and Zn8) during culture for 3 and 7 days. After 7 days, cell proliferation on glass-
ceramics was better in comparison to that observed after 3 days. Glass-ceramic Zn4 
exhibited the highest rate of cell proliferation. 
 
 However, the decreasing cell viability with increasing zinc concentration in glasses 
may be attributed to its dose-dependent effect. Zn
2+
 has been reported to play a dual role in 
affecting the cell death: although zinc seems to be inhibitor of many forms of apoptosis [190], 
exposure to excessive concentrations may contribute to neuronal cell death in acute 
neurological disorders and to apoptosis of human peripheral blood lymphocytes [191]. The 
mechanism by which Zn
2+
 induces cell death and oxidative stress is still unresolved. 
According to the available literature, an increase in Zn
2+
 concentration in cellular medium 
higher than ~2 ppm can lead to cytotoxicity and cell death [44]. Similar results with respect 
to proliferation of endothelial cells and osteoblasts have also been reported by Aina et al. 
[120, 157] where it has been shown that 45S5 Bioglass
®
 doped with 5 wt% ZnO enhanced 
cell proliferation on its surface while increasing zinc concentration led to significant release 
of lactate dehydrogenase (index of cytotoxicity) thus, resulting in cell death. With respect to 
the bioactivity of glass-ceramic Zn4, the cell growth kinetics in this sample is significantly 
higher in comparison to that reported for apatite-wollastonite [192] as well as for diopside-
flouroapatite [105] glass-ceramics, respectively.  
 
Zn-0 (3d) 
Zn-0 (7d) Zn-4 (7d) 
Zn-4 (3d) Zn-8 (3d) 
Zn-8 (7d) 
100 m 100 m 100 m 
100 m 100 m 100 m 
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Figure 4.3.9 Alkaline phosphatase activity of the MSCs during culture for 7 and 14 days on 
the glass compacts (Zn0 to Zn8) and on tissue culture plastic control. For all the 
investigated glass-ceramics, irrespective of their ZnO content, ALP levels were always higher 
in comparison to that of control (p < 0.05, ANOVA, n=3) 
 
The osteogenic differentiation of the MSCs cultured on the glass-ceramic samples 
was investigated in terms of ALP activity (Figure 4.3.9). Under the osteogenic medium used 
herein, rat bone marrow MSCs have been shown to switch to the lineage of osteoblastic cells 
[193]. When cultured on the control dish, MSCs showed an increased ALP level from days 7 
to 14. The ALP levels for all the investigated glass-ceramics were higher in comparison to 
control irrespective of their zinc content. However, among all the investigated glass-ceramics, 
Zn4 exhibited the highest ALP activity of cells during 7 and 14 days of culture. It should be 
noted that ALP is a homodimeric metalloenzyme that catalyses the hydrolysis of almost any 
phosphor monoester with the release of phosphate and alcohol. Its properties have been 
associated with the mineralization process and phosphate homeostasis in bone tissue [194]. 
ALP acts as a nucleation centre for hydroxyapatite as it is able to release phosphate and 
captures calcium ions. In this way, the presence of ALP and a solution rich in Ca
2+
 ions 
induces the deposition of hydroxyapatite (bone forming mineral) crystals and amorphous 
calcium phosphate.  
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4.3.3 Conclusions 
A detailed investigation about the influence of adding increasing amounts of ZnO to 
partially replace MgO in a parent bioactive glass composition (TCP-20) was shown to have 
consequences in terms of sintering and crystallisation behaviours and on the relevant 
properties of the resulting glass-ceramics, including mechanical and biological responses. 
The glass forming ability of the glasses was unaffected by the level of MgO substitution. All 
the glass compositions investigated exhibited good sintering ability upon heat treating at 850 
ºC for 1 h thus, resulting in well sintered and mechanically strong glass-ceramics with 
diopside and fluorapatite as the primary crystalline phases. A minor crystalline phase 
(petedunnite) was also formed for ZnO > 4 mol%. The ZnO content also revealed to play an 
essential role on the in vitro bioactivity. The glass-ceramic composition with ZnO = 4 mol% 
exhibited the highest levels of mesenchymal cell proliferation and alkaline phosphatase 
activity, while further increasing ZnO contents led to a significant decrease in the in vitro 
performance of the investigated glass-ceramics.  
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4.4 Role of glass structure in defining the chemical dissolution behaviour, bioactivity 
and antioxidant properties of zinc- and strontium- co-doped alkali-free phosphosilicate 
glasses 
4.4.1 Introduction 
Since the chemical degradation of multi-component glasses is strictly related to their 
atomic and molecular structure [5]
 
the design of bioactive glasses requires a thorough 
understanding of the relationship between their atomic/molecular structure and dissolution 
behaviour. In fact, it has been well established that the ionic dissolution products are key to 
understand the behaviour of their parent inorganic materials in vitro and in vivo, especially in 
the context of TE applications [195]. This relationship becomes more important when 
functional ions (for example: Sr
2+
, Zn
2+
, F

, etc.) are incorporated in the glasses with an aim 
to enhance their biological efficacy because these ions interact with and modify the phospho-
silicate glass matrix, thus, affecting the dissolution behaviour of resultant glass compositions. 
Therefore, it is of paramount importance to understand the influence of these functional ions 
on the structure and bioactivity of glasses so as to design glass compositions with controlled 
chemical dissolution and ion release rates.  
Zinc and strontium are two such functional ions whose biological importance has been 
well documented in literature [42, 56, 59, 121]. Despite being present in trace amounts, both 
these ions play essential roles in the chemistry of bone [196, 197]. For this reason several 
studies describing the influence of zinc and/or strontium on various aspects of bioactive 
glasses and their properties have been reported in literature during the last few years [42, 58, 
82, 114, 119-122, 198]. Further, most of the work on strontium and zinc co-doped bioactive 
glasses available in literature has been published by Boyd and co-authors [125, 154, 199-203] 
in the CaO–SrO–ZnO–Na2O–SiO2 glass system.  
The present section aims at defining the structure-property relationships in a series of 
alkali-free phosphosilicate glass composition in Di-FA-TCP system co-doped with Zn
2+
 and 
Sr
2+
. An attempt has been made to understand the structural role of Sr
2+
 and Zn
2+
 co-doping 
on the chemical dissolution behaviour of glasses and its impact on their apatite forming 
ability, osteoblast proliferation and antioxidant behaviour. The very promising glass 
composition TCP-20 discussed in section 2.1 was adopted as the starting point for synthesis 
of present series of glasses. The structure of the as-obtained glasses has been 
investigated by MAS-NMR while the biodegradation of glasses has been investigated by their 
immersion in Tris–HCl and SBF. Furthermore, the influence of glass structure and the 
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dissolution behaviour on osteoblast proliferation and oxidative stress levels has been 
discussed. 
 
4.4.2 Results  
4.4.2.1 Glass forming ability 
For all the investigated glass compositions with varying Zn
2+
/Mg
2+
 and Ca
2+
/Sr
2+
 
ratio: (mol%) (36.07–x) CaO – xSrO – (19.24–x) MgO – xZnO – 5.61P2O5 – 38.49SiO2 – 
0.59 CaF2 (x = 0–10), melting at 1570 ºC for 1 h was sufficient to obtain bubble-free, 
transparent and XRD-amorphous glasses (Figure 4.4.1). Table 4.4.1 presents the detailed 
compositions of the as-designed glasses. 
 
 Table 4.4.1 Nominal composition of the as-designed glasses (mol%). 
 
Glass CaO MgO SiO2 P2O5 ZnO SrO CaF2 
ZS-0 36.07 19.24 38.49 5.61 0.00 0.00 0.59 
ZS-2 34.07 17.24 38.49 5.61 2.00 2.00 0.59 
ZS-4 32.07 15.24 38.49 5.61 4.00 4.00 0.59 
ZS-6 30.07 13.24 38.49 5.61 6.00 6.00 0.59 
ZS-8 28.07 11.24 38.49 5.61 8.00 8.00 0.59 
ZS-10 26.07 9.24 38.49 5.61 10.00 10.00 0.59 
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Figure 4.4.1 X-ray diffractograms of glass powders 
 
4.4.2.2 Structure of glasses 
The 
29
Si MAS-NMR results of all the glasses as presented in Figure (4.4.2a, 4.4.3a), 
depict the dominance of Q
2
 (Si) structural units in the glasses. Furthermore, the dominance of 
Q
2
 structural units is confirmed by the quantitative analysis of deconvoluted NMR spectra 
(Table 4.4.2b). The Qn distributions for the three compositions are rather close to each other, 
i.e. the silicate distribution is dominated by Q
2
 chain species, with substantial amounts of 
chain-terminators Q
1
 and branched Q
3
 species. Further, only slight shift in the peak positions 
of spectra could be observed and all the spectra are centred between –81 ppm and –82 ppm, 
thus depicting no significant changes in the silica coordination in glass structure. The 
31
P 
MAS–NMR spectra of all the glasses (Figure 4.4.2b)  and the corresponding de-convolution 
(Table 4.4.3) show a predominance of orthophosphate–type species with chemical shifts 
centred at around 2–2.5 ppm, close to that of the calcium orthophosphate (3.1 ppm) [137]. 
Besides the dominant Q
0
 orthophosphates, Table 4.4.3 also highlights the presence of non-
negligible amounts of non-orthophosphate species, in agreement with the MD models, a 
phosphorus environment thus qualitatively similar to that found for the 45S5 glass [127, 167]. 
Similar results were obtained for alkali-free bioactive glasses doped with ZnO and SrO on 
independent basis where insignificant influence on silicate network connectivity was 
observed by varying SrO/CaO ratio [204] or ZnO/MgO [42] ratio in the glasses while most of 
the phosphorus component was found in orthophosphate environment. 
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Figure 4.4.2 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
Thus NMR results shows that Zn
2+
/Mg
2+
 and Ca
2+
/Sr
2+
 substitutions do not affect the silicate 
network connectivity of these glasses. 
 
Table 4.4.2 Q
n
 (Si) distribution for glasses ZS-4 and ZS-10 obtained by NMR de-
convolution. 
 
  
  
Q
n
 
ZS-4 ZS-10 
peak position 
(ppm) 
% integral 
peak position 
(ppm) 
% integral 
Q
0
 -66.5 0.3 -66.0 0.3 
Q
1
 -75.7 22.7 -75.8 28.8 
Q
2
 -81.7 50.6 -82.6 48.0 
Q
3
 -88.3 24.1 -90.5 22.7 
Q
4
 -96.7 2.2 -107.4 0.1 
ZS-8 
ZS-2 
ZS-4 
ZS-6 
ZS-10 
-200-150-100-50050
-81.5 ppm 
29Si Chemical Shift (ppm) 
(a) 
ZS-2 
ZS-4 
ZS-6 
ZS-8 
ZS-10 
-40-2002040
2.5 ppm 
2.03 
31P Chemical Shift 
(b) 
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Table 4.4.3 Q
n
 (P) distribution for glasses ZS-4 and ZS-10 obtained by NMR deconvolution. 
 
 
 
  
  
Figure 4.4.3 (a) 
29
Si MAS NMR spectra and (b) 
31
P MAS NMR spectra after deconvolution 
of investigated glasses. 
  
Q2 
Q1 
ZS-10 
(a) 
Q3 
-130-110-90-70-50-30
ZS-10 
(b) 
Q0 (Mg) 
Q0 (Ca) 
Q1 
-30-101030
ZS-4 
Q3 
Q4 
Q2 
Q1 
-130-110-90-70-50-30
29Si chemical shift (ppm) 
Q0 (Ca) 
ZS-4 
Q0 (Mg) 
Q1 
-30-101030
31P Chemical Shift (ppm) 
Q
n
 
ZS-4 ZS-10 
peak position 
(ppm) 
% integral 
peak position 
(ppm) 
% integral 
Q
0 
(Ca) 3.2 52.3 3.2 67.4 
Q
0
(Mg) 0.5 27.5 0.8 17.3 
Q
1
 -1.0 20.3 -1.9 15.2 
Q
2
 - - - - 
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4.4.2.3 SBF immersion studies 
In the present case, FTIR spectra of all the glass powders before immersion in SBF 
solution are presented in Figure 4.4.4a. All the investigated glasses show three broad bands in 
350–1300 cm–1 region. The broadness clearly shows the disorder in the glass structure with 
uneven distribution of Q
n
 units. The band ranging from 800–1300 cm–1 corresponds to 
presence of two optical modes of Si–O–Si groups: Si–O bending mode identified around 800 
cm
–1
 and the asymmetric stretching mode Si–O (s) in 1000–1300 cm–1 region. The ~500 cm–1 
band can be attributed to Si–O–Si bending modes, while the weak shoulder around ~750 cm–1 
may be due to Si–O–Si symmetric stretching with simultaneous Si cations motion [205]. 
Further, the band centred around 559 cm
–1
 corresponds to P–O bending modes [206].   
The immersion of glass powders in SBF for varying time durations led to a 
considerable change in the glass chemistry which is evident from the FTIR data presented in 
Figure 4.4.4b-4.4.4d. The soaking of glass powders in SBF for 1 h resulted in the appearance 
of a strong low frequency band around ~503 cm
–1
 (Figure 4.4.4b) typical for the deformation 
mode of silica gel–like layer.  In addition to that the main IR band now appeared at 1051 cm–1 
along with a weak shoulder at 1180 cm
–1
 which could be assigned to Si–O–Si stretching 
vibrations [206]. These bands indicate the development of interfacial high-area silica gel 
layer, as postulated in Hench’s inorganic reactions set [20] and can be observed in all the 
glasses. The peaks around ~560, 600, 1035 cm
–1
 present in all the glasses are evidence for the 
formation of crystalline hydroxyapatite and other crystalline phosphate species as these bands 
correspond to P–O bending vibrations in a PO4
–3
 tetrahedron. Further, the bands at 1296 cm
–1
 
and 1461 cm
–1 
corresponding to the formation of complex carbonate species imply towards 
formation of carbonated HA. It is noteworthy that formation of any calcium carbonate 
(CaCO3) polymorphs has been negated considering their absence in the XRD data obtained on 
glasses after immersion in SBF solution as shown in Figure 4.4.5. 
The XRD data obtained on glass powders after immersion in SBF solution for varying 
time durations support the FTIR results as all the glasses exhibit well defined characteristic 
X-ray peak at 2θ = 31.77º corresponding to the formation of crystalline hydroxyapatite [HA; 
(Ca5(PO4)3OH; ICDD: 00–09–0432] after 1 h of immersion (Figure 4.4.5).  
The intensity of the XRD phase reflections for HA increased with increase in SBF 
immersion time, thus, depicting the high apatite forming ability of these glasses. 
Interestingly, the apatite forming ability of same parent glass (ZS–0) was observed to 
decrease considerably when doped with SrO (at the expense of CaO) or ZnO (at the expense 
of MgO) on individual basis as has been reported in our previous articles [42, 204]. 
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Figure 4.4.4 FTIR spectra of glass powders (a) before, after (b) 1h, (c) 24h, and (d)14 days 
immersion in SBF. 
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Figure 4.4.5 X-ray diffractograms of glass powders after immersing the glass powders in 
SBF solution for (a) 1 h (b) 3 h (c) 6 h (d) 24 h (e) 3 days and (e) 14 days.  
 
 In order to gain a better insight into the glass dissolution process and apatite forming 
ability of the investigated glasses, the elemental release profile of these glasses was studied 
when immersed in SBF solution for initial 24 h. The trends observed for variation in 
concentration (mg l
–1
) of different ionic species (Ca
2+
, Mg
2+
, PO4
3
, SiO4
4
, Zn
2+
, Sr
2+
) in 
SBF detected during initial 24 h are presented in Figure 4.4.6. The results obtained have been 
summarized below:  
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i) The trend of Ca2+ concentration after 1 h of immersion corresponds to an increase for 
all glasses which reaches its maximum within 12 h of immersion in SBF solution 
(Figure 4.4.6a). The increasing Ca
2+
 concentration in SBF during initial immersion for 
all glasses imply towards the initiation of the bio-mineralization process, where 
modifier cations in the glass exchange with hydronium ions in the external solution 
[20]. This increase in the Ca
2+
 concentration may be attributed to the exchange of Ca
2+
 
with the hydronium ion present in the SBF solution due to disruption of the glass 
network. Thereafter, a kind of saturation plateau is reached for all the investigated 
glasses. The similar dissolution behaviour for all the glass compositions may be 
ascribed to the similar network connectivity exhibited by all the glasses. The release of 
Ca
2+
 seems to depend on their actual concentration in parent glasses as increasing 
SrO/CaO ratio in glasses decreased the Ca
2+
 ion release concentration in the SBF 
solution.  
ii) The concentration of PO4
3
 follows steadily decaying profiles, an indication that the 
dissolution rate from glasses is lower than the rate of surface deposition of such species.  
iii) The Mg2+ ion concentration profile is similar to that of Ca2+ in SBF solution and was 
detected to be highest after 12 h of immersion time for all the glass compositions while 
no significant variations were observed after prolonged SBF immersions (Figure 
4.4.6c), possibly due to attainment of equilibrium between the Mg
2+
 concentration in 
glass and SBF. In general, the amount of Mg detected after any particular immersion 
time was highest for ZS–2 and lowest for ZS–8 possibly due to higher magnesium 
content in ZS–2 as compared to ZS–8.  
iv) Sr2+ can accumulate in bone by exchanging with Ca2+ in the hydroxyapatite crystal 
lattice due to the chemical analogy to Ca
2+
. As shown in Figure 4.4.6d, glass 
compositions up to ZS–4 exhibit Sr release profiles that are similar to other alkaline 
earth ions for all compositions with a maximum after 12 h of immersion in SBF 
solution. With further increasing the ZnO and SrO content to ZS–8, the strontium 
release profile was observed to steadily increase beyond 12 h. Although we did not
 
make elemental analysis of the SBF solution obtained after immersion of glass ZS–10 
for varying time durations, a similar behaviour is expected from this glass too.  
v) In general SiO4
4–
 ion concentration increases with increase in immersion time, 
thereafter reaching a saturation plateau after 6–12 h of immersion (Figure 4.4.6e). It is 
worth noting that Si concentrations reached highest values for ZS–2, an indication that 
the chemical resistance of glasses somewhat increased with increasing added amounts 
of doping ions.  
vi) The Zn ion release profiles for the investigated glasses over 24 h are shown in Figure 
4.4.6f. In all the investigated glasses the Zn ion concentration in SBF increases with 1 h 
of immersion time, thereafter decreases to a saturation value. Zn
2+
 release from these 
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glasses appears to be independent from the Zn content in the glasses. Also it is worth 
noting that co-doping of glasses with SrO and ZnO does not prevent the formation of 
HA on the glasses.  
 
 
  
 
 
 
Figure 4.4.6 ICP plots of elemental concentration of (a) Ca, (b) P, (c) Mg, (d) Sr, (e) Si and 
(f) Zn, in SBF solution versus immersion time for the investigated glass powders. 
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4.4.2.4 Chemical degradation of glasses in Tris-HCl 
All the glasses were XRD amorphous after immersion in Tris-HCl for 120 h, thus 
negating the possibility of any phase formation due to chemical reaction between the 
dissolution products (Figure 4.4.7). 
 
Figure 4.4.7 X-ray diffractograms of glass powder after 120 days of immersion in TRIS-
HCL 
 
The variation in pH of Tris–HCl along with weight loss of the glasses with respect to 
SrO and ZnO content in glasses is presented in Figure 4.4.8a. A slight change in pH of Tris–
HCl from 7.54 to 7.24 was observed with increasing SrO and ZnO content in glasses after 
120 h of immersion. This depicts good chemical stability of glasses which in turn should 
support cell viability due to the absence of sudden pH changes in the dissolution medium. A 
steep decrease in the weight loss of glass was observed with increasing equimolar 
concentrations of ZnO and SrO content up to 6 mol%. Further increase in ZnO and SrO 
content in glasses did not lead to any significant change in the weight loss of glasses. 
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Figure 4.4.8 (a) Graphs depicting the change in solution pH and weight loss of glass 
powder samples (with respect to variation in ZnO and SrO content in glasses) after 
immersion in Tris–HCl; (b) ICPAES plots of elemental concentrations of Ca, Mg, P, 
Si, Sr and Zn in Tris–HCl after 120 h of immersion of glass powder. It should be noted 
that Si refers to SiO4
4
 and P refers to PO4
3
 species. 
 
With respect to the ion release profile the ICP–OES analysis revealed that studied 
glasses demonstrated SiO4
4 
ion release in the range of 39–157 ppm (1 ppm = 1 mg l–1). Also 
increasing strontium and zinc content in the glasses decreased the release of SiO4
4
 species in 
Tris–HCl as shown in Figure 4.4.8b, thus explaining the lower chemical degradation of 
glasses. Previous studies have shown that SiO4
4
 release levels in the range 0.1100 ppm 
from bioactive glass and other biomaterials show stimulatory effects on osteoblasts and the 
expression of TGF–b mRNA in human osteoblast–like cells [207]. Furthermore, gradual 
release of soluble silica over time enhances bone bonding due to the increased formation of 
Si–OH (silanol) groups. Therefore, it is apparent that any bioactive glass releasing SiO4
4 
within these ranges will have similar beneficial effects. Hence, all the glasses in the present 
study may possess beneficial properties towards various biological processes.  
Phosphorus being a major component of the inorganic phase of human bone plays an 
important role in bone formation as mentioned in section 2. In the present study, the ionic 
concentration of phosphorus released (8.6–24 ppm; Figure 4.4.8b) from the glasses in Tris–
HCl lies within the above mentioned limit required to promote favourable biological activity. 
Further, Ca
2+
 ion release from experimental glasses in Tris–HCl solution decreased 
from 268–53 ppm (Figure 4.4.8b) probably owing to the decrease in CaO concentration in 
glasses. The significance of calcium in bone mineralization is well established and its gradual 
release over time is bound to enhance therapeutic efficacy of the glasses. Similarly, 
Magnesium concentration in the extracellular fluid ranges within 1725.5 ppm. In the present 
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study the concentration of Mg
2+
 released from the investigated glasses in Tris–HCl solution is 
higher than the concentration vital for favourable biological properties. However, due to 
efficient excretion of Magnesium in the urine, incidences related to hyper–magnesium 
conditions are rare [60].
 
With respect to release of strontium and zinc from the studied 
glasses, all the glasses demonstrated a release of 23–32 ppm of strontium and 0.1–9.8 ppm of 
zinc over 5 days of immersion in Tris–HCl (Figure 4.4.8b). Although, the amount of 
strontium released from glasses is within the limits of its therapeutic efficacy, the amount of 
zinc released from glasses with ZnO content >4 mol% is slightly higher than required for 
biomedical purpose.  
 
4.4.2.5 Cellular response on bioactive glasses  
4.4.2.5.1 In vitro proliferation of MG63 cells  
Figure 4.4.9 depicts the cell viability on glasses under investigation in comparison 
with commercially available culture plates, of ZS–2, ZS–4, and ZS–6 and ZS–8 bioactive 
glasses. MG-63 cells were used for the following reasons firstly, MG-63 cells display suitable 
integrin molecules required for cell adhesion making them a more appropriate model under 
the present study, secondly the response of MG-63 cells to 1,25(OH)2D3 administration has 
been shown to be similar to normal human osteoblast cells [208]. Additionally, human and 
MG63 cells produce cAMP in response to Parathyroid hormone therapy [209, 210]. 
Moreover, MG-63 cells provide an excellent model for studying the antioxidant properties of 
bioactive glasses as they have been used in variety of studies especially for their use in 
capsaicin induced apoptosis via the caspase cascade and the antioxidant enzyme system and 
Okadaic acid induced apoptosis through the PKR, NF-κB and caspase pathway. These 
pathways are similar to the apoptotic death caused by H2O2 used and oxidizing agent in the 
present study which have earlier been used to studying protection of MG63 cells by 
Melatonin and Simvastatin [211, 212]. Apparently, the proliferation of MG63 cells was 
89.0±4.2%, 86.7±3.9%, 80.25±3.6% and 72.8±3.1% on glasses ZS–2, ZS–4, ZS–6 and ZS–8, 
respectively (Figure 4.4.9a).  
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Figure 4.4.9 Plots showing the cell growth kinetics of the glasses (ZS–2, ZS–4, ZS–6, and 
ZS–8) (a) under normal condition during culture after 4 days under normal conditions (b) 
under H2O2 (250 μM) induced oxidative stress in MG63 cell after 3 days. *(C for control) 
 
The antioxidant potential of investigated glasses was examined on H2O2 induced 
oxidative damage in MG63 cell line after 24 h of cell growth. H2O2 is one major contributor 
to the oxidative damage and leaks from mitochondria in the cells. According to Li et al. [213] 
H2O2 stops cells proliferation in MG63 cells by reducing the levels of cycline B1 and 
induction of G2 cell cycle arrest. Although, the cell viability was higher (in comparison to 
control) in the presence of Sr- and Zn-doped bioactive glasses under investigation; 
interestingly, the cell viability decreased for SrO- and ZnO-concentration in glasses beyond 
ZS–4, as is evident from Figure 4.4.9b. Accordingly, the highest cell viability under oxidative 
stress was observed for glass ZS–2 (163%) followed by ZS–4 (151%), ZS–6 (138%) and ZS–
8 (135%) when compared with control cultures at LD50 dose of H2O2 (Figure 4.4.9b).  
 
4.4.3 Discussion 
From MD simulation results [214], the network connectivity (NC) in the investigated 
glasses is ~1.95. Based on the qualitative interpretation of the correlation between solubility 
and NC, an empirical upper limit of NC~3 has been defined separating bioactive (NC <3) 
from bio-inert (NC >3) glasses [39]. According to O´Donnell and Hill [112], melt-quenched 
silicate glasses with NC = 2 are good candidates for bioactive materials as biological 
response and other properties of glasses rapidly change around this value. Invert glasses with 
NC below 2 usually exhibit very high dissolution rates (due to highly depolymerized glass 
structure), being considered less practical in biological systems [112]. However, this 
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empirical interpretation based on NC should be considered only as a qualitative guideline for 
designing bioactive glasses. As a matter of fact, our investigated glasses having a NC <2 
would be expected to exhibit excessive dissolution rates and unsuitable bioactivity, which is 
at odds with their apatite forming ability in SBF (Figure 4.4.5) and very moderate weight loss 
in Tris–HCl shown in Figure 4.4.8a.  
Further, the 
29
Si MAS–NMR data reveal the predominance of Q2 units along with 
considerable fraction of Q
1
(Si) and Q
3
(Si) in all the glasses (Table 4.4.2). The phosphate 
component in the glass is predominantly coordinated in orthophosphate environment thus, not 
contributing to the glass network backbone. This is again a desired feature because the low 
connectivity of phosphorus in the glass structure along with its ability to rip off the network 
modifying cations (mainly Ca
2+
) from the silicate network not only facilitates the release of 
additional soluble phosphate species into the contact fluid which will increase the local super-
saturation but also accelerate the bone bonding ability of glass by enhancing the HA 
deposition on the glass surface.  
The network modifying role of SrO/CaO along with the intermediate role of 
ZnO/MgO seems to play the major role in deciding the biological efficacy of the investigated 
glasses. This is evident from the significant disparity in the leaching behaviour of ZnO and 
SrO from glasses in SBF solution or Tris–HCl despite the fact that both these oxides have 
been incorporated in the glasses in the equimolar concentrations. The slow release of zinc 
(due to its ability to enhance the strength of inter-tetrahedral cross-links) and the 
comparatively faster release of strontium along with other elements help in enhancing the 
osteoblast proliferation and anti-oxidative properties of the studied glass compositions. 
According to literature, strontium when released in concentrations of <10 ppm has the ability 
to inhibit H2O2 induced oxidative stress in osteoblasts (CRL-11372) within a duration of 6–
12 h [215]. For concentrations >87.6 ppm, strontium becomes an apoptotic agent and induces 
the apoptotic effect of H2O2 [215]. The blood active Sr
2+
 concentration in postmenopausal 
osteoporotic patients treated with strontium ranelate (Protelos
®
, Servier Laboratries, Ireland) 
has been measured to be 10.5 ppm [56]. On the other hand, zinc concentrations have been 
observed to follow a strict dose-dependent behaviour with their therapeutic efficacy being 
restricted to the dose limits of <2 ppm. According to Aina et al. [157], when the 
concentration of zinc released from bioactive glasses exceeds 2 ppm, it causes damage to the 
osteoblasts (MG63) via oxidative stress. In a similar study, Bergandi et al. [216] explained 
the role of fluoride ions released from F-doped 45S5 Bioglass
®
 in inducing the oxidative 
stress when in contact with MG63 human osteoblast cell line due to inhibition of the pentose 
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phosphate oxidative pathway and, in particular, through the oxidative inhibition of glucose 6-
phosphate dehydrogenase. A similar observation has been made in the present study as the 
glass ZS–2, which releases <1.5 ppm zinc and ~10 ppm strontium in SBF (Figure 4.4.6) 
exhibits antioxidant behaviour  by enhancing the cell viability and negating the effect of 
oxidative stress induced by H2O2 addition in the cell culture medium. Further increasing the 
ZnO and SrO contents in glasses led to an increase in their released zinc and strontium 
concentrations. However, the decrease of their antioxidant behaviour could only be clearly 
noticed for the glass compositions with their respective ZnO and SrO content ≥6 mol%. 
Interestingly, although our glasses contain equimolar concentrations of ZnO and SrO, the 
release of Sr
2+
 into the SBF or Tris–HCl solutions is significantly higher than that of Zn2+. 
This depicts the importance of the structural coordination of zinc ions as intermediate in the 
glass structure (at variance with the stronger network modifying role of strontium, and its 
higher ionic field strength in comparison to strontium.  
Oxidative stress plays a prominent role in bone healing and regeneration. It arises due 
to the formation of reactive oxygen species (ROS). ROS (•O2
, •OH, H2O2, OCl

, etc.), which 
are generally produced in cellular mechanisms during conversion of oxygen to water (in 
order to produce energy) by mitochondria or during an encounter between white blood cells 
(WBCs) and pathogens in our body [217]. In case of a bone fracture, oxidative stress injury 
may be caused by an ischemia–reperfusion mechanism. In such a scenario, tissue damage is 
caused due to oxidative stress when blood supply returns to the tissue after a period of lack of 
oxygen. These radicals may cause oxidative injury to the fractured bone as has been seen in 
other tissues with reperfusion injury [218, 219]. The protection of MG63 cell line from H2O2 
induced oxidative stress in the present study by alkali–free bioactive glasses (mainly by 
glasses ZS–2 and ZS–4) may be attributed to the anti–apoptotic effect of zinc and strontium 
when released in a controlled manner. It has been recently reported that zinc is involved in 
direct inhibition of H2O2 induced apoptosis by activation of the P13K/Akt and MAPK/ERK 
pathways [220], while in case of strontium, a recent study by Jebahi et al. [221] reports an 
increase in the Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase 
(GPx) in vivo as the prominent features providing antioxidant behaviour to the materials 
doped with these trace elements. In the overall context of bone healing and regeneration, the 
as designed glasses are potential candidates for applications in the treatment of osteoporosis.  
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4.4.4 Conclusions 
The effects of co-doping of zinc and strontium on the structure, chemical dissolution 
behaviour of alkali-free phosphosilicate glasses and its impact on their apatite forming 
ability, osteoblast proliferation and antioxidant behaviour have been studied with NMR, 
FTIR, XRD, chemical degradation and cell culture experiments. An increase in the Zn
2+
/Mg
2+
  
and  Sr
2+
/Ca
2+
 ratio did not induce any significant change in Q
n 
speciation and network 
connectivity, as revealed by MAS–NMR. The chemical durability of investigated glass 
improved (as observed from Tris-HCl studies), however all the glasses exhibit good apatite 
forming ability. The glass ZS–2 which releases < 1.5 ppm zinc and ≤ 10 ppm strontium in 
SBF, is exhibiting good antioxidant behaviour by enhancing the cell viability and negating 
the effect of oxidative stress induced by H2O2 addition in the cell culture medium. However, 
further increase in ZnO and SrO content in glasses led to an increase in their released zinc 
and strontium concentrations, thus, decreasing their antioxidant behaviour. Thus zinc 
concentration < 1.5 ppm has an anti-oxidant effect. The anti-oxidant behaviour may be 
attributed to the anti–apoptotic effect of zinc and strontium when released in a controlled 
manner. Although promising results suggest possible clinical use of bioactive glass, further 
investigations of long-term outcomes are going on for the glass to be used in orthopaedic 
applications. 
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4.5 Thermo-mechanical behaviour of alkali-free bioactive glass-ceramics co-doped with 
strontium and zinc 
4.5.1 Introduction 
TE has emerged as an effective approach in response to the challenges in 
reconstructive and orthopaedic surgeries which involve restoring the diseased or damaged 
tissue by applying a combination of functional cells and scaffolds made of synthetic 
biomaterials. TE offers a feasible solution to the problems associated with the allograft and 
autograft [23]. This approach requires scaffolds with a well-defined architecture which not 
only provide temporary mechanical strength but also act as guiding channels for cell 
proliferation and tissue ingrowths [161]. The ideal scaffold should (i) be biocompatible (non-
toxic) and should promote cell adhesion and proliferation; (ii) exhibit mechanical properties 
that are comparable to those of the tissue to be replaced; (iii) exhibit controlled degradation 
rate and should degrade into nontoxic products that can be easily resorbed or excreted by the 
body; and (iv) be capable of being machined easily into required shapes [161]. All these 
properties are highly dependent on the substrate material properties and it is due to this 
reason that the choice of the material plays an important role in designing a suitable scaffold.  
In today’s scenario, bioactive glass-ceramics are considered to be potential materials 
for bone TE because of a number of salient features not only in relation with their good 
bioactivity but also owing to their good sintering ability, high mechanical strength and 
controlled chemical degradability [141, 189, 206]. The aim of the present section is 
understand the influence of co-doping of Zn
2+
 and Sr
2+
 on the thermal and mechanical 
behaviour of TCP-20. Although, good amount of literature is available on the influence of 
these two ions on various properties of bioactive glasses on individual basis as mention in 
section 4.4, it is rare to find literature describing the influence of both these ions on thermal 
behaviour of glasses.  
 
4.5.2. Results and Discussion 
4.5.2.1 Glass-forming ability 
For all the investigated glass compositions shown in Table 4.4.1, melting at 1570 ºC 
for 1 h was sufficient to obtain bubble-free, transparent and XRD-amorphous glasses. 
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4.5.2.2 Thermal analysis 
The DTA thermographs of fine glass powders with b= 20 K min−1 are shown in 
Figure 4.5.1. All the glass compositions feature a single endothermic dip which corresponds 
to Tg before Tc followed by an exothermic crystallization curve. The characteristic 
parameters obtained from DTA thermographs are summarized in the Table 4.5.1. In general, 
Tg decreases with increase in SrO and ZnO content in glasses. This decrease in Tg can be 
attributed to decrease in oxygen density (o) of glasses with addition of SrO and ZnO as 
shown in Figure 4.5.2. Oxygen density is a measure of compactness of the glass structure 
and can be calculated by using the following relation [114]: 
v
OPSiO
M
xMgOxZnOxCaOxSrOxxOM )52()(
522
o

  
Where, M(O) is the molecular mass of oxygen atom and x corresponds to the molar 
concentration of the respective oxides and Mv corresponds to the molar volume of the 
glasses. In general, the decrease in oxygen density points towards the expansion of glass 
structure resulting in the weakening of the glass network and an associated decrease in Tg. 
 
Figure 4.5.1 DTA thermographs of glasses at a heating rate of 20 K min
−1
. 
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Figure 4.5.2 Oxygen density plotted against percentage zinc and strontium substitution. 
 
Table 4.5.1 Thermal parameters measured from DTA at 20 K min
1
. 
 ZS-2 ZS-4 ZS-6 ZS-8 ZS-10 
Tc(±2 ºC) 885 884 871 866 870 
Tg(±2 ºC) 756 734 725 721 720 
ΔT(=TcTg) 129 150 146 145 150 
 
 
4.5.2.3 Sintering and Crystallization behaviour 
Figure 4.5.3 presents variation in the relative area and heat flow with respect to 
temperature as obtained from HSM and DTA, respectively, for all the investigated glasses at 
a similar heating rate of 5 K min
−1
. Table 4.5.2 summarizes the values of the temperature of 
first shrinkage (TFS; log  = 9.1 ± 0.1,  is viscosity in dPa s), temperature for maximum 
shrinkage (TMS; log = 7.8 ± 0.1) and ratio of the final area/initial area of the glass powder 
compact (A/A0) at TMS1, as obtained from the HSM data along with temperature for Tc and 
Tp, as obtained from the DTA of the glasses.  
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Figure 4.5.3 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions: (a) ZS-2, (b) ZS-4, (c) ZS-6, (d) ZS-8 and (e) ZS-10. 
 
(i) TFS decreased monotonically from 765 to 740 ºC with increasing SrO/CaO and 
ZnO/MgO ratios. 
(ii) Two stage sintering behaviours, with the main shrinkage occurring along the first step, 
were observed for glasses ZS–2, ZS–4 and ZS–6, while a gradual shift to single stage 
shrinkage was registered for glasses ZS–8 and ZS–10 (Figure 4.5.3). The first sintering 
stage is accomplished at TMS1 while the second one at TMS2.  In all the glass 
compositions TMS1 was observed at temperatures lower than Tc (i.e., TMS1<Tc). This 
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feature will ensure the production of well sintered and mechanically strong glass 
powder compacts. The second stage of densification occurred in competition with 
crystallization and ended at temperatures higher than Tc. This depicts that shrinkage 
continued in the glass powders even after onset of crystallization, possibly due to the 
presence of residual glassy phase in the glass-ceramics. 
(iii) The thermal stability parameter, ΔT=Tc – Tg varied from 129 ºC for ZS–2 to ~150 ºC 
for the remaining compositions (ZS–4 to ZS–10), Table 4.5.1. This suggests that 
thermal stability was enhanced with the increasing amounts of ZnO and SrO within the 
composition range, thus favouring densification during sintering. On the other hand, no 
particular trend could be observed for the variation in Sc values reported in Table 4.5.2. 
However, all the glasses exhibited a comfortable Tc-TMS difference which enables 
delaying the nucleation events thus, providing a wide processing window for attaining 
maximum densification [23].  
(iv) The DTA thermographs of glasses (ZS–2 to ZS–8) exhibited single crystallization 
exothermic curves. This signifies that the obtained glass-ceramics are formed either as a 
result of single phase crystallization or of an almost simultaneous precipitation of more 
than one crystalline phase. The two distinct exothermic events observed for ZS-10 
suggests the almost simultaneous precipitation of two crystalline phases 
(v) Values of A/A0 ranged from 0.65 to 0.67 (Table 4.5.3) for all the glasses implying 
towards good densification levels of 95–98%. 
 
Table 4.5.2 Thermal parameters measured from DTA and HSM at 5 K min
1
 
 ZS-2 ZS-4 ZS-6 ZS-8 ZS-10 
TFS  (±5 ºC) 765 752 748 746 740 
TMS1 (±5 ºC) 803 794 790 789 782 
TMS2 (±5 ºC) 862 865 854   
Tc(±2 ºC) 855 856 831 829 855 
Tp(±2 ºC) 892 887 872 869 879 
Sc(=TcTMS1) 52 62 40 41 73 
A/A0 at TMS1 (±0.02) 0.65 0.67 0.65 0.65 0.65 
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4.5.2.4 Structural transformation in glasses during heat treatment: 
4.5.2.4.1 XRD 
In agreement with HSM and DTA data, Figure 4.5.4a shows that amorphous glass 
powder compacts were obtained for the ZS–2 and ZS–4 samples after sintering for 1 h at 800 
ºC, while crystalline peaks corresponding to strontium-containing FA (Sr-fluorapatite) 
(Sr0.59Ca4.41 (PO4)3) (ICDD card: 01-070-3522) with a maximum intensity at 2θ = 31.75º 
were observed for the other compositions (ZS-6 – ZS-10). Further increase in temperature to 
850 and 900 ºC led to the crystallization of strontium containing Di phase (Sr-Diopside), 
(Sr0.15Ca0.75Mg1.1(Si2O6)) (ICDD card: 04-015-0688) in all the glass-ceramics. The XRD data 
revealed that solid solutions involving partial substitution of Ca
2+
 by Sr
2+
 in FA and Di 
crystal structures were formed. Considering the higher ionic radius of Sr
2+ 
(132 Å) in 
comparison to that of Ca
2+
 (114 Å), variations in lattice parameters are likely to occur. As a 
matter of fact, Figure 4.5.4b-c shows slight shifts in the peak positions to lower 2θ angles, 
especially in case of Sr-FA. Concerning the evolution of the XRD peaks with increasing 
contents of SrO and ZnO in the glass-ceramics, Figure 4.5.4b-c also show two opposite 
trends for the two identified crystalline phases. Namely, the intensity of the XRD peaks 
increases for Sr-FA and decreases for Sr-Di. 
 
 
 
 
 
 
 
 
 
 
Figure 4.5.4 X-ray diffractograms of glass-ceramics heat treated for 1 h at: (a) 800 ºC, 
(b) 850 ºC and (c) 900 ºC. 
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Figure 4.5.5 Intensity ratio of the main XRD intensity peaks of Sr-diopside to Sr-fluorapatite 
plotted against percentage of zinc and strontium substitution for glass-ceramics heat treated 
for 1 h at 850 ºC and 900 ºC.  
 
Figure 4.5.5 shows the variation of the ratio between the highest intensity XRD peaks 
of Sr-Di / Sr-FA with respect to the ZnO + SrO content in the glass. Linear decreasing 
intensity trends are observed. The decrease in Sr-Di phase with increasing SrO/CaO and 
ZnO/MgO ratios can be attributed to the decrease in the Mg content in the glass network due 
to ZnO substitution. Along with the two major crystalline phases mentioned above, low-
quartz (SiO2) and willemite (Zn2SiO4) also precipitate out as minor phases in the glass-
ceramics sintered at 850 and 900 ºC. It is worth noting that the presence of willemite as minor 
phase indicates that zinc predominantly remains in the residual glassy phase.  
Representative SEM images and EDS data collected in the areas indicated in the SEM 
micrographs are shown in Figure 4.5.6 for glass-ceramics ZS8 samples sintered for 1 h at 
different temperatures. At 800 ºC, the microstructure is essentially amorphous and the few 
FA crystals are still isometric. With increasing the sintering temperature, the typical 
elongated morphology of FA became evident. Although the results are informative, there are 
significant deviations in the measured atomic percentages of the different elements relatively 
to those planned for the starting glass compositions or relatively to their proportions in the 
crystalline phases. This is not surprising considering that the area being analysed is larger 
than a single crystal and the measured result is influenced by the surrounding area. In 
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contrast, there is a good agreement between the XRD results (Figure 4.5.4) and the SEM 
observations (Figure 4.5.6). 
 
  
  
  
  
 
Figure 4.5.6 SEM images and EDS results of glass-ceramic ZS–8 sintered for 1 h at: (a) 800 
ºC, (b) 850 ºC, (c) 900 ºC, after a heating rate ramp of 5 K min
−1
.  
 
4.5.2.5 Mechanical Behaviour: 
The flexural strength was calculated for powder compacts sintered at 800, 850 and 
900 ºC (Figure 4.5.7). Despite their highly amorphous nature, the glass powder compacts 
sintered at 800 ºC exhibited flexural strength of ~ 60 – 70 MPa depicting their good sintering 
ability.  
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Figure 4.5.7 Flexural strength of glass-ceramics heat treated for 1 h at: (a) 800 ºC, (b) 850 ºC 
and (c) 900 ºC, using a heating rate of 5 K min
−1
.  
 
Further, higher values of flexural strength were obtained for glass-ceramics sintered 
at 850 ºC as sintering at 900 ºC led to a decrease in their mechanical strength. The variation 
in mechanical strength with the sintering temperature can be explained on the basis of 
crystalline phase evolution, including the type of predominating phase and, eventually, the 
size of crystals formed in these glass-ceramics. The mechanical strength was firstly enhanced 
with the predominate formation of Di, a mechanically strong crystalline material. Therefore, 
the relatively higher intensity XRD peaks of Di in glass-ceramics sintered at 850 ºC in 
comparison to their counterparts sintered at 800 and 900 ºC suggests an enhanced fraction of 
this phase that confers  to these samples higher mechanical strength. At 900 ºC, FA became 
the dominant crystalline phase in glass-ceramics with higher SrO and ZnO content. This 
resulted in lower mechanical strength owing to the poor mechanical properties of FA in 
comparison to Di [131]. 
 
4.5.3 Discussions 
We have investigated the influence of strontium and zinc oxides on the sintering and 
mechanical behaviour of alkali-free bioactive phosphosilicate glass-ceramics. The increase in 
SrO and ZnO concentration leads to the expansion of the glass structure and to concomitant 
decreases in Tg. all the investigated glasses exhibit good sintering behaviour and good 
flexural strength with Sr-diopside and Sr-fluorapatite evolved as the major crystalline phases 
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in the glass-ceramics along with willemite and quartz as minor phases. Due chemical 
similarity between strontium and calcium increase in concentration of SrO at the expense of 
CaO led to the partial replacement of Ca
2+
 by Sr
2+
 in the FA crystal structure whereas ZnO 
predominantly remained in the glassy phase. 
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4.6 Understanding the influence of composition on structure bioactive and thermal 
behaviour of Diopside – Tricalcium phosphate based glasses 
4.6.1 Introduction 
 The present work aims at gaining an insight about the influence of composition on the 
structure, bioactivity and thermal behaviour in alkali-free bioactive glasses in the 
CaOMgOSiO2P2O5 system designed along DiTCP binary join by varying Di/TCP ratio 
and These glass compositions are derived from the ternary DiFATCP system which has 
been extensively studied in this thesis. Furthermore, the glass compositions derived from 
these binary and ternary systems have been regarded with much of interest to biomaterials 
community for their potential applications in bone regeneration and tissue engineering  [131-
134, 139, 140, 222]. 
 
Table 4.6.1 Nominal composition of the as-designed glasses (mol%).  
 
Glasses CaO MgO SiO2 P2O5 
Di-0 75 – – 25 
Di-10 68.13 3.43 6.87 21.57 
Di-20 61.82 6.59 13.18 18.41 
Di-30 55.99 9.5 19.02 15.49 
Di-40 50.57 12.22 24.42 12.79 
Di-50 45.55 14.73 29.44 10.28 
Di-60 40.88 17.06 34.12 7.94 
Di-70 36.52 19.24 38.48 5.76 
Di-80 32.44 21.28 42.57 3.71 
Di- 90 28.60 23.20 46.40 1.80 
Di-100 25.00 25.00 50.00 – 
 
4.6.2 Results 
4.6.2.1 Glass forming ability 
For all the investigated compositions (Table 4.6.1), we could obtain amorphous 
glasses only from compositions with Di ≥ 50 wt%. The melting of compositions with Di 
content varying between 3050 wt% at 1570 ºC for 1 h resulted in a highly viscous liquid 
which was prone to spontaneous crystallization even after quenching in cold water, thus 
resulting in a white, opaque material. Decreasing further the Di content to 20 wt% led to the 
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formation of highly viscous, non-homogeneous melt under the same experimental conditions. 
Therefore, the present study will be dedicated towards the investigation of structure, 
bioactivity and chemical degradation of glasses with Di content varying between 50 – 100 
wt%. 
 
4.6.2.2 Structure of glasses by MAS-NMR  
The 
29
Si MAS-NMR spectra of the glasses are shown in Figure 4.6.1a. All glasses 
exhibit a broad peak with full width half maximum in the range of 16–17 ppm centred around 
–81 to –82 ppm indicative of both Q2 and Q3 silicate species along with very low amounts of 
Q
0
, Q
1
 and Q
4
. There is a slight change in the peak position towards higher ppm up to Di-90; 
afterwards the peak shifts towards less negative ppm. 
  
Figure 4.6.1 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
Figure 4.6.1b represents the 
31
P spectra of the investigated glass samples. Irrespective 
of the content of the modifiers in the glasses, all the spectra are characterised by a relatively 
symmetric peak with chemical shift within the range of 1–3 ppm with an approximate line 
width of 8–9 ppm. The line width and the chemical shift values correspond to phosphorus in 
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orthophosphate environment (Ca–Mg orthophosphate). A downfield shift from 2.2–1.7 ppm 
was observed with the increments in Di content. 
In general, infrared spectra of all investigated glasses exhibit three broad 
transmittance bands in the region of 300–1300 cm–1 (Figure 4.6.2). This lack of sharp 
features is indicative of the general disorder in the silicate and phosphate network mainly due 
to a wide distribution of Q
n
 units occurring in these glasses. The most intense bands in the 
800–1300 cm–1 region correspond to the stretching vibrations of the SiO4 tetrahedron with a 
different number of BO atoms [205]. In all the glasses this band further split in two 
transmittance bands, a low frequency band at 940 cm
–1
 and a second band in the range 1030–
1038 cm
–1
. The high frequency bands can be assigned to the Si–O asymmetric stretching 
mode of BOs, whereas the ~940 cm
–1
 may be attributed to the Si–O asymmetric stretching 
mode of the NBOs [205, 223]. While the weak 750 cm
–1
 shoulder may be due to Si–O–Si 
symmetric stretching with simultaneous Si cation motions. Further, a weak shoulder ~600 
cm
–1
 corresponds to P–O bending modes [206]. 
 
Figure 4.6.2 FTIR spectra of the investigated glasses 
  
4.6.2.3 SBF immersion studies 
The immersion of glass powders in SBF for varying time durations led to a 
considerable change in the glass chemistry that occurred due to the reaction between glass 
and SBF (Figure 4.6.3). The soaking of glass powders in SBF for 1 h resulted in the splitting 
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of a strong low frequency band in the region 350–650 cm–1 into two small bands at ~470 cm–1 
and ~563 cm
1 
(Figure 4.6.3a). The band centred around 470 cm
–1
 can be ascribed to a 
deformation mode of the silica gel layer that develops on the dissolution of glass particles 
[83], while small band at ~563 cm
1 
characteristic phosphates as it corresponds to P–O 
bending vibrations in a (PO4)
3–
 tetrahedron. The band now occurring at ~1060 cm
–1
 and a 
nearby shoulder, centred at ~1240 cm
–1
are attributed to Si–O–Si vibration [147]. These bands 
indicate the development of interfacial high–area silica gel layer, as postulated in Hench’s 
inorganic reactions set [20] and can be observed in all the glasses. After 6 h of immersion the 
bands pertaining to the formation of complex carbonates 875, 1430, 1485 cm
1
 and silica gel 
layer (~1235 cm
1
) became more evident (not shown). Further, an increase in immersion time 
up to 24 h (Figure 4.6.3b), resulted in the sporadic appearance of new bands around 798 and 
960 cm
1
, indicating towards silica gel layer, and also, band at ~560 cm
1 
suggests the 
presence of non-apatitic or amorphous calcium phosphate, which is usually taken as an 
indication of the presence of precursors to HA. Immersion of glass powder for 3 days (Figure 
4.6.3c) led to the formation of well-defined bands in all the glasses at ~563 and 604 cm
1
, 
attributed to crystalline apatite. After 14 days of immersion (Figure 4.6.3d), no new bands 
formation could be seen apart from the increase in intensity of the bands corresponding to 
crystalline apatite i.e., at ~563 and 604 cm
1
, indicating an increase in crystallinity. In 
addition, a small band at ~1420 cm
1
 along with a broad but intense band at ~850 cm
1 
present in all glasses. 
 In agreement with the FTIR results, the XRD patterns of the samples immersed in 
SBF for different time periods are displayed in Figure 4.6.4. Although there are a few 
sporadic peaks apparently related to hydroxyapatite (HA) even after 1 h of immersion (see 
Di80), the indubitable formation of crystalline HA at the surface of the samples Di50 – 
Di90 only becomes clearly evident after 3 days of immersion. With the increase in 
immersion time to 14 days, the intensity of XRD peaks increased irrespective of the glass 
composition (Di–50 – Di–90). Further, the formation of any calcium carbonate (CaCO3) 
polymorphs along the entire immersion period was not observed whereas, formation of 
calcite under similar testing conditions has been reported for pure Di glass [105]. 
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Figure 4.6.3 FTIR spectra of glasses powders after immersion in SBF solution for (a) 1 h, (b) 
24 h, (c) 3 days, and (d) 14 h. 
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Figure 4.6.4 X-ray diffractograms of glass powders before and after immersion in SBF 
solution for (a) 1 h (b) 24 h (c) 3 days and (d) 14 days. HA refers to hydroxyapatite. 
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Figure 4.6.5 Variations in pH and weight loss of glass powders upon immersion in Tris-HCl 
solution for 7 days 
 
4.6.2.4 Chemical degradation of glasses in Tris-HCl 
Chemical durability of the glasses is a critically dependent on the pH and the nature of 
the solution. The leaching behaviour depends on the diffusability of the ions which 
determined by the ionic field strength of the ions and structure of the glasses. In the present 
case, a slight in pH of TrisHCl solution from 7.8 to 8.33 was observed with increasing TCP 
content (Figure 4.6.5). The increase in the final pH value with increasing TCP content can be 
attributed to the increase in the CaO content in the glass. However, the weight loss of the 
analysed samples (Figure 4.6.5), does not reflect well the expected mass balance through the 
ion exchange, in particular less weight loss of the sample Di–50 (~0.12%). 
Glasses with TCP content varying between 10 – 40 wt.% did show some stability in 
observed weight loss, thus approaching more the expected trend when one considers that the 
weight losses derived only from the passage of species from the solid to the solution. Further, 
all the glasses were XRD amorphous (Figure 4.6.6) after immersion in Tris-HCl solution for 
7 days.   
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Figure 4.6.6 X-ray diffractograms of glass powder after 120 days of immersion in TRIS-
HCL 
 
Table 4.6.2 Thermal parameters measured from DTA at 20 K min
1
. 
 
Glasses Tg (±2) Tc (±2) DT 
Di–50 747 825 78 
Di–60 748 861 113 
Di–70 748 881 133 
Di–80 749 901 152 
Di–90 736 880 144 
Di–100 744 839 95 
 
4.6.2.5 Thermal analysis 
The DTA thermographs of fine glass powders with b= 20 K min−1 are shown in 
Figure 4.6.7. All the glass compositions feature a single endothermic dip between 748736 
ºC before the Tc, corresponding to Tg,, estimated from the inflection temperature in DTA 
curve where the first derivative is null [224].  This thermal event was then followed by a 
single exothermic crystallization peak/band for glasses Di60 to Di100, whereas two 
crystallization peaks points (Tp1 and Tp2) were observed in glass Di–50. We could not 
observe any significant differences in the variation of Tg values with varying Di/TCP ratio in 
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the glasses. The characteristic thermal parameters, Tg, Tc and thermal stability, defined as 
ΔT(=TcTg) obtained from DTA thermographs are summarized in the Table 4.6.2.  The 
thermal stability parameter, ΔT=TcTg varied from 78 ºC for Di50 to ~152 ºC for Di80.  
Figure 4.6.7 DTA thermographs of glasses at a heating rate of 20 K min
−1
  
 
4.6.2.6 Sintering and crystallization behaviours 
The variations in the relative area and heat flow as functions of the heat treatment 
temperature as obtained from HSM and DTA, respectively, under a similar heating rate of 5 
K min
−1
 are presented in Figure 4.6.8a–f for all the investigated glasses. The DTA 
thermographs of glasses with Di contents varying between 60 and 100 wt.% exhibit single 
crystallization exothermic peaks Figure (4.6.8bf), confirming the crystallization behaviour 
discussed above observed under a higher heating rate of 20 K min
−1
. Table 3 summarizes the 
values of some relevant thermal parameters including the temperature of first shrinkage (TFS; 
log  = 9.1 ± 0.1,  is viscosity in dPa s), temperature for maximum shrinkage (TMS; log = 
7.8 ± 0.1) and ratio of the final area/initial area of the glass powder compact (A/A0) at TMS1, 
as obtained from the HSM data. The temperatures corresponding Tc, and Tp obtained from 
the DTA of the glasses are also reported. From these DTA and HSM results the following 
observations can be made: 
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1. The temperature of first shrinkage (TFS) showed a slight increase with increasing TCP 
contents in the glasses before decreasing abruptly to at Di50; 
2. The first sintering stage is accomplished at TMS1 while the second one at TMS2. In all 
the glass compositions (except the extreme ones Di50 and Di100), TMS1 was lower 
than Tc meaning that maximum shrinkage was reached before onset of crystallization. 
The second stage of densification TMS2 occurred in much smaller extent and in 
competition with crystallization, ending at temperatures around Tc. This general trend 
is more obvious in the intermediate glass compositions from Di60 to Di90.  
3. The sintering parameter, defined as Sc =Tc–TMS, reflects the extent of separation 
between the sintering and crystallization events in the temperature scale. The Sc values 
for all investigated glasses are reported in Table 4.6.3.  Initially the sintering ability 
increased with increase in TCP content until glass Di80, while further TCP 
increments led to its degradation. In case of Di100, TMS coinciding with Tc, Sc (Tc – 
TMS) = 0 as shown in Figure 4.6.8f. 
4. The values of the A/Ao ratio between the area (A) of the sample at TMS to its initial 
area (Ao) decreased from 0.94 in Di50 (the less prone composition for sintering) to 
0.66 in Di90. Except for Di50, all other glass–powder compacts exhibited good 
densification with A/Ao ratios varying within the range of 0.72 –0.66. 
 
Table 4.6.3 Thermal parameters (ºC) and A/Ao ratio derived from DTA and HSM at 5 K 
min
1
. 
 
TFS (±5) TMS1 (±5) TMS2 (±5) Tc (±2) Tp (±2) Tp2 (±2) Sc A/Ao 
Di–50 737 786 932 795 845 910 9 0.94 
Di–60 786 826 – 831 881 903 5 0.72 
Di–70 763 850 – 874 905 – 24 0.75 
Di–80 774 812 – 899 955 – 87 0.68 
Di–90 777 824 – 857 895 – 33 0.66 
Di–100 756 823 – 823 853 – 0 0.69 
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Figure 4.6.8 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions: (a) Di50, (b) Di60 (c) Di70, (d) Di80 (e) Di90 and (f) Di100 
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Figure 4.6.9 X-ray diffractograms of glass-ceramics heat treated at (a) 900 (b) 1000, and (c) 
1200 ºC for 1 h. (Di: Diopside, OAp: oxyapatite, W: Whitlockite, CaS: Calcium Silicate)  
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4.6.2.7 Structural transformations during heat treatment 
Figure 4.6.9 shows the XRD patterns of the glass powder compacts heat treated for 1 
h at 900, 1000 and 1200 ºC. The peak at 2q = 29.83º position appeared in all glasses and 
became more intense as the Di content is increased. The peak around of 2q = 31.74º was 
restricted to the composition with higher TCP contents (Di50 to Di70). In addition, a 
number of low intensity peaks were also present as minor crystalline phase, being more 
prominent in these compositions (Di50 to Di70). The crystalline phase assemblage did not 
change much upon further increasing the heat treatment temperature to 1000 ºC (Figure 
4.6.9b), traces of new peaks at 2q = 31.30º  start appearing at this temperature especially for 
Di50 to Di70 compositions. Further, with the increase in the heat treatment temperature to 
1200 ºC peaks ~2q = 31.74º disappeared along with some minor phases and new peaks with 
maxima at 2q = 31.30º appeared as the prominent phases (Figure 4.6.9c).  
 
4.6.2.8 Density  
The experimental density data measured for bulk glasses and glass-ceramics heat treated at 
different temperatures are reported in Table 2.6.4. The density of glass Di-50 was not 
measured due to its partial crystallization upon casting/slow cooling. It can be seen that 
density of the glass tends to decrease with increasing proportions of Di. All the glass-
ceramics, except Di-50, exhibited good densification ability, achieving densities that are 
superior in comparison to those of bulk glasses. The density values show a general increasing 
trend with temperature increasing followed by its reversion with further augmenting the 
sintering temperature, with small composition dependent variations.  
 
Table 4.6.4 Density (kg m3) of glasses and glass-ceramics. 
Compositions Bulk glass 
Glass ceramics heat treated at 
900 ºC 1000 ºC 1200 ºC 
Di-50* - 2,819±47 2,863±60 2,893±16 
Di-60 2.945 2,951±12 2,972±4 2,964±15 
.Di-70 2.921 2,972±60 2,953±6 2,962±1 
Di-80 2.897 2,933±1 2,973±6 2,924±3 
Di-90 2.871 2,930±7 2,936±6 2,925±11 
Di-100 2.852 2,897±3 2,936±17 2,892±4 
* Partial crystallisation upon casting 
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Figure 4.6.10 Flexural strength of glass-ceramics heat treated for 1 h at (a) 900 ºC (b) 1000 
ºC, and (c) 1200 ºC. 
 
4.6.2.9 Mechanical properties 
 The 3-point bending strength was calculated for glass powder compacts sintered for 1 
h at 900, 1000 and 1200 ºC (Figure 4.6.10). In general, the flexural strength increased form 
Di50 – Di100 in all the glass powder compacts heat treated at 900 and 1000 ºC. 
Interestingly, for the glass-ceramics sintered at 1200 ºC a point of inflection was observed 
after Di70, i.e., at 1200 ºC there was a gradual decrease in the flexural strength of the glass-
ceramics with increasing Di content.  
 
4.6.2.10 Cell culture studies 
hMSCs’ metabolic activity on Di–60, Di–70 and Di–90 and Tissue culture 
polystyrene (TCPS) after 1, 3, 7, 14 and 21 days under both conditions are shown in Figure 
4.6.11. 
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Figure 4.6.11 Metabolic activities of hMSCs on Di–60, Di–70 and Di–90 and TCPS after 1, 
3, 7, 14 and 21 days. 
 
An increase in cells’ metabolic activity was observed under both basal and osteogenic 
conditions for the culture period tested. On day 14 of culture in a basal medium, the 
metabolic activity of cells on Di–60 and Di–70 showed superior and significant statistical 
difference when compared with the control. However, no statistically significant difference 
was found after 21 days. Under osteogenic conditions, by day 14, cells’ metabolic activity 
was inferior and exhibited significant statistical difference with Di–90 in comparison with the 
control. On day 21, cell’s on Di–70 presented a higher metabolic activity than cells on Di–60, 
D–90 and the control. At this time point, it was also possible to notice a potential recovery of 
cells’ metabolic activity on Di–90. 
 
4.6.3 Discussions 
The gradual replacement of Di (CaO●MgO●2SiO2) by TCP (3CaO
●P2O5) changes the 
balance between glass formers and glass modifiers, implying structural variations that will 
influence the properties of glasses. The decreasing contents of Si lead to the formation of an 
increasing number of non–bridging oxygens in the glass structure. Further, no abrupt change 
in the glass structure was observed with increasing amounts of Di. However, the change in 
peak position towards more negative ppm values with increase in content of Di may be 
attributed to addition of silica and removal of phosphate from the glass network. On the 
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contrary, the up field peak shift in case of Di-100 can be attributed to complete removal of 
phosphate ion and simultaneous movement of modifier ions towards SiO2 which were earlier 
attached to P2O5. 
 Figure 4.6.1b shows that 
31
P MAS-NMR continuously shifts for all the glasses lying 
predominantly in the range for calcium orthophosphate (13 ppm), and a small amount of 
magnesium orthophosphate (0.5 ppm) can be expected. This therefore suggests that 
phosphorus is present in mixed calcium and magnesium orthophosphate. The phosphate 
component in the glass is predominantly coordinated in orthophosphate environment thus, not 
contributing to the glass network backbone. This facilitates the release of additional soluble 
phosphate species into the surrounding fluid, increasing their local super-saturation levels and 
accelerating the bone bonding ability of glass by enhancing the HA deposition on the glass 
surface. Further Lockeyer et al. [225] attributed the presence of orthophosphate-like 
environment as a result of phase separation in glasses. All the glasses prepared by Lockeyer 
et al [225] were annealed for 6 h at 450 ºC before slow cooling. However, the compositions 
under investigation were rapidly quenched in water, thus reducing the possibility of phase 
separation. Further, as the cation field strength and electronegativity of the modifiers 
significantly affect the 
31
P chemical shift in glasses. The peak shift observed in the spectra 
with increasing Di contents can be attributed to the increase in the Mg
2+
 (high field strength) 
and the concomitant decrease in the amount of Ca
2+
 content (low field strength). 
In terms of bioactive behaviour ,all the investigated glasses have shown good in vitro 
bio-mineralization activity in terms of the formation ability of an HCA surface layer over 14 
days of soaking in SBF (Figure 4.6.3), except for pure Di (Di100) [104]. The inability of 
Di100 to form a HCA surface layer after 14 days of immersion can be attributed the 
relatively high amount of MgO which retards the formation of apatite-like calcium phosphate 
[148]. However, the presence of ACP could be detected for these glasses after 24 h of 
immersion (Figure 4.6.3). Further, despite the differences in P2O5 content, all the investigated 
alkali-free glasses show similar rate of biomineralisation  in contrast to the results reported by 
O'Donnell et al. [226] and Mneimne et al. [227]. The possible reason behind these different 
behaviours could be attributed to high alkali content (22–29 mol%) of the bioglass 
compositions used by O'Donnell et al [228] and Mneimne et al. [227]. The eventual 
association of P with Na in the form Na-orthophosphate is likely to contribute to faster rates 
of dissolution and release of phosphates species from these glasses into the surrounding fluid 
in comparison to alkali–free counter parts. Interestingly, the presence of varying amounts of 
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magnesium did not apparently affect the rate of apatite formation in our alkali-free bioactive 
glasses, even though a supressing role in apatite formation has been reported in literature for 
Mg [229]. However, the results obtained in this study are in line with findings reported 
elsewhere [99] about the negligible effects of Mg on the apatite forming ability of other 
bioactive glass compositions. Thus, it seems reasonable to conclude that the effects of MgO 
on the properties of bioactive glasses do not exclusively depend on the added amount of MgO 
but also on the presence and relative contents of other oxides in each glass composition [229].  
 The foremost requirement for optimizing the fabrication of glass–ceramics scaffolds 
is to understand the sintering and crystallization behaviours of the glass powder compacts and 
avoid the overlapping of these two thermal events. A thorough understanding of the 
transformations that occur during the thermal treatment of glasses and how they depend on 
the starting compositions is therefore essential for designing biomedical applications/devices 
based on bioactive glasses that have to undergo high temperature treatments. We could not 
observe any significant differences in the variation of Tg values with varying Di/TCP ratio in 
the glasses. Further, the presence of single crystallization exotherm anticipates that the glass–
ceramics are formed as a result of either single phase crystallization (Di100) or an almost 
simultaneous precipitation of different crystalline phases (Di60 – Di90), while the 
appearance of two crystallization peaks points (Tp1 and Tp2) in Di50 glass points towards the 
separate precipitation of two different crystalline phases. Further, good sintering behaviour 
was observed in the glasses as TMS1 was lower than Tc, meaning that maximum shrinkage 
was reached before onset of crystallization. Further, the higher values of the sintering 
parameter, Sc = (Tc – TMS) for intermediate compositions (Table 4.6.3) clearly explain why 
these compositions perform better upon sintering. The observed decrease in the sintering 
ability for the higher added amounts of TCP is attributed to the formation of phosphate rich 
phases that degrade the sintering ability by enhancing the crystallization tendency of the 
glasses. In case of Di100, TMS coinciding with Tc (Tc – TMS) = 0, (Figure 4.6.8f). However, 
well sintered glass powder compacts were obtained as maximum shrinkage was achieved just 
before the onset of crystallization. This is confirmed by the density data reported in Table 
4.6.4. The lowest density of Di50 glass-ceramics is in good agreement with its poorer 
densification ability as deduced from the DTA-HSM results, with TMS2 coinciding with the 
onset of crystallization. Some bubbling was observed upon immersing the Di-50 glass-
ceramics in diethyl phthalate due to the presence of some open pores, a tendency that 
deceased with increasing temperature, but was not completely eliminated. The absence of 
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bubbling for the remaining glass-ceramics samples and their higher sintered density values in 
comparison to the parent bulk glasses attest their good sintering ability, in good agreement 
with the predictions derived from DTA-HSM studies. Density data confirm that the 
compositions within the range of Di60 to Di80 exhibit the higher sintering ability, being 
the most interesting ones for scaffolds fabrication. The general tendency of density to 
decrease with heat treatment increasing can be attributed to the elimination of a few pores left 
at lower temperatures and or to the formation of increasing amounts of denser crystalline 
phases. The reversion of this trend with temperature further increasing might be due to partial 
re-melting of crystalline phases, crystalline phase transformations. Therefore, exact 
information about the nature of crystalline phases formed upon heat treating the bioactive 
glasses is of great interest as they determine the relevant final properties of the glass-ceramic 
materials. Besides being composition dependent, the phase assemblage might be also affected 
in a certain extent by the heat treatment schedule.  
In the present study, Di (CaMgSi2O6) (ICDD: 01-072-1497) and oxyapatite (ICDD: 
65-1659) were the principal crystalline phases formed at 900 ºC (Figure 4.6.9a). The presence 
of oxyapatite was restricted to the composition with higher TCP contents (Di50 to Di70). 
Calcium silicate (Ca2SiO4) (ICDD: 01-086-0401) was also present as minor crystalline phase, 
being more prominent in these compositions (Di50 to Di70) as evident from the X-ray 
diffractograms. The crystalline phase assemblage did not change much upon further 
increasing the heat treatment temperature to 1000 ºC, but traces of whitlockite 
(Ca2.71Mg0.29(PO4)2) (ICDD: 01-070-0682) start appearing at this temperature especially for 
Di50 to Di70 compositions. The absence of calcium silicate and whitlockite phases in the 
glass-ceramics with higher Di contents can be attributed to the gradual depletion in Ca 
required to form those phases and the concomitant increasing amounts of MgO that tend to 
enhance the viscosity of the melts. Further increasing the heat treatment temperature to 1200 
ºC led to the dissolution of oxyapatite and calcium silicate phases, favouring the formation of 
whitlockite along with Di as the prominent phases. The dissolution of oxyapatite and calcium 
silicate at 1200 ºC can be attributed to increase in the amount of Di phase and the associated 
decrement of calcium content in the residual glassy phase available for apatite/Ca2SiO4 
formation. 
 Mechanical strength of the scaffolds is a very important aspect to take into 
consideration when designing glass-ceramics for bone tissue engineering applications. The 
mechanical strength of glass-ceramics is dependent on the mechanical properties of the 
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constituting crystalline phases and the densification ability of glass-powder compacts. In the 
present investigation the mechanical strength of the glass-ceramics (Di–60 – Di–100) exhibit 
good mechanical strength which can be attributed the mechanical properties of the 
constituting crystalline phases and high density obtained by the glass-ceramics (2,890–2,970 
kg m
–3
). In case of Di50, the poor sintering/densification ability and lower mechanical 
strength of the dominant phase can attributed to the lower mechanical strength upon sintering. 
Further glass-ceramics with higher amounts of Di (a mechanically stronger phase) [230] 
exhibit high mechanical strength values when heat treated up to 1000 ºC. Further, the overall 
decrease in the mechanical strength of the resultant glass-ceramics heat treated at 1200 ºC can 
be due to the decline in the densification ability of the glass-ceramics and formation of 
considerable volume fraction of whitlockite (a mechanically weaker phase), explaining the 
overall decrease in the mechanical strength of the resultant glass-ceramics. 
The cell culture studies showed an excellent cellular response to the investigated glass 
compositions, with the exception of the cells tested with osteogenic supplements and Di–90. 
Under these conditions, cells had lower metabolic activity than control, Di–60 and Di–70. 
Since Di–90 has higher amount of silica and MgO than the other compositions, the release of 
the compounds to the culture medium may induce some levels of cytotoxicity towards the 
hMSCs. Previous studies have shown that high Si concentrations can be cytotoxic [231, 232]. 
However this behaviour was more prominent under osteogenic conditions, which might be 
attributed to the inhibition of the stimulatory effect of osteogenic supplements in the presence 
of high Si concentrations [233]. At the end of the culture period, these cells seem to recover 
from the imposed toxic levels as suggested by an increase in their metabolic activity. This 
behaviour has been reported by several authors [231, 234]. On the contrary, Di–60 and Di–70 
promoted a good cell adhesion, metabolic activity into an osteoblastic phenotype, suggesting 
a potential stimulatory effect of these materials on hMSCs by the release of soluble factors or 
by the fastest formation of a CaP layer [235]. It has been reported the Si–, Ca– and Mg–
containing bioactive ceramics can release soluble ionic products to stimulate the proliferation 
and osteogenic differentiation of osteoblasts and human mesenchymal stem cells [236-238]. 
 
4.6.4 Conclusions 
An attempt has been made gain an insight into composition - structure - bioactivity 
relationships of alkali-free bioactive glasses in the CaO–MgO–SiO2–P2O5 system. The 
glasses have been designed in the Di (CaO•MgO•2SiO2) – TCP (3CaO•P2O5) binary join by 
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varying the Di/TCP ratio. We could obtain amorphous glasses only from compositions with 
Di ≥ 50 wt%. The melting of compositions with Di contents varying between 30-50 wt% at 
1570 ºC for 1 h resulted in a highly viscous liquids which were prone to spontaneous 
crystallization even after quenching in cold water, thus resulting in a white, opaque material. 
Further decrease in Di content to 20 wt% led to the formation of highly viscous, non-
homogeneous melts under the experimental conditions. Further, there was no significant 
change in the structure of the glass with decrease in Di content as investigated glasses have 
predominantly Q
2
 (Si) units while phosphorus is mostly in orthophosphate type environment. 
As expected from the structure of the glasses, all other investigated glasses have shown good 
in vitro bio-mineralisation activity in terms of the formation ability of an HCA surface layer 
over 14 days of soaking in SBF. All the glasses exhibited considerably lower weight loss in 
comparison to 45S5 Bioglass
®
 in Tris-HCl with Di–50 exhibiting lowest weight loss. The cell 
culture studies showed an excellent cellular response to the investigated glass compositions, 
with the exception of the Di–90. Further, all the glasses exhibit good thermal stability and 
processing window wide enough for the fabrication of scaffolds. TCP addition resulted in 
slight Tg variations. Good densification was achieved for the glass powder compacts at all 
investigated temperatures, resulting in well sintered and mechanically strong glass-ceramics. 
Diopside, oxyapatite were the major phases present at 900 ºC and 1000 ºC with calcium 
silicate and whitlockite as the minor phases. At 1200 ºC, diopside and whitlockite were the 
major phases present with no other minor phase detected. 
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5. General conclusions 
The present work aimed at developing alkali-free bioactive glasses in the ternary 
system of Di-FA-TCP having high bioactivity, lower dissolution rate and good sintering 
behaviour for bone regeneration and tissue engineering applications. In this pursuit, an 
attempt was made to understand the structure-property relationships in alkali-free bioactive 
glasses. Further, the influence of various functional ions on the structure and their 
implications on the biodegradation, sintering and crystallization behaviour of bioactive 
glasses was studied. In terms of structure, the glasses are almost similar to 45S5 Bioglass®, 
while significantly differing in the properties that are relevant for the intended applications. 
The designed alkali-free bioactive glasses exhibit: (i) higher bioactivity and slower chemical 
degradation in comparison to 45S5 Bioglass®; (ii) enhanced sintering ability resulting in well 
sintered and mechanically strong glass-ceramics with high residual amorphous content; (iii) 
good ability to be dispersed in aqueous media and to fabricate scaffolds for bone regeneration 
and tissue engineering applications with good mechanical properties and high bioactivity; (iv) 
the pH of the media is kept at moderate values owing to the absence of alkali metals in the 
composition, making them non-cytotoxic.  
Further, the addition of zinc to the parent glasses enhanced their chemical durability 
and the sintering ability without causing a substantial change in the structure. The flexural 
strength of 200 MPa achieved for Zn-8 We is comparable to that of the A-W glass-ceramics. 
Glasses doped with equimolar concentrations of ZnO and SrO showed excellent bioactivity 
despite of their very low degradation in comparison to 45S5 Bioglass®. In addition, the glass 
ZS–2 released doses of zinc and strontium into the SBF that are within the considered 
therapeutic ranges (< 1.5 ppm Zn and ≤ 10 ppm Sr), and exhibited good antioxidant 
behaviour by enhancing the cell viability and negating the effect of oxidative stress induced 
by H2O2 addition in the cell culture medium. Thus zinc concentration < 1.5 ppm has an anti-
oxidant effect.  
Moreover, we have elucidated that a straightforward correlation between the glass 
structure as evaluated by the network connectivity (Qn units) and dissolution behaviour of 
alkali-free bioactive glasses is difficult to establish as the bulk molecular structure of glasses 
does not completely control the hydroxyapatite formation on the surface of bioactive glasses. 
The structural coordination of functional ions in the glass plays a crucial role in deciding their 
elemental release profile thus, affecting the bioactivity of glasses. In the investigated alkali-
free bioactive glasses, all the glasses had almost similar molecular structure (Qn and NC). 
However, the structural coordination of zinc (five-coordinated) and strontium (six 
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coordinated) played an important role in deciding their biodegradation and sintering and 
crystallization behaviour. Also, in order to obtain a comprehensive picture about the 
dissolution mechanism and surface reactivity of glasses, it is of utmost importance to explore 
the surface chemistry of bioactive glasses and correlate it with their molecular structure. 
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6. Future works 
During this research work, an attempt has been made to develop diopside based Alkali-
free bioactive glasses for bone regeneration applications. We have succeeded in shedding 
some light on the composition-structure-property relationships in the glasses and the effect of 
various functional ions on the biodegradation, sintering, thermal and in vitro behaviour of 
bioactive glasses, which render them suitable for further experimentation as potential 
candidates in various bone regeneration applications. However, a lot work still needs to be 
accomplished in order to understand the biodegradation behaviour of the glasses. Therefore, 
in our opinion, the future work in this area may be addressed to the following issues: 
1. Surface chemistry of the glasses is highly important aspect to study the bioactive 
phenomenon. It could be interesting to study the relation of surface chemistry of 
glasses with their biodegradation behaviour and compare them with alkali-containing 
counterparts. 
2. In addition, biologically relevant additives (Co, Mn, Cu etc.) can be added to study 
their effect on bio-degradation behaviour in order to enhance the therapeutic efficacy 
of the glasses 
3. Further in depth in vitro tests are required to see the interaction of bioglass with 
variety to cellular environments. 
4. Also, in vivo tests of glasses/glass-ceramics are required to further establish its 
application in human biomedicine. 
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1. Introduction 
A glass can be defined as an amorphous solid completely lacking in long range, 
periodic atomic structure, and exhibiting a region of glass transformation behaviour. Any 
material, inorganic, organic, or metallic formed by any technique, which exhibits glass 
transformation behaviour is considered to be a glass [1]. 
Humans have been using glass for thousands of years, from the first uses of natural 
glass (e.g. obsidian, a volcanic glass) for tools and arrow heads, to the early man-made glass 
beads and drinking vessels of the Egyptians. Since then, glass has fascinated and attracted 
much interest both scientifically and technologically. The multiple forms and uses of glasses 
are becoming increasingly important in science, industry and in general daily life. During the 
last century, glasses and glass-ceramics became widely used for decorative articles, optics, 
architectural purposes (from windows to whole glass facades), and glassware for chemical 
reactions or fibres for telecommunication applications. The major advantage of glasses and 
glass-ceramics among its ceramic counterparts is their ability to accommodate various 
functional ions in their amorphous or crystalline phase, thus providing the flexibility to tailor 
and optimize their compositions with respect to different technological applications. 
In particular bioactive glasses have been a relatively young group of materials 
discovered in 1970´s by Larry Hench. Bioactive glasses and glass-ceramics constitute a class 
of bioactive materials, i.e. “Materials which elicit a special response on their surface when in 
contact with biological fluids, leading to strong bonding to living tissue”. Since its discovery, 
45S5 Bioglass
®
 has been used in >650,000 human patients and is being marketed for various 
dental and orthopaedic applications under different commercial brand names [2-4]. Due to 
number of attractive properties for bone regeneration and tissue engineering (TE), increasing 
efforts have been made towards expanding the range of potential applications and 
understanding the fundamental science governing the physical, chemical and thermal 
properties of bioactive glasses in order to develop novel compositions with superior set of 
properties for biomedical applications [5-10]. Irrespective of this huge success, high alkali-
containing glasses face some drawbacks which do restrict their application in some of the 
most advanced areas of human biomedicine. High alkali-content in glasses increase their 
crystallization tendency upon sintering, hindering the densification process and limiting the 
mechanical strength of sintered materials. Further, the relatively high chemical dissolution 
rates of such glasses in aqueous media decrease their in vitro and in vivo efficacy [11]. All 
these features constitute serious drawbacks in terms of fabrication of porous scaffolds or 
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porous coatings, and mitigate the potential benefits that could be drawn from their usage as 
biomedical devices for bone regeneration and TE.  
Despite many comprehensive studies leading to the development of bioactive glasses 
from different systems, the majority of these studies were based on 45S5 Bioglass
®
 or 
compositions inspired by it. Therefore, this work aims at designing new alkali-free bioactive 
glasses in the Diopside (Hereafter referred as Di) – Tricalcium phosphate (Hereafter referred 
as TCP) – Fluorapatite (Hereafter referred as FA) system having good bioactive properties 
and to understand the structure–property relationships in the as designed glasses.  
In the light of the above mentioned perspective, this dissertation comprises of five 
chapters. The first chapter, i.e., the Introduction, provides an outlook of the content of each 
chapter; the second chapter will focus on the literature survey in the field of bioactive glasses 
for biomedical applications, with special emphasis on alkali-free silicate systems. The second 
chapter has been divided into different subsections; the first section aims at providing a 
historical background on the development and evolution of bioactive glasses in general, while 
the second section outlines the motivations and purpose behind the present work. The third 
chapter deals with the description of the general experimental procedures and methodologies 
used along the thesis. It provides details about all the experimental techniques and procedures 
employed in order to synthesise, characterize and test our samples. Chapter four is the most 
important part of this work as it presents all the experimental results obtained on alkali-free 
glasses and glass-ceramics during past 3 years along with the pertaining discussions. In 
chapter five we have tried to conclude all the results and achievements obtained during this 
work and chapter six provides future directions in this field of research.  
Several experimental techniques were used throughout this investigation aiming at a 
better understanding of the glass structure, biodegradation behaviour and the sintering and 
crystallization behaviour of the corresponding glass powder compacts. Some properties of 
glasses and glass-ceramics such as density, mechanical strength, were also evaluated to 
achieve a better understanding concerning the structure-properties relations. 
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2. State of the art 
2.1 Need for Biomaterials for bone regeneration 
Human bone is a dynamic, highly vascularised connective tissue which provides 
structural support and act as a protective casing for the delicate internal organs of the body 
[12]. It is a tissue that is constantly remodelling to adapt to mechanical stresses imposed and 
repair minor injuries occurring during the lifetime. However, if the injuries suffered are 
extensive leading to very large bone defects, the use of bone grafts is required in order to 
repair the damaged part.  
Worldwide, millions of people are affected by degenerative and inflammatory 
problems related to bone and joint. In fact, they account for half of all chronic diseases in 
people over 50 years of age in developed countries. Further, every year there are roughly 8.9 
million cases of fractures, which occur due to osteoporosis only [13]. Also, approximately 1.6 
million hip fractures occur worldwide each year, by 2050 this number could reach between 
4.5 million [14] and 6.3 million [15]. Current treatments for filling bone defects and 
subsequent repair are based on autograft and allografts. Autologous grafts are the ones which 
contain essential elements for bone regeneration (osteogenic cells, osteoinductive growth 
factors and a matrix that supports adhesion and bone growth), are collected from the 
individual, minimizing the risk of rejection. Although autograft present relatively good 
percentages of success, however the range of applications is restricted, mainly due to the 
limited availability of living tissues and due to donor site morbidity [16]. Further, allograft 
bone introduces the possibilities of immune rejection and of pathogen transmission from 
donor to host. Although infrequent, infections could occur in the recipient’s body after the 
transplantation [16]. Therefore there is a severe need to search for new bone regeneration 
strategies in order to meet the increasing medical and socioeconomic challenge of our aging 
population. Hence, materials that enhance bone regeneration have a wealth of potential 
clinical applications from the treatment of non-union fractures to spinal fusion. Synthetic 
biomaterials, developed in an effort to overcome the inherent limitations of autograft and 
allograft, represents an alternative strategy. 
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2.2 Biomaterials for bone repair 
A biomaterial according to the American National Institute of Health is “Any 
substance (other than a drug) or combination of substances, synthetic or natural in origin, 
which can be used for any period of time, as a whole or as a part of a system which treats, 
augments, or replaces any tissue, organ, or function of the body”. The development of 
novel biomaterials is an iterative process that involves the creation of increasingly safer, more 
reliable, less expensive and more physiologically appropriate replacements for damaged or 
diseased human tissues. In the last 60 years, biomaterials for orthopaedic applications have 
evolved from materials available from different industrial applications into the materials with 
inherent capabilities to interact with the biological environment and to elicit specific 
biological responses. Most of the problems that orthopaedic surgery has to face have not 
basically changed, and are practically the same that orthopaedics had to face 50 years ago; 
however, the choice of possible solutions has been greatly expanded because new materials  
have allowed the design of innovative devices. Based on the evolution of biomaterials, these 
can be roughly divided into three broad categories depending upon the interaction 
mechanisms of the materials; namely inert materials (first generation biomaterials). Bioactive 
and biodegradable materials (second generation), and materials designed to stimulate specific 
cellular responses at the molecular level (third generation) [17]. This division represent the 
development in the field of biomaterials based on the requirements and properties of the 
materials involved. The present research is still devoted to the first or the second generation 
depending upon their properties and application. This means that the materials that each new 
generation brings in do not necessarily outweigh the existing materials. 
 
First generation biomaterials: Developed in the early 1950s [18], the principle 
underlying the development of first generation biomaterials was that they should be as 
chemically inert as possible in order to minimize the immune response to the foreign body  
[17]. Initially, the first generation of biomaterials consisted of already functional materials 
which were being applied in industrial applications (for e.g. aerospace) where mechanical 
properties were the main benchmark for the selection of candidate materials for implant 
manufacture. These biomaterials are mainly metallic or alloys (Co–Cr–Mo alloys, Ti6Al4V, 
etc.), ceramics (alumina, zirconia, etc.) and polymers (silicone rubber, acrylic resins) [19]. 
Though bio-inert in nature, these tend to form a thin non-adherent fibrous capsule over their 
surface with the passage of time after implantation which inhibits further interaction with 
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tissue [20]. The thickness of the layer developed is a function of the level of reactivity of the 
implant. Formation of this thin layer is attributed to the absorption of unspecific proteins that 
results in unspecific signalling to the cellular environment. This thin layer leads to loosening 
and deterioration of the mechanical fit. Eventually, surgical removal of the device is required. 
Therefore the development of bioactive interfaces eliciting a specific biological response and 
avoiding any fibrous layer was one of the main driving forces behind the development of 
second generation biomaterials. 
 
Second generation of biomaterials: Developed between the years 1970-1980. These 
biomaterials mainly include ceramics (bioactive glasses, glass-ceramics and calcium 
phosphates), biodegradable polymers (polylactic acid (PLA) and polyglycolic acid (PGA) 
etc.) [20]. Bioactive glasses discovered by Larry Hench in 1969-1971 [21] provided an 
alternative to the bio-inert materials used in orthopaedic applications. These second 
generation biomaterials were defined by their ability to interact with the biological 
environment in a controlled manner to enhance the biological response and the tissue/surface 
bonding. Further progress of the second generation biomaterials was the development of 
bioresorbable or bio-absorbable materials with the ability to undergo a progressive 
degradation while new tissue regenerates and heals [20, 22]. Bioactivity is defined as the 
ability of the material to bond to bone tissue via the formation of a bone-like hydroxyapatite 
(HA) layer on its surface [23]. The HA phase that forms on bioactive implants is equivalent 
chemically and structurally to the mineral phase in the bone, and is responsible for strong 
interfacial bonding, allowing for bone regeneration rather than replacement.  
 Second generation biomaterials have been in clinical use since 1980 in many 
orthopaedics and dental applications, including various compositions of bioactive glasses, 
ceramics, glass-ceramics, and composites. Synthetic calcium phosphate ceramics have been 
routinely used as bone cements and coatings over metallic prosthesis to facilitate bioactive 
fixation [20]. Different phases of calcium phosphate ceramics are used depending upon 
whether a bioresorbable or bioactive material is desired. Bioactive glasses and glass-ceramics 
are used as middle-ear prostheses to restore the ossicular chain and treat conductive hearing 
loss and as oral implants to preserve the alveolar ridge from the bone resorption that follows 
tooth extraction [20, 24, 25]. In comparison to the bioactive glasses and glass-ceramics, 
calcium phosphate based cements have been used in many orthopaedic applications such as 
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bone substitution, repair of bone fractures (including ligament fixation), cartilage, meniscus 
and intervertebral disc. 
 
Third generation of biomaterials: Developed in the 21
st
 century, third generation of 
biomaterials brought together separate concepts of bioresorbable and bioactive materials of 
second generation. The motive behind the design and development of these materials was to 
enhance the self-healing capabilities of the body, by the systematic stimulation of specific 
cellular responses at the molecular level [20]. Primarily, third generation biomaterials were 
developed by interchanging and intermixing of the properties of bioresorbable and bioactive 
materials. Consequently, these tailored biomaterials with new levels of bio-functionality have 
led to new approaches for the treatment of bone defects. Two main strategies have been 
followed during the last two decades with respect to tissue regeneration are TE and in situ 
tissue regeneration. 
TE is one of the approaches in which cells planted in the scaffolds are made to 
proliferate and differentiate in vitro. These tissue-engineered constructs are then implanted 
into the patients to replace diseased or damaged tissues. Clinical applications include repair 
of articular cartilage, skin, and the vascular system, although stability of the repaired tissues 
needs improvement. Another method was in situ tissue regeneration which involved the use 
of biomaterials directly implanted into the body in the form of powders, solutions, or doped 
micro-particles to stimulate local tissue repair. These materials release controlled amount of 
ionic dissolution products or growth factors such as bone morphogenic protein (BMP) by 
diffusion or network breakdown.  
 
2.3 Bioactive glasses  
Bioactive glasses are amorphous materials, compatible with the human body; bond to 
bone and can stimulate new bone growth while dissolving over time. They therefore have the 
potential to restore diseased or damaged bone to its original state and function (bone 
regeneration). Bioactive glasses belong to class A of bioactive materials which are osteogenic 
and osteoconductive materials. The first bioactive glass (silicate based) was discovered by 
Larry Hench and colleagues in 1969 using melt-quench method, at the University of Florida 
[26]. The glass composition of the first bioactive glass was 46.1% SiO2, 24.4% NaO, 26.9% 
CaO and 2.6% P2O5 (mol%), termed 45S5 Bioglass
®
, which is now a trademarked name 
(Figure 2.1).  
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Figure 2.1 Compositional dependence of bioactivity in Na2O-CaO-SiO2-P2O5 glass system 
[2].  
  
When in contact with a physiological fluid, bioactive glasses undergo a specific set of 
reactions, leading to the formation of an amorphous calcium phosphate (ACP) or crystalline 
HA phase on the surface of the glass, which is responsible for their strong bonding with the 
surrounding tissue [20]. Further, ionic dissolution products released from bioactive glasses 
(e.g. Si, Ca, P) are also reported to activate osteogenic gene expression [27, 28] and to 
stimulate angiogenesis [29, 30]. In addition to it, bioactive glasses offer remarkable 
advantages such as the ease of controlling chemical composition and, thus, the rate of 
degradation which make them attractive materials for orthopaedic applications. The structure 
and chemistry of glasses can be tailored over a wide range by changing either composition, or 
thermal or environmental processing history. Therefore, it is possible to design bioactive 
glasses with variable degradation rates to match that of bone ingrowth and remodelling.  
Based on the type of glass former, there are mainly three types of bioactive glasses: 
the conventional silicate-based glasses; phosphate-based glasses; and borate-based glasses. 
Recently, there has been an increase in interest in borate based bioactive glasses [31, 32], 
largely due its potential ability to heal chronic wounds that would not heal under 
conventional treatment [33]. The soft tissue response may be due to their lower chemical 
durability (faster dissolution) in comparison to the silica-based counterparts [31]. Also 
phosphate-based glasses have shown great potential in regenerative medicine [31], as the 
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solubility of these glasses can be controlled by modifying their composition; therefore these 
glasses show additional clinical potential as resorbable materials. Thus, benefits of phosphate 
glasses are probably related to their very rapid solubility which is strongly composition 
dependent rather than bioactivity [34].  
Oxide glasses are conventionally produced by melting the precursors (inorganic 
oxides, carbonates, fluorides and others) in precious metal or ceramic crucibles at high 
temperatures (for bioactive glasses typically above 1000 ºC, depending on the composition). 
If the cooling is rapid enough (with the necessary cooling rates depending, again, on the 
composition) crystallization will be inhibited and an amorphous material, a glass, will result. 
Another common way of preparing bioactive glasses is by a polycondensation reaction from 
organic precursors, alkoxides such as tetraethyl orthosilicate [35]. Synthesized in the early 
1990s [35], this new class of bioactive glasses displays higher compositional range of 
bioactivity: bioactive sol-gel glass compositions have been synthesized within the ternary 
SiO2:CaO:P2O5 or even within the binary SiO2:CaO systems, and might contain between 60 
and 90 mol% of silica [36, 37]. As the synthesis of glasses is highly dependent on 
composition and external conditions, sol-gel method gives better control over the surface and 
structural properties (such as surface area and porosity) of the resultant glass in comparison to 
melt-quenching method. The introduction of sol-gel synthesis technique has opened the 
research to new types of biomaterials. Many possible dopants can be introduced in a material 
synthesized via sol-gel. For example, it has been shown that sol-gel derived glasses 
containing 5 mol% ZnO resulted in increased alkaline phosphatase activity (ALP) activity 
and osteoblast proliferation [38].  
However, in the frame of the present thesis, melt-quenching was used to prepare 
glasses and sol-gel derived glasses are beyond the scope of this PhD work program. Hence, 
the subsequent discussion will solely be based on the silicate based glasses prepared by melt-
quenching. 
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2.4 Glass structure and bioactivity 
Within the glass structure, three different components are usually described. Network 
formers are able to form amorphous materials without the need for additional components. 
The basic building unit of silicate glasses is the SiO4 tetrahedron, which can be connected to 
neighbouring SiO4 tetrahedra via Si—O—Si bonds, known as bridging oxygens (BO). 
Silicon possess a charge of 4
+
 thus in the glasses when SiO4 tetrahedral forms a network these 
building units can share all their four oxygen atoms to give the stoichiometry (SiO4/2 or SiO2 
which is charge-balanced (assuming a charge of 2
– 
on the oxygen). 
 
Figure 2.2 2-dimensional representation of structure of silica glass [1].  
 
Each oxygen atom is shared between two silicon atoms, which occupy the centres of 
linked tetrahedra. Randomness in the structure is facilitated by the variability in the Si–O–Si 
angle connecting adjacent tetrahedra. Further rotation of adjacent tetrahedra around the point 
occupied by the oxygen atom linking the tetrahedra, and by rotation of the tetrahedra around 
the line connecting the linking oxygen with one of the silicon atoms results in augmentation 
in disorder in the structure. These tetrahedra are commonly referred to as Q
n
 (n = 1, 2, 3, 4) 
units, where n describes the number of BO connected to the tetrahedron. Silica glass therefore 
consists of Q
4
 units only. A 2-dimensional representation of such a structure is shown in 
Figure 2.2, where the fourth oxygen, which would sit directly above the small silicon ion, is 
not shown.  
 
Alkali-free bioactive glasses for bone regeneration  
Page 14 
 
Network modifiers, on the other hand, alter the glass structure by turning BO’s 
(predominantly covalent in character) into non-bridging oxygens (NBO’s) (Si—O- M+ 
linkages, predominantly ionic in character, where M
+
 is a modifier cation). Typical modifiers 
include the oxides of alkali or alkaline-earth metals having co-ordination number 6 or more. 
The more modifiers we have in the glass composition, lower is the average number of SiO4 
tetrahedra each tetrahedron is linked to. At the same time, the number of NBO’s in the glass 
structure increases. In conventional silicate glasses, we find large concentrations of Q
4
 and Q
3
 
units, i.e. SiO4 tetrahedra connected to neighbouring ones in four or three directions, forming 
a silicate network. The relative concentrations of BO’s and NBO’s have an important 
influence on the structure and properties of the glasses. The rigidity of the glass network 
decreases gradually by replacing bridging atoms by non-bridging atoms. 
Intermediates on the other hand can either act like typical network modifiers or enter 
the backbone of the glass structure, acting more like a network former. These have a co-
ordination ranging from 4 to 6. 
Bioactive glasses, by contrast, contain larger concentrations of network modifiers and 
smaller amounts of silica than conventional soda-lime silicate glasses, and they therefore 
consist of a more disrupted silicate network of mostly Q
2
 units. According to Tilocca [5] 
maximum bioactivity for bioactive glasses is achieved if the structure is dominated by chains 
of Q
2
 metasilicates, which are occasionally cross-linked through Q
3
 units, whereas the Q
1
 
species terminate the chain. Further, the structure of glass can also be estimated based on the 
glass composition. Different parameters have been suggested for describing the glass 
structure in the literature [39-41]. Strnad [40] introduced the concept of network connectivity 
(NC) model to describe the average number of bridging oxygens per network forming 
element and to correlate the molecular structure of silicate glasses with their bioactivity 
(apatite forming ability). In a pure silica glass (containing no network modifiers) we have 
only Q
4
 units, thus has a NC = 4. With the introduction of the network modifiers the NC 
decreases as the BO’s are converted into NBO’s. Bioactive glasses with NC value in the 
range of 2 and 3 are believed to show good bioactive properties (45S5 Bioglass
®
 has a NC of 
1.90 [39], corresponding to a structure consisting of silicate).  
However, while NC may be a useful as a qualitative and a preliminary tool to predict 
the bioactivity of glasses, its predictive power rapidly decreases when: (i) a wider range of 
glass compositions are considered; (ii) cations of similar charge are partially substituted in 
the glass compositions. It has been shown that there is no straightforward correlation between 
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the NC and the degradation behaviour bioactive glasses. For example, glass compositions 
with NC similar to that of 45S5 Bioglass
®
 (NC = ~1.95) have been shown to exhibit slower 
chemical dissolution behaviour in aqueous solutions than the latter while partial substitution 
of Zn
2+
 in bioactive glasses at the expense of  Mg
2+
 retards the apatite forming ability of 
bioactive glasses despite their NC being unchanged [42]. 
 
2.5 Mechanism of HCA layer deposition 
Even though all the composition of silicate based bioactive glasses synthesized till 
date are quite different, the mechanism of HA or HCA (hydroxycarbonate apatite) formation 
are analogous for all of them. The apatite layer forms following solution-mediated dissolution 
of the glass with a mechanism very similar to conventional glass corrosion [43]. 
Accumulation of dissolution products causes both the chemical composition and the pH of 
the solution to change, providing surface sites and a pH conducive to apatite nucleation. 
There are five proposed stages for apatite formation in body fluid in vivo or in SBF in vitro 
[20].  
STEP 1 – Reactions for the rapid exchange of ions between the modifiers in the glass 
network (Na
+
 and Ca
2+
) with H
+
 ions or H3O
+
 in solution , leading to hydrolysis of the groups 
of silica and creating silanol groups (Si–OH ) on the glass surface. This process results in a 
net increase of pH of the solution due to the increasing OH ions. 
Si − O − Na+ +  H+ → Si − OH+ +  Na+  (1) 
STEP 2 – The increase of pH leads to attack on the glass network, breaking Si–O–Si bonds. 
Soluble silica is lost in the form of Si–OH to the solution, leaving more Si–OH (silanols) at 
the glass–solution interface. These silanol groups play a vital role as the nucleation centres of 
the apatite formation.  
Si − O − Si + H2O → Si − OH + OH − Si  (2)   
 
STEP 3 – Condensation and repolymerization of SiO2-rich layer on the glass surface depleted 
in alkali and alkaline earth cations. 
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STEP 4 – Migration of Ca2+ and PO4
3–
 groups to the surface through the silica-rich layer, 
forming a film rich in amorphous CaO–P2O5 on the silica-rich layer. 
 
STEP 5 – Incorporation of hydroxyls and carbonate from solution and crystallization of the 
CaO–P2O5 film to form apatite. After the apatite layer is formed the adsorption of growth 
factors, attachment, proliferation and differentiation of osteoprogenitor cells are the 
biological mechanisms of bonding to bone. In addition to this, adsorption of adhesion 
proteins (e.g., fibronectin, vitronectin, etc.) is necessary condition for cellular attachment.  
 
2.6 Role of various functional ions  
The processes of bone formation and bone resorption (bone remodelling) are 
regulated by variety of systematic and local regulated agents including growth factors and 
hormones. Single inorganic ions are known to be involved in the bone formation and bone 
resorption (bone remodelling) and play a physiological role in angiogenesis, growth and 
mineralization of bone tissues. In particular, some metal ions act as enzyme co-factors and 
therefore influence signalling pathways and stimulate metabolic effects during tissue 
formation [44]. These properties make metal ions attractive for use as therapeutic agents in 
the fields of hard and soft TE. 
Further, bioactive glasses have the ability to exhibit surface reactivity when in contact 
with body fluids leading to the release of ionic dissolution products (example: Si, Ca, P, Mg, 
F) which further stimulate the various vital mechanisms in human body like gene expression, 
osteoblast proliferation, angiogenesis and also provide anti-bacterial as well as anti-
inflammatory effects [28, 30, 45]. In fact, it has been well established that ionic dissolution 
products are key to understand the behaviour of parent inorganic materials in vitro and in 
vivo, especially in context of TE applications [46].  
 
2.6.1 Silicon 
Silicon (Si) is a non-metallic element with an atomic weight of 28. It is the second 
most abundant element in the Earth's crust at 28 wt%. Si is known to be an essential element 
Si O 
O 
O 
H O Si OH 
O 
O 
O H 2 O + + Si 
O 
O 
O Si 
O 
O 
O O   (3) 
Alkali-free bioactive glasses for bone regeneration  
Page 17 
 
for metabolic processes related with the formation and calcification of bone tissue [44]. 
Silicon is present in all body tissues, but the tissues with the highest concentrations of silicon 
are bone and other connective tissue including skin, hair, arteries, and nails [47]. Silicon 
plays an important role in the formation of cross-links between collagen and proteoglycans 
[48-50]. In vitro studies have demonstrated that silicon stimulates type I collagen synthesis 
and osteoblast differentiation [51]. Studies in rats have demonstrated that silicon at 
physiological levels improves calcium incorporation in bone when compared to rats that are 
deficient in silicon [52-54]. Additionally, dietary Si intake was shown to increase the bone 
mineral density (BMD) in men and premenopausal women. Further Si intake has shown to 
improve BMD by bone resorption in case of calcium deficiency in rats [55]. Moreover, it has 
been reported that Si has a biochemical function in bone growth processes affecting bone 
collagen turn over and sialic acid-containing ECM proteins like osteopontin. Moreover, 
orthosilicate acid (Si(OH)4) at physiological concentration of 10 mmol has been shown to 
stimulate collagen I formation in human osteoblast cells (HOC) and to stimulate osteoblastic 
differentiation [44].  
 
2.6.2 Strontium 
Strontium (Sr) is an abundant and widely distributed element in the geosphere, natural 
water and human tissues. The amount of Sr in the skeleton is only 0.335% of its Ca content 
[56]. The biological properties of strontium are related to its chemical similarity to calcium. 
Sr can accumulate in bone by exchanging with Ca in the HA crystal lattice Thus strontium 
accumulates to a high degree in bone, can displace calcium in hard tissue metabolic processes 
and at high concentrations interferes with normal bone development. Low levels of Sr have 
been known to be associated with low energy fracture sites. Presence of strontium lactate 
enhances Ca deposition in the bone and reduces bone pain in osteoporosis patients. Sr ions 
have been shown to stimulate osteoblastic bone formation and to inhibit osteoclastic bone 
resorption both in vitro and in vivo [56, 57]. Sr drew attention as a drug for the management 
of osteoporosis in the 1950s. Indeed, strontium ranelate (Protelos) is a drug approved for 
treatment and prevention of osteoporosis.  Owing to the above-mentioned beneficial aspects 
of Sr in bone regeneration and considering the ion releasing ability of glasses in aqueous 
medium, bioactive glasses incorporated with Sr have gained considerable attention in the 
recent past for various orthopaedic applications. Sr-containing bioactive glasses were shown 
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to combine the known bone regenerative properties of bioactive glasses with the anabolic and 
anti-catabolic effects of Sr cations in vitro [58]. 
 
2.6.3 Zinc 
Zinc (Zn) plays a vital role in bone formation, resorption and TE as it directly 
activates aminoacyl–tRNAsynthetase (a rate-limiting enzyme at translational process of 
protein synthesis) in osteoblastic cells and stimulates cellular protein synthesis [42]. Zn has 
also been shown to stimulate gene expression of the transcription factors: runt-related 
transcription factor 2 (Runx2) that is related to differentiation into osteoblastic cells. 
Moreover, Zn inhibits osteoclastic bone resorption by inhibiting osteoclast–like cell 
formation from bone marrow cells and stimulating apoptotic cell death of mature osteoclasts 
[42].  
In case of soft tissue regeneration, Zn has been proved to be an essential element for 
wound healing [30, 44, 45]. It is an essential trace mineral for DNA synthesis, cell division 
and protein synthesis during the proliferative phase of wound healing [42]. Zn deficiency has 
been associated with poor wound healing and decreased breaking strength of animal wounds 
[44] which can result from decreased protein and collagen synthesis during healing found in 
Zn deficient animals. Agren et al [59] demonstrated the beneficial aspect of topically applied 
Zn on leg ulcer healing and wound healing in animal models. It was shown that topical zinc 
oxide promotes cleansing, re–epithelialisation and inhibits bacterial growth. 
 
2.6.4 Magnesium 
Magnesium (Mg) is the fourth most abundant cation in human body with 
approximately half of the total physiological Mg stored in bone tissue [60]. It is essential to 
bone metabolism and has been shown to have stimulating effects on new bone formation 
[61]. Mg is a co-factor for many enzymes, and stabilizes the structures of DNA and RNA. 
Depelition of Mg in body results in impaired bone growth, increased bone resorption and loss 
in trabecular bone [62, 63]. The level of Mg in the extracellular fluid ranges between 17 ppm 
and 25.5 ppm, where homeostasis is maintained by the kidneys and intestine [60, 64]. 
Although Mg levels exceeding 25.5 ppm can lead to muscular paralysis, hypotension and 
respiratory distress and cardiac arrest occurs for severely high serum levels of 145–170 ppm, 
the incidence of hyper- Mg is rare due to the efficient excretion of the element in the urine 
[60, 64, 65].  
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2.6.5 Calcium 
Calcium (Ca) accounts for 1-2 % of the adult human body weight [66], and a major 
component of mineralized tissues, approximately 99% of body Ca is found in bone, where it 
serves a key role as a component of HA. Ca plays an important role in osteoblast proliferation 
and bone remodelling by directly activating intracellular mechanisms by affecting Ca-sensing 
receptors in osteoblastic cells. The influence of Ca in the body is highly concentration 
dependent. Maeno et al. [67] found that Ca concentrations in blood varying within the range 
of 48 mmol are suitable for osteoblast proliferation, differentiation and extracellular matrix 
(ECM) mineralization, whereas higher Ca concentrations (>10 mmol) are cytotoxic. 
Extracellular Ca also plays an important role in the control of bone remodelling by directly 
regulating parathyroid cells through activation of the seven-transmembrane-spanning 
extracellular calcium-sensing receptor (CaSR), a member of the G-protein coupled receptor 
(GPCR) family [68]. Similar results were observed by Valério et al. [69], who found that 
extracellular Ca increases the glutamate release of osteoblastic cells. Since glutamate 
signalling pathways are known to play an important role for bone mechano sensitivity [70], 
extracellular Ca concentration must be considered as an important regulating agent in bone 
metabolism 
 
2.6.6 Phosphorus 
Phosphorus (P) is an essential nutrient for human and animal life. It is fundamental to 
growth, maintenance, and repair of all body tissues, and is necessary, along with calcium and 
magnesium, for proper growth and formation of bones in infants and children. P being a 
major component of the inorganic phase of human bone plays an important role in bone 
formation as it stimulates expression of matrix Gla protein (MGP), a key regulator for bone 
formation, in osteoblastic cells when added (10 mmol) to cell culture medium in 
concentration of <30 ppm [71, 72]. This release in controlled amounts has been shown to 
favour biomineralisation and induce expression of osteogenic messenger RNA transcripts 
while an increase in concentration of P beyond 30 ppm results in decrease in cell viability 
[72].  
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2.7 Introduction to the present work 
Since the discovery of 45S5 Bioglass
®
 in 1971 there has been a heightened interest in 
the science and biomedical application of bioactive glass over the last two decades, as 
evidenced by the growing number of publications in the field (Figure 2.3). Many artificial 
biomaterials based on, or inspired by Hench’s glass have been developed and successfully 
employed in clinical applications for repairing and replacing parts of a human body 
Figure 2.3 Number of papers published per year in the field of ‘‘bioactive glass’’ (compiled 
from a literature search SCOPUS carried out in November 2014). 
 
. This field is continuously expanding: new processing routes have extended the range 
of applications towards new exciting directions in biomedicine [17], many of which still rely 
on the original Hench’s base formulation, which is now considered a benchmark for the 
bioactive materials. Table 2.1 lists some bioactive glass compositions compiled from 
literature. Although the use of 45S5 Bioglass
®
 in numerous clinical programs has exhibited 
favourable healing capability, one of the main problems associated with this glass is its high 
dissolution rate [73], mainly owing to its high alkali content. Our recent studies have shown 
that alkali-incorporation in bioactive glasses decreased their apatite forming ability during 
initial 72 hours of reaction with body fluids due to excessive release of sodium from the 
glasses [74], thus leading to apoptosis.  
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Table 2.1 Selected bioactive glass compositions (mol%). 
 
With reference to the use of 45S5 Bioglass
®
 in vivo, Vogel et al. [81] showed that this 
glass has good biological efficacy in cases where shorter healing periods are required (~1 
month). However, this glass may not be a good option for serious injuries requiring 
prolonged treatment. Similarly, most of the bioactive glass compositions investigated so far 
and reported in papers [75-80, 82-87] and registered in a number of patents [75, 88-92] 
contain significant amounts of alkali oxides (Na2O, K2O). Although the incorporation of 
alkali oxides in bioactive glass is advantageous for their production, as they reduce their 
melting temperature, their presence in bioactive glass can reduce the usefulness of the glass 
in vivo. Often bioactive glasses for certain biomedical applications require heat treatments 
(coatings, sintering of porous scaffolds). When intended for coatings metal prosthesis the 
coefficient of thermal expansion has to match that of the metallic substrate. On the other 
hand, a good sintering ability is essential for achieving the required mechanical stability. 
These essential requirements are not fulfilled by alkali-rich bioactive glass compositions. As 
a matter of fact, high alkali contents degrade the working range of bioactive glasses by 
increasing the crystallization tendency of glass, thus rendering them unfit for use as bioactive 
porous scaffolds or porous coatings [93]. For example, in the case of 45S5 Bioglass
®
, owing 
to its poor sintering ability, there have been problems with the manufacture of highly porous 
scaffolds possessing good mechanical. Hence, these drawbacks related to the alkali content of 
the bioactive glasses can be overcome by reducing the alkali contents or even by adopting 
alkali-free bioactive glass compositions.  
 SiO2 P2O5 Na2O CaO K2O MgO CaF2 
45S5 [26] 46.1 2.6 24.4 26.9    
45S5F [75] 46.1 2.6 24.4 16.9   10 
S53P4 [76] 53.9 1.7 22.7 21.8    
13-93 [77] 54.6 1.7 6.0 22.1 7.9 7.7  
6P61 [78] 61 2.5 10 13.5 2.4 10.7  
6P55 [78] 54.1 2.5 11.5 15.9 3.4 12.6  
A-W [79] 35.4 7.2 - 49.9 - 7.1 0.4 
ICIE1[80] 49.46 1.07 26.38 23.08    
ICIE16 [80] 49.46 1.07 6.6 36.27 6.6   
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The initial work for the development of alkali-free bioactive was made by Kukubo et 
al. in the year 1982, who designed a series of alkali-free glasses in the 3CaO•P2O5 – 
CaO•SiO2 – MgO•CaO•2SiO2 system [79]. The Apatite-Wollastonite (A-W) glass-ceramics 
designed by Kukubo et al. [94, 95] exhibit excellent mechanical properties as well as good in 
vitro and in vivo behaviour. Kasuga et al. [96] studied the effect of magnesium and 
aluminium on the bioactivity of the alkali-free glasses. Results indicated that Al2O3 tends to 
inhibit the apatite forming ability of the glasses and magnesium tends to slow down (but not 
hinder) the apatite forming ability of glasses when immersed in SBF solution. K. Ohura et al. 
[97] incorporated various ions into CaO-SiO2 based glasses and studied their effect on the in 
vivo performance. The formation of a calcium phosphate layer was achieved in the all the 
glasses except for the ones containing Fe2O3. In the mid 1990 Galliano et al. [98] investigated 
the influence of Mg
2+
 and Sr
2+
 on the structure and thermal behaviour of glasses in the 
CaOSiO2P2O5CaF2 system. To the best of our knowledge, this is one of the foremost 
studies on Sr-containing bioactive glasses. 
In another study, Salinas et al. [99] reported on the influence of Mg on the in vitro 
bioactivity of slightly modified A-W glasses and glass-ceramics. The results showed 
negligible changes in bioactivity of glasses; however, presence of Mg led to the appearance 
of new crystalline phases in the glass-ceramics which were able to suppress the in vitro 
bioactivity. Further, an extensive work has been done by Oliveira et al. [100-102] using 
29
Si 
and 
31
P MAS-NMR to investigate the structure versus bioactivity (assessed through 
immersing the glass samples in SBF) relationship of bioactive glasses compositions without 
alkali content. In 2006 Kamitakahara et al. [103] designed alkali-free Di based glass-ceramics 
and investigated their mechanical strength and bioactivity. They found that the flexural 
strength of an eutectic glass–ceramic composition 38 TCP–62 Di (wt.%) was higher than 200 
MPa. However, no further studies dealing with this system have been reported since that, and 
our attempts to reproduce these results were unsuccessful. Recently, Kansal et al. [104-106] 
investigated the structure, thermal and dissolution behaviours of alkali-free glasses and glass-
ceramics in Di-based glasses using MAS-NMR and ICP-AES. The as developed glasses 
exhibited better sintering ability than 45S5 Bioglass
®
 and good in vitro bioactive properties.  
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2.7.1 Aim of the thesis 
Despite of extensive amount of work done by scientists all over the world, literature 
survey reveals that since the earnest 1970s, most of the work in the field of bioactive glasses 
has been mainly focused upon understanding the compositional dependence of glass 
dissolution for 45S5 Bioglass
®
 (46.1% SiO2, 24.4% Na2O, 26.9% CaO and 2.6% P2O5 in 
mole percent) or other silicate glasses with similar compositions [77, 107-109]. Further, last 
few years have witnessed a consistent upsurge of studies attempting correlating the atomic 
and molecular structure of silicate glasses with their chemical dissolution and bioactivity 
behaviours [5, 80, 110-112]. Simultaneously, significant efforts have been made either to 
unearth the influence of functional ions on the structure of bioactive glasses [113-118] or to 
study their influence on the chemical dissolution behaviour of glasses [119-125]. However, 
few attempts have been made to elucidate about the correlation between the structural role of 
these functional ions and the chemical degradation and bioactivity of glasses [23, 42, 87, 104, 
126] especially in case of alkali-free bioactive glasses. Despite significant progress made in 
the pursuit of establishing relationships between chemical composition, molecular structure 
and bioactivity of silicate glasses, we are still not in a position to develop scientifically robust 
and statistically accurate models to predict the chemical dissolution and bioactivity of glasses 
mainly because most of the studies available in scientific literature still revolve around 
structure-property relationships of glasses based on or inspired by 45S5 Bioglass
®
 [5, 110, 
111, 127-129].  
 Therefore, in the present doctoral work we have tried to design and characterize 
glasses covering far from region of high alkali-content in an attempt to find a possible 
solution for the above discussed long-standing problem of alkali-containing glasses. 
Accordingly, the work reported in this dissertation has been directed towards fulfilment of the 
following aims: 
1. To design alkali-free bioactive glasses having high bioactivity, lower dissolution rate and 
good sintering behaviour so as to prove their efficacy for bone regeneration and TE 
applications.  
2. To understand on the structure-property relationships in alkali-free bioactive glasses  
3. To understand effect of various functional ions on the structure and its implications on 
the biodegradation behaviour of the glasses and its impact on in vitro behaviour of 
glasses. 
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4. To understand the effect of these functional ions on sintering, crystallization behaviour 
of bioactive glasses and glass-ceramic. 
 
We hope that the work reported in this dissertation will be a good contribution to the growing 
literature in the field of bioactive glasses, that will enable us to create a succinct database 
which can be further used to develop models for designing bioactive glasses with controlled 
chemical degradation rate and high bioactivity with novel applications in the field of human 
biomedicine.    
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Chapter 3 
Experimental 
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3. Experimental 
3.1 Glass synthesis 
High purity powders of SiO2 (BDH Chemicals Ltd., UK, purity >99.0%), CaCO3 
(BDH Chemicals Ltd., UK, purity >99.0%), MgCO3 (BDH Chemicals Ltd., UK, purity 
>99.0%), NH6PO4 (Sigma Aldrich, Germany, >99.0%), ZnO (Sigma Aldrich, Germany, 
>99.9%), SrCO3 (Sigma Aldrich, Germany, >99.9%) and CaF2 (Sigma Aldrich, Germany, 
325 mesh, >99.9%) were used. All the glass compositions have been prepared by melt-
quenching technique. Homogeneous mixtures of batches (~100 g) obtained by ball milling, 
were preheated at 900 ºC for 1 h for calcinations and then melted in platinum (Pt) crucibles at 
1570-1590 ºC for 1 h. The glasses were obtained in bulk form by casting the glass melt on a 
metallic mould and then annealing the glass at 500-700 ºC for 1 h. The glasses were obtained 
in frit form by quenching of glass melts in cold water. The frits were dried and then milled in 
a high-speed agate mill resulting in fine glass powders with mean particle sizes of ~ 10–20 
μm (determined by light scattering technique; Coulter LS 230, Beckman Coulter, Fullerton 
CA; Fraunhofer optical model). The amorphous/crystalline nature of frits was confirmed by 
X-ray diffraction (XRD) analysis (Rigaku GeigerflexD/Max, Tokyo, Japan; C Series; Cu Kα 
radiation; 2θ angle range 10º–60º; step 0.02º s−1. 
 
3.2 Density and Molar volume 
Archimedes’ method [i.e. immersion in diethyl phthalate (C12H14O4) (molar mass: 
222.24 g mol
–1
; density: 1.12 g cm
–3
)] was employed to measure the apparent density of the 
bulk annealed glasses and glass-ceramics. Molar volume (Vm), was calculated using the 
density data for the bulk glasses using following relations: 
𝑉𝑚 =  
𝑀
𝜌
 
Where M is the molar mass of the glass and  is the apparent density of the bulk glasses. 
 
3.3 Structural characterization of glasses 
3.3.1 Magic angle spinning (MAS) – Nuclear magnetic resonance (NMR) spectroscopy 
The 
29
Si MAS-NMR spectra were recorded on a Bruker ASX 400 spectrometer 
operating at 79.52 MHz (9.4 T) using a 7 mm probe at a spinning rate of 5 kHz and 60 
seconds delay time was used. Kaolinite was used as the chemical shift reference. The 
31
P 
MAS-NMR spectra of glasses were recorded using 4 mm probe on a Bruker ASX 400 
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spectrometer operating at 161.97 MHz with 45º pulses, spinning rates of 12 kHz, a 60 s 
recycle delay and the chemical shift was quoted in ppm from phosphoric acid (85%). 
 3.3.2 Infra-red spectroscopy.  
Fourier transform infrared (FTIR) spectra of the glasses (before and after immersion 
in SBF) were obtained using an Infrared Fourier spectrometer (FTIR, model Mattson Galaxy 
S-7000, USA). For this purpose glass powders were mixed with KBr in the proportion of 
1/150 (by weight) and pressed into a pellet using a hand press. 64 scans for background and  
64 scans per sample were made with signal gain 1. The resolution was 4 cm
–1
. The bands 
were assighned as per the Table 3.1 [119, 208]. 
 
Table 3.1 Infrared bands of functional groups of bioactive glasses.  
Vibration mode Wavenumber (cm
˗1
) 
Si-O-Si 415-540 
P-O bend crystal 515-530 
P-O bend crystal 550-560 
P-O bend amorphous 570-600 
P-O bend crystal 600-610 
C-O stretch 800-890 
Si-O-Si tetraedral 860-1175 
Si-O stretch 1000-1100 
P-O stretch 910-1040 
P=O stretch 1180-1350 
 
 
3.4 Biodegradation of glasses 
The in vitro bioactivity of glasses, reflected in their capability of inducing HA-
formation onto their surfaces, was investigated by immersion of glass powders in simulated 
body fluids (SBF) (0.10 g glass powder in 50 ml SBF solution) at 37 ºC. SBF had an ionic 
concentration (Na
+
 142.0, K
+ 
5.0, Ca
2+
 2.5, Mg
2+
 1.5, Cl
−
 125.0, HPO4
−
 1.0, HCO3
2− 
27.0, 
SO4
2− 
0.5 mmol l
−1
) nearly equivalent to human plasma, as discussed by Tas [130]. The 
powder–SBF mixtures were immediately sealed into sterilized plastic flasks and were placed 
in an oven at 37 ºC (± 0.5 ºC). The SBF solution was replaced every 48 h and sampling took 
place at variable times ranging from days to weeks. The experiments were performed in 
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duplicate in order to ensure the accuracy of results. The apatite forming ability on glass 
powders was followed by XRD and FTIR analysis.  
The degradation tests were performed according to the standard ISO 10993–14 
“Biological evaluation of medical devices – Part 14: Identification and quantification of 
degradation products from ceramics”. The test simulates the more frequently encountered in 
vivo pH (7.4 ± 0.1) and therefore investigates the degradation of glasses/ceramics in freshly 
prepared Tris–HCl buffered solution. The glass powder with particle size varying between 
300 – 400 μm was added to the Tris–HCl solution (2.5 g glass powder in 50ml Tris–HCl 
solution). The tests were carried out without solution replacement at 37 ºC and with a mixing 
speed of 120 rpm. The sampling was done after 120 h, when the solid and liquid phases were 
separated by filtering (0.22 μm, Millex GP, Millipore Corporation, USA). The solid samples 
were then washed in deionised water and dried in an oven to a constant weight. The structural 
changes (if any) in the glasses after immersion in Tris–HCl were analysed by XRD and FTIR 
analysis. The pH and elemental concentrations (Ca
2+
, Sr
2+
, Mg
2+
, PO5
5-
, SiO4
4+
) (ICP-AES; 
JobinYvon, JY 70 plus, France) of the soaking solutions were measured. The relative weight 
loss percentage (WL) of the glass samples after 120 h of immersion in the solutions was 
calculated from the following equation: 
100
0
0 




 

W
WW
W tL  
Where W0 refers to the weight of the glasses before immersion and Wt refers to their weight 
after immersion in Tris-HCl. 
 
3.5 Thermal analysis 
3.5.1 Sintering behaviour- hot stage microscope (HSM) 
 The sintering behaviour of the glass powders was investigated using a side-view hot 
stage microscope (HSM) EM 201 equipped with image analysis system and 1750/15 Leica 
electrical furnace. The cylindrical shaped samples with height and diameter of ~3 mm were 
prepared by cold-pressing the glass powders. The cylindrical samples were placed on a 10 × 
15 × 1 mm alumina (>99.5 wt% Al2O3) support. The temperature was measured with a Pt/Rh 
(6/30) thermocouple contacted under the alumina support. The microscope projects the image 
of the sample through a quartz window and onto the recording device. The computerized 
image analysis system automatically records and analyses the geometry changes of the 
sample during heating. The image analyser takes into account the thermal expansion of the 
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alumina substrate while measuring the height of the sample during firing, with the base as a 
reference. The HSM software calculates the percentage of decrease in height, width and area 
of the sample images. The measurements were conducted in air with a heating rate (β) of 5 K 
min
–1
.  
 
3.5.2 Differential thermal analysis 
 The values of the glass transition temperature (Tg), crystallization onset temperature 
(Tc) and peak temperature of crystallization (Tp) were obtained by differential thermal 
analysis (DTA)  using a Setaram LabSys TG–DTA16 instrument (Setaram Instrumentation, 
France) calibrated in the temperature range 25–1000 ºC. The measurements were performed 
using powdered glass samples (50 mg) in an alumina crucible and –alumina powder as 
reference at a heating rate (β) of 5 K min–1 and 20 K min–1. 
 
3.6 Preparation of glass-ceramics 
Glass-ceramics can be prepared either by nucleation and crystallization through 
suitable heat treatments given to monolithic glasses, or by sintering and crystallization of 
glass powder compacts. Rectangular bars with dimensions 4 × 5 × 50 mm
3
 and circular disc 
shaped pellets with diameter 20 mm and thickness ~3 mm were prepared from fine glass 
powders by uniaxial pressing (80 MPa). The glass powder compacts were sintered under 
isothermal conditions for 1 h at the different temperatures. A slow heating rate (β) of 5 K 
min
–1
 was maintained in order to prevent deformation of the samples. 
 
3.7 Characterization of glass-ceramics 
3.7.1 Mechanical Properties of sintered glass-ceramics 
The mechanical properties were evaluated by measuring the three-point bending 
strength of rectified parallelepiped bars (3 × 4 × 50 mm
3
) of sintered glass-ceramics 
(Shimadzu Autograph AG 25 TA, Columbia, MD; 0.5 mm min
–1
 displacement). The mean 
values and the standard deviation presented for shrinkage and density were obtained from (at 
least) ten different samples. 
 
3.7.2 Microstructural characterization- SEM and EDS 
 Microstructural observations were made on polished surfaces of the sintered and heat 
treated glass powder compacts (chemically etched by immersion in 2 vol% HF solution for 
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duration of 2 min) by scanning electron microscopy (SEM; SU–70, Hitachi). In addition, 
energy dispersive spectroscopy (EDS; Bruker Quantax, Germany) has been utilized to study 
the distribution of elements.  
 
3.8 In vitro studies 
3.8.1 Alkali-free glasses for bone tissue engineering: A preliminary investigation 
3.8.1.1 Mesenchymal stem cell proliferation  
The biological performance of the as developed glass-ceramics was addressed by the 
in vitro cellular responses, including cell proliferation and osteoblastic differentiation. The 
results were compared with the tissue culture plastic used as a control. For the cellular study, 
mesenchymal stem cells (MSCs) derived from rat bone marrow were used. MSCs have been  
a potential source for the regenerative therapy of tissues including bone, because of their 
multipotent and self-renewal capacity without the concern of ethical issues. The experimental 
procedures were based on their previous work [28] and followed by the guidelines approved 
by the Animal Ethics Committee of Dankook University. MSCs gathered from the bone 
marrow of rats were maintained in a normal culture medium containing -minimal essential 
medium (MEM) supplemented with 10% foetal bovine serum (FBS), 100 U ml
–1
 penicillin 
and 100 mg ml
–1
 streptomycin in a humidified atmosphere of 5% CO2 in air at 37 ºC.  
MSCs maintained up to 3-4 passages were used for cellular study. The glass-ceramics 
were sterilized with 70% ethanol for 1 h prior to seeding cells. For the cell growth study, 
MSCs were seeded on each sample (15 mm × 2 mm disc type) and then cultured in the 
normal culture medium condition as described above. After culture for 3, 7 and 14 days, the 
cell growth level was analysed by the cell counting kit (CCK) assay. At each time of 
culturing (3 and 7 days), the CCK-8 reagent was added to each sample and incubated for 3 h 
at 37 ºC. The absorbance was measured at a wavelength of 450 nm using a microplate reader 
(Molecular Devices, USA). The cell growth morphology was observed by SEM (Hitachi) 
after fixation the cells with 2.5% glutaraldehyde, dehydration with a graded series of ethanol 
(50, 70, 90 and 100%) and coating with gold.  
 
3.8.1.2 Alkaline phosphatase activity 
The osteoblastic differentiation of the MSCs on the glass-ceramics was determined 
by measuring the ALP activity. Cells were seeded on each sample (15 mm × 2 mm disc type), 
and cultured in the osteogenic medium containing 50 μg ml−1 sodium ascorbate, 10 mM β-
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glycerol phosphate, and 10 nM dexamethasone. After culture for 7 and 14 days, cellular 
samples were gathered and added to the ALP reaction media to allow an enzymatic reaction 
according to the manufacturer’s instruction (Sigma). The quantity of samples used for the 
reaction was determined based on the total protein content which was determined by using a 
commercial DC protein assay kit (BioRad). As a result of the reaction, the product p-
nitrophenol appears as the colour change which was then measured at an absorbance of 405 
nm using a spectrophotometer.  
The CCK and ALP assays were performed on three replicate samples (n = 3). Data 
were represented as means ± standard deviations. Statistical analysis was carried out by 
analysis of variance (ANOVA) and significance level was considered at p < 0.05.  
 
3.8.2 Influence of ZnO/MgO substitution on sintering, crystallization, and bio-activity of 
alkali-free glass-ceramics 
Similar procedure as mention in section 3.8.1 was used.  
 
3.8.3 Role of glass structure in defining the chemical dissolution behaviour, bioactivity 
and antioxidant properties of zinc- and strontium- co-doped alkali-free phosphosilicate 
glasses 
3.8.3.1 In vitro cellular tests  
For investigating the cellular responses and antioxidative effect for the developed 
glass compositions (ZS–2 to ZS–8), thin slices of glasses measuring ~1 mm of thickness were 
prepared by cutting and polishing the bulk annealed glasses. Tissue culture plastic was used 
as a control.  
 
3.8.3.1 Cell Culture studies   
Human osteosarcoma cell line MG63 was obtained from National Centre for Cell 
Science (NCCS), Pune, India and maintained on Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with streptomycin (100 U ml
1), gentamycin (100 μg ml1), 10% 
FBS (Sigma-Aldrich) at 37 ºC and humid environment containing 5% CO2. MTT was used to 
assess cell integrity and potential cytotoxicity of the plant extract by monitoring the uptake of 
the vital mitochondrial dye, 3-[4,5-dimethylthiazol-2-yl]- 2,5-diphenyl tetrazolium bromide 
(MTT) by cell mitochondria. 
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Binding of MG63 cells to glass samples was carried out in 24 well plates. Rectangular 
shaped, sterilized glass slices were kept in triplicates in the 24 well plates. The wells without 
glass samples were considered as control. 500 µl of lymphocyte suspension at a concentration 
of 2×10
4 
cells ml
1 
was added to each well. The plate was then incubated at 37 ºC, 5% CO2 in 
air and 90% relative humidity in CO2 incubator for 96 h. Four hours before the termination of 
cultures, 500 l of MTT (2 mg ml1) prepared in serum free medium was added to each well. 
After 4 h, 500 l of DMSO (Dimethyl sulfoxide) was added to each well. The blue colored 
formazan formed was read at 570 nm with Labsystems Multiskan EX ELISA reader against a 
reagent blank. 
The cells on disks were fixed with freshly prepared Karnovsky’s fixative (2% 
paraformaldehyde; 2.5% glutaraldehyde in 0.1 M phosphate buffer pH 7.4.) at 4 ºC for 90 
min. After fixation, the fixative was removed and cells were washed for 2 min with 0.1 M 
phosphate buffer. Further, cells were fixed in 1% buffered osmium tetroxide (prepared in 
phosphate buffer) for 90 min at 4 ºC. The cells were further dehydrated with various 
concentrations of ethanol starting with 30% for 5 min twice and repeating the same with 50, 
75, 95% and absolute ethanol. After critical point drying, cells were photographed with 
EVO
®
 LS10 Life Science SEM. 
 
3.8.3.2 Cytoprotective assay 
Cytoprotective effect of bioactive glasses was carried out on hydrogen peroxide 
(H2O2) induced oxidative stress in human MG63 cells. The H2O2 dose (LD50) for 
cytoprotection studies was calculated by treating cells at 50% confluency with H2O2 (7.5 µM 
to 1000 µM diluted in medium) for 12 h in serum free medium. The glass slices were kept in 
triplicates in the 24 well plates. The wells without glass samples and H2O2 were considered as 
negative control and cells with H2O2 along with glass samples were kept as positive controls. 
500 µl of cell suspension at a concentration of 2×10
4 
cells ml
1 
was added to each well. The 
plate was then incubated at 37
 
ºC, 5% CO2 in air and 90% relative humidity in CO2 incubator 
for 72 h. The LD50 dose of H2O2 was given at this point to induce the oxidative stress for 12 
h in the wells with and without glass samples except negative control. Four hours before the 
termination of cultures, 500 l of MTT (2 mg ml1) prepared in serum free medium was 
added to each well. After 4 h, 500 l of DMSO was added to each well. The blue colored 
formazan formed was read at 570 nm with Labsystems Multiskan EX ELISA reader against a 
reagent blank. 
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3.8.4 An experimental approach towards understanding the composition-structure-
bioactivity relationships in silicate glasses 
3.8.4.1 Cell Culture Studies 
Human mesenchymal stem cells (hMSC, Lonza) were thawed and then cultured in 
175 cm
2
 tissue culture flasks containing DMEM (Gibco), supplemented with 10% v/v 
inactivated FBS (Gibco), and 1% v/v penicillin/streptomycin (P/S, Gibco). Cells were 
maintained at 37 ºC under a 5% CO2 humidified atmosphere. The medium was changed every 
third day until confluence, when cells were be sub-cultured in order to prevent cell death. In 
order to sub-culture, the cell monolayer was washed with phosphate buffered saline (PBS) 
(Sigma) and incubated with a trypsin/ethylene diamine tetra acetic acid (EDTA) solution for 
8 min at 37 ºC to detach the cells. The effect of trypsin was then inhibited by adding culture 
medium at room temperature. Cells were used in the passage six. 
The glass samples were autoclaved (120 ºC, 20 min) and placed in untreated 48-well 
plates (~ 1 cm
2
 surface area) (Cellstar
®
) to avoid cell adhesion to the bottom of the wells. The 
controls were wells treated with poly-D-lysine. The cells were seeded at 2×10
4
 cells per well 
and fresh medium was added, followed by incubation at 37 ºC for 4 h to allow cell adhesion. 
Afterwards, fresh medium was added until it reached a final volume of 400 µl per well. To 
induce the hMSCs differentiation along the osteoblastic lineage, cells were also cultured with 
osteogenic medium: basal medium supplemented with 10 µl ml
1
 glycerophosphate (Sigma), 
10 µl ml
1
 dexamethasone (Sigma), and 10 μl ml1 ascorbic acid (1.61 mg ml1) (Fluka). 
hMSCs were cultured on samples of the glass for periods of 1, 3, 7, 14 and 21 days. At each 
time point, the samples were evaluated for cell metabolic activity, viability, morphology and 
differentiation. 
 
3.8.4.2 Cell metabolic activity 
A resazurin method was used to assess metabolic activity at days 1, 3, 7, 14 and 21. A 
resazurin solution (Sigma) was added to fresh medium at a final concentration of 10% (v/v). 
Cells were incubated in this solution at 37 ºC for 3 h, after which, 100 µl per well were 
transferred to a 96-well black plate and fluorescence was measured (530 nmEx/590 nmEm) 
in a Spectra Max Gemini XS (Molecular Devices). 
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4 Results and Discussion 
4.1 Alkali-free glasses for bone tissue engineering: A preliminary investigation  
4.1.1 Introduction 
The present chapter reports on a preliminary attempt to find a feasible solution for the 
above discussed long-standing problem of designing alkali-free bioactive glasses. In this 
pursuit, the alkali-free glass compositions have been designed in the system Di–FA–TCP 
with a general formula (Di) (90x)–(FA)10–(TCP)x (x = 10–40 wt%). Table 4.1.1 presents 
the detailed compositions of the glasses. The present composition has been selected due to 
following reasons:  
 
Table 4.1.1 Nominal composition of the as-designed glasses (mol%).  
 
Glass SiO2 P2O5 CaO MgO CaF2 
TCP-10 42.57 3.57 32 21.29 0.57 
TCP-20 38.49 5.61 36.07 19.24 0.59 
TCP-30 34.12 7.79 40.42 17.06 0.61 
TCP-40 29.44 10.12 45.08 14.73 0.63 
 
Di belongs to the group of inosilicates and is an important member of clinopyroxene 
group with composition CaMgSi2O6. The structure of amorphous Di is dominated by Q
2
 unit 
which is a positive attribute for bioactivity in glasses. Also, it has been demonstrated that Di-
based ceramics and glass-ceramics have no general toxicity in cell cultures and help in bone 
regeneration [131, 132]. Nakajima et al. [133, 134] found that Di possessed ability to form 
apatite in SBF and could closely bond to bone tissue when implanted in rabbits. Aza et al. 
[132] investigated the reactivity of the material in a natural medium of high protein content 
by soaking Di based ceramic pellets in human parotid saliva (HPS) over various time 
intervals. Also Yoganand et al. [135] synthesized bioactive glass-ceramics with the help of 
transferred arc plasma technique in the system CaOMgOSiO2 with Di as the major 
crystalline phase.  
In addition to the biocompatibility aspect of Di based ceramics and glass-ceramics; 
they are known to exhibit superior mechanical properties in comparison to many of their 
ceramic counterparts. Nonami et al. [131] reported significantly improved fracture toughness 
values for pure sintered HA with added Di.  It was reported that the bending strength and 
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fracture toughness of Di-HA composite was 2 to 3 times higher in comparison to that of 
sintered HA. Therefore, owing to the presence of Di, we can expect superior mechanical 
properties for the glass-ceramics without compromising their biomedical characteristics. 
Further, the presence of hydroxy-, oxy- or fluoro- apatite is highly favourable for 
biomedical applications. In particular, FA based glasses and glass-ceramics have gained 
attention [104, 105, 136, 137] due to their structural and chemical similarities with bone 
forming mineral, HA [87]. Also, fluoride is known to increase bone density and also has anti-
carcinogenic properties [104]. Further, intracellular or plaque-associated enzymes have been 
reported to be affected by fluoride ions [104]. Alkali-free Di-FA-W bioactive glass-ceramics 
for replacement materials for tooth roots, dental crowns were developed by Shibuya et al. 
[88], while Tulyaganov et al. [138] developed glass-ceramics in ternary system tetrasilicic 
mica-FA-Di. Recently Kansal et al. [104, 105] reported the biodegradation behaviour of the 
Di-FA based glasses.  
Similar to Di-FA join, glass-ceramics along Di-TCP join have been a subject of 
interest due to their potential biomedical applications. TCP is a typical bioresorbable material 
which is widely used in bone repair [139]. Also TCP ceramics bear excellent properties for 
bone marrow stromal cells culture towards osteogenic differentiation [140]. Therefore, the 
addition of TCP at the expense of Di in the glass compositions is expected to enhance their 
solubility as well as their bioactivity in physiological fluids. Also, the addition of TCP to Di 
is expected to improve its sintering ability as it has been reported that the flexural strength of 
eutectic glass-ceramic composition 38TCP-62Di (wt%) is higher than 200 MPa [103]. 
Kamitakahara et al. [103] studied the bioactivity and mechanical properties of bioactive 
scaffolds. Also,  Ashizuka et al. [141] reported on the mechanical properties of Di-TCP based 
glass-ceramics. Thus it’s expected that the combination of Di, FA and TCP phases is 
expected to result in the development of glasses with excellent bioactive properties, low 
chemical degradation and good sintering ability.   
 
4.1.2 Results and discussions 
4.1.2.1 Glass forming ability 
For all the investigated glass compositions (x = 10  40 wt%), melting at 1570 ºC for 
1 h was sufficient to obtain bubble-free, transparent and amorphous glasses (Figure 4.1.1). 
The glass forming ability diminished with further increase in TCP content in glasses (x > 40 
wt%) as resultant glass frits were prone to spontaneous crystallization even after super-
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cooling in cold water thus, resulting in white, opaque material with FA as the only crystalline 
phase, as revealed by XRD analysis (not shown).  
 
 
 Figure 4.1.1 X-ray diffractograms of as-quenched glass frits. 
 
4.1.2.2 Structure of glasses (MAS – NMR spectroscopy) 
The molecular structure of glasses plays a crucial role in deciding their bioactivity. 
Therefore, understanding their structural features allows designing new glasses with 
improved chemical durability and tailored biodegradability for specific applications. In the 
present study, MAS-NMR results are presented in Figure 4.1.2, the 
29
Si spectra (Figure 
4.1.2a) for all the investigated glasses depict the dominance of Q
2
 (Si) structural units in the 
glasses. In particular, the broad 
29
Si spectra centred around –81 to –82 ppm indicative of Q2 
as predominant silicate species [188]. Further, with decrease in the amount of SiO2 no change 
in structure was observed (TCP: 10  40 wt%), however a slight chemical peak shift towards 
more negative ppm was observed. 
 Further, we could not observe any significant change in peak maxima for spectra of 
31
P nucleus with predominance of an orthophosphate-type environment (Figure 4.1.2b). In 
fact, the observed chemical shifts, 1–2 ppm, are close to that of the calcium orthophosphate 
(3.1 ppm) and that of the amorphous magnesium orthophosphate (ca. 0.5 ppm) [137]. 
However, it should be noticed that bioactivity is not solely a function of glass structure and 
also depends on their chemical nature [142].
  
According to Tilocca and Cormack [143], low 
contents of P2O5 in glasses (~ 10 mol%) enhance their bioactivity while further increase in 
P2O5 amount affects the bioactive nature of glasses in a negative manner.  
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Figure 4.1.2 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
4.1.2.3 Apatite formation and chemical degradation of glasses 
 Immersing the materials in SBF is a relatively simple technique to evaluate the 
biomineralization activity and this method can be regarded as a first approach to assess 
bioactivity in vitro. However, even the preparation conditions of the SBF solution are tricky 
and there exist a lack of consensus regarding the usefulness of SBF tests in the literature 
[144]. But there are a large number of evidences about the good correlation between the bio-
mineralization ability a given bioactive material (understood as the ability to form a 
carbonated apatite layer onto its surface) in SBF and its performance in vivo [145, 146]. 
The in vitro bioactivity analysis by immersion in SBF solution revealed the presence 
of apatite formation in all the glass powders. The results presented here have been mainly 
explained with an emphasis on glasses TCP-20 and TCP-40 due to their high potential for use 
in human biomedicine. The XRD patterns observed for all as-quenched glasses (Figure 4.1.1) 
exhibit an amorphous halo, thus depicting the absence of any crystallinity. However, the X-
ray diffractograms of investigated glasses (including 45S5 Bioglass
®
) after soaking in SBF 
solution for time durations varying between 1  12 h (Figure 4.1.3) showed considerable 
differences in comparison to the diffractograms of their respective parent glasses. A small X-
ray peak at 2q = 31.77º corresponding to the formation of crystalline HA [(Ca5(PO4)3OH; 
ICDD: 00-09-0432] can be seen for glass TCP-40 after immersion in SBF for 1 h, while 45S5 
Bioglass
®
 suggests that calcite (CaCO3; ICDD: 01-083-0577) formation under similar 
conditions (Figure 4.1.3a). The XRD pattern for glass TCP-20 depicted a broad amorphous  
halo after 1 h immersion in SBF (Fig. 4.1.3a) while the infrared spectra of this glass (Figure 
4.1.4) 
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Figure 4.1.3 X-ray diffractograms of glass powders after immersion in SBF solution for (a) 1 h; (c) 3 
h; (c) 12 h, (d) 3 days and (e) 7 days. C refers to calcite while HA refers to hydroxyapatite. 
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exhibited significant structural differences before and after immersion in SBF. As is evident 
from Figure 4.1.4, a strong low frequency band centred at ~ 480 cm
1
, ascribed to a 
deformation mode of silica layer that develops on the dissolving glass particles could be seen 
in glass TCP-20 after immersion in SBF solution for 1 h [83]. The main IR band now occurs 
at 1080 cm
1
 and a nearby shoulder, centred at ~1235 cm
1
 attributed to Si-O-Si vibration  
can be observed [147], owing to the interfacial formation of high-area silica gel layer, as 
postulated in Hench’s inorganic reaction set [20]. These features were common for all the 
glasses investigated in present study. Further, band at ~ 1440 cm
1
 along with another one at 
~880 cm
1
 present in all glasses corresponds to incorporation of carbonate into the apatite, 
resulting in hydroxyl carbonated apatite, rather than stoichiometric HA [83].  
Furthermore, a small broad band was observed in case of glass TCP-20 (Figure 4.1.4) 
at ~565 cm
1
 after immersion in SBF solution for 1 h. This is the most characteristic region 
for apatite and other phosphates as it corresponds to PO bending vibrations in a PO4
3
 
tetrahedron. A single peak in this region suggests the presence of non-apatitic or ACP, which 
is usually taken as an indication of presence of precursors to HA. Apatitic PO4
3
 groups have 
characteristic split bands at ~560 and 600 cm
1
, with a third signal at ~575 cm
1
 observed for 
crystallites of small size [83, 87]. However, apart from a band at ~565 cm
1
 as is evident in 
Figure 4.1.4, no other bands in this region could be observed for glass TCP-20 even after 12 h 
of immersion in SBF solution while the XRD data of the same sample as presented in Figure 
4.1.3c reveals the presence of sharp peak corresponding to formation of HA along with minor 
amounts of calcite. It is noteworthy that no HA formation could be observed instead a small 
X-ray peak at 2q = 29.41º corresponding to the presence of calcite was observed in 45S5 
Bioglass
®
 even after 12 h of immersion in SBF solution (Fig. 4.1.3c) 
The increasing tendency towards development of ACP rich layer leading to formation 
of crystalline HA with increasing TCP content in glasses may be explained on the basis of 
decreasing Mg concentration in glasses. It has been reported that Mg tends to associate 
preferentially with phosphorus at glass surface, which consequently leads to the decrease in 
concentration of apatite like-calcium phosphate domains on the glass surface that are 
supposed to act as nucleation centres for apatite formation [148]. Also, glass compositions 
containing phosphorus are known to be more soluble and exhibit faster release of silica in 
solution. Further, isolated orthophosphate groups can be directly released without breaking 
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any chemical bond; thus high rate of formation of HA in TCP containing glasses is likely 
related to the high availability of this species [149].  
Figure 4.1.4 FTIR spectra of glass powder (TCP-20) before and after immersion in SBF 
solution for time durations varying between 1 h – 12 h. 
 
The XRD data after 3 days of immersion in SBF solution (Figure 4.1.3d) depicts the 
highly amorphous character of glasses with a small phase reflection corresponding to HA in 
composition TCP-20 and TCP-40. Similar structural features could be observed in all the 
investigated glasses. Since intense ionic exchanges occur at the bioactive glass surface that 
cause major changes in the degree of super-saturation for HA formation in biological fluids, 
the potential for each glass to form an apatite layer can be extrapolated from the 
corresponding evolution of the degree of super-saturation. According to Lao et al. [122], the 
degree of super-saturation may be defined as: SD = Q/Ksp, where Ksp is the solubility product 
of HA in aqueous solution while Q is the ionic activity product for the formation of HA. 
Therefore, the solution and HA mineral phase reach equilibrium when SD = 1. For SD < 1, 
the dissolution of HA mineral phase is favoured, while the solution is supersaturated with 
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respect to HA mineral and its precipitation is favoured when SD > 1. In the present scenario, 
during the initial hours of immersion of the glass in SBF, the SD increases because of 
dealkalinization of the glass surface, while the formation of a silica-rich layer provides 
regions of low interfacial energy, thus providing favourable sites for the nucleation of HA. 
However, the decreasing intensity of the XRD phase reflections for the HA phase in 
investigated glasses after 72 h of immersion in SBF may be attributed to the changing degree 
of super-saturation owing to the refreshing of the SBF solution after every 48 h. 
An increase in immersion time of glasses in SBF solution led to complete 
disappearance of calcite from the investigated glasses and depicted the formation of HA as 
the only crystalline phase as shown in Figure 4.1.3d. However, calcite still persisted in 45S5 
glass as a minor phase along with HA even after 7 days of immersion in SBF.  According to 
Jones et al. [150], the in vitro apatite forming ability of 45S5 glass decreases with increasing 
glass powder / SBF ratio beyond 0.002 g ml
1
 as further increase in this value will favour the 
formation of calcite at the expense of HA on the glass surface. In the present study, the 
calcite formation in 45S5 glass may be attributed to the fact that we are exactly at this 
threshold value of glass powder / SBF ratio. It is noteworthy that Ca-carbonate phases present 
a higher solubility product (Kps calcite = 1.7 × 10
−8
) with respect to HA 
(Kps HA = 1.6 × 10
−58
) at pH 7.4 [83] and this should favour the precipitation of the latter. 
Nevertheless, Ca-carbonate phases are likely to present a higher rate of crystallization 
because of the presence of basic surface species (for instance: O
2
 ions, OH

 ions or 
coordinatively unsaturated cation-anion pairs), which can coordinate with CO2, thus giving 
rise to many possible types of carbonate like species. According to Cerruti and Morterra 
[147], the carbonate formation in silica-based bioactive glasses occurs only if both CO2 and 
an excess of water are present at the same time as it is believed that the gas-phase admission 
of both CO2 and an excess of water mimics the long-lasting process of carbonate formation.  
One of the relevant parameters in the study of glass dissolution is the kind of medium 
used. The pH and ionic strength of the medium play an important role in the rate at which the 
glasses dissolve. The variation in pH of Tris–HCl with respect to TCP content in glasses is 
presented in Figure 4.1.5. A slight increase in pH from 7.4 to 8.4 was observed in case of 
Tris-HCl with increasing TCP content in glasses while highest pH value of 9.7 was observed 
for the 45S5 glass, which exhibited higher dissolution rate than the investigated glasses. In 
the present study, an increasing pH of simulated solution with increasing TCP content in the 
glasses may be attributed to the increasing dissolution of Ca and Mg ions from glasses due to 
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the dissolution of charged ion pairs (Ca-F)
+
 or (Mg-F)
+
. 45S5 glass exhibited the highest 
weight loss in Tris-HCl (3.7%).  
 
Figure 4.1.5 Graph depicting changes in pH of solution and weight loss of glass powders 
after immersion in Tris-HCl for 120 h. 
 
Among all the investigated glasses, an increment in TCP content in glasses did not 
affect the weight loss significantly as it varied between 1.6–1.7% (Fig. 4.1.5). 
  
4.1.2.4 Differential thermal analysis  
The DTA plots of fine powders with a heating rate (β) of 20 K min−1, shown in Figure 
4.1.6, feature an endothermic dip in the temperature interval of 750 – 755 ºC corresponding 
to Tg before Tc followed by a well-defined single exothermic crystallization curve for glasses 
TCP-10, TCP-20 and TCP-30. We could not observe any significant differences in the 
variation of Tg values with varying Di/TCP ratio in the glasses. 
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Further, the presence of a single crystallization exothermic peak in TCP-10 and TCP-
20 samples anticipates that the resulting glass-ceramics are formed either by single crystalline 
phase, or derived from an almost simultaneous precipitation of different crystalline phases 
(TCP-30); while the appearance of two distinct crystallization peaks (Tp1 and Tp2) in glass 
TCP-40 points towards the formation of two different crystalline phases. The Tp values for 
glasses TCP-10 and TCP-20 are almost similar (i.e. 932 ºC) while further decrease in Di/TCP 
ratio resulted in shifting of Tp to 907 ºC for glass TCP-30 and 843 ºC (Tp1) for glass TCP-
40. 
  
Figure 4.1.6 DTA thermographs of glasses at a heating rate of 20 K min
−1
. 
 
This decrease in Tp values with increasing TCP content in glasses may be attributed to 
their increasing crystallization tendency as will be shown further in section 4.1.6.  
 
4.1.2.5 Sintering and crystallization behaviour of glasses 
The prerequisite for optimizing the fabrication of glass-ceramics scaffolds is to 
understand the sintering conditions of glass powders and the interaction between sintering 
and crystallization of the material. By knowing the structural transformations which occur 
during the heat treatment of glasses, the scaffold fabrication process can be tailored, like in 
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terms of achieving the highest possible density of the sintered scaffolds and the required 
crystallinity which itself controls the material´s bioactivity. It is due to this reason that a 
comparison between DTA and HSM thermographs obtained under the same heating 
conditions can reveal a great deal of information in this regard. In general, two different 
trends can be observed related to the sintering and crystallization behaviours of the glasses: 
(i) Tc occur after the final sintering stage. Therefore, under such circumstances, sintering and 
crystallization are independent processes. This is the required trait to obtain well sintered 
glass-ceramic scaffolds with good mechanical properties; (ii) Tc appears before maximum 
density has been reached. In this case, the crystallization process starts before complete 
densification, thus, preventing sintering.  
In the present study both of the above mentioned trends related with sintering and 
crystallization behaviour of glasses have been observed depending on the glass compositions. 
Figure 4.1.7 presents the DTA and HSM thermographs of glasses TCP-20 (Figure 4.1.7a) and 
TCP-40 (Figure 4.1.7b), respectively at b = 5 K min1 depicting a single stage sintering 
behaviour for the investigated glass compositions while Figure 4.1.7c presents the changes in 
different thermal parameters with respect to variation in TCP content in glasses. As is evident 
from Figure 4.1.7c, the values for temperature of first shrinkage (TFS; log  = 9.1 ± 0.1, 
where  is viscosity; dPa.s) and temperature of maximum shrinkage (TMS; log  = 7.8 ± 0.1) 
exhibited a slight decrease with increasing TCP content in glasses while values for Tc showed 
an initial increase and then a steep decrease with decreasing Di/TCP ratio.  
With respect to TMS and Tc, different trends were observed for the investigated glass 
compositions which can be explained with the aid of sinterability parameter (Sc), where Sc = 
Tc - TMS. The parameter Sc is the measure of ability of sintering versus crystallization: the 
greater this difference, the more independent are the kinetics of both processes [151]. The 
estimated error for data points is smaller than ± 10%, approximately equal to the size of the 
data symbols. As can be seen from Figure 4.1.7c, the value of parameter Sc increased with 
increasing TCP content in the glasses until 20 wt%.  However, further decrease in Di/TCP 
ratio led to a gradual decrease in the value of Sc with glass TCP-40 (Sc = - 24 ºC) exhibiting 
the lowest value for Sc. These results imply that sintering precedes crystallization in glass 
compositions TCP-10, TCP-20 and TCP-30 with glass composition TCP-20 exhibiting better 
sintering ability in comparison to the other investigated compositions. 
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Figure 4.1.7 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions (a) TCP-20 and (b) TCP-40 at the heating rate of 5 K min
1
; (c) influence of 
TCP content on different thermal parameters of glasses obtained from DTA and HSM, 
respectively 
 
Therefore, we can expect well sintered, dense and mechanically stronger glass-
ceramics from composition TCP-20 in comparison to its counterparts. On the other hand, 
crystallization precedes sintering in glass TCP-40 which should result in a poorly sintered 
and mechanically weak glass-ceramic material. The decreasing/poor sintering ability for 
glasses TCP-30 and TCP-40 is mainly due to predominance of FA in these glasses (as has 
been presented ahead in XRD results) which masks the influence of Di which is a crystalline 
phase with good mechanical strength. 
Figure 4.1.8 presents the SEM images of the glass powder compacts after sintering in 
temperature interval of 800900 ºC for 1 h. In agreement with HSM and DTA results, the 
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sintering of glass powder compacts at 800 ºC resulted in well sintered and dense glass-
powder compacts for compositions TCP-10 (Figure 4.1.8a), TCP-20 (Figure 4.1.8b) and 
TCP-30 (Figure 4.1.8c), respectively, while TCP-40 resulted in a poorly sintered and 
mechanically weak glass powder compact.  
 
  
  
 
Figure 4.1.8. SEM images of glass powder compacts (a) TCP-10, (b) TCP-20, (c) 
TCP-30, after sintering at 800 ºC for 1 h, respectively while (d) and (e) represent 
glass composition TCP-10 after sintering at 900 ºC for 1 h. 
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Figure 4.1.9 X-ray diffractograms of glass compositions after sintering at (a) 800 ºC; (b) 900 
ºC and 1000 ºC, respectively. 
 
The flexural strength values as obtained for composition TCP-20 sintered at 800 and 
850 ºC are 85 ± 6 MPa and 135 ± 9 MPa, respectively. The qualitative crystalline phase 
analysis of sintered glass powders as presented in Figure 4.1.9 revealed that compositions 
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TCP-10 and TCP-20 were completely amorphous after sintering at 800 ºC while FA (ICDD 
card: 71-880) precipitated as the major crystalline phase in compositions TCP-30 and TCP-40 
along with Di (ICDD card: 78-1390) and the intensity of XRD peaks increased with 
increasing TCP content in glasses, thus, indicating an increase in crystallinity (Figure 4.1.9a). 
These results are in co-relation with the microstructural evolution of sintered glass-ceramics 
as studied through SEM. Figure 4.1.8c depicts the formation of crystals beneath the 
amorphous layer in composition TCP-30, thus depicting the presence of crystallinity. Further 
increase in sintering temperature to 850 ºC (Figure 4.1.9b) and 900 ºC (Figure 4.1.9c) 
resulted in appearance of crystallinity in all the investigated glass compositions with Di as the 
major crystalline phase in compositions TCP-10 and TCP-20, thus rendering them good 
sintering ability while FA dominated the crystalline phase assemblage in compositions TCP-
30 and TCP-40, thus leading to their poor sintering ability. The SEM images (Figure 4.1.8d 
and 4.1.8e) obtained from glass-ceramics TCP-10 after sintering at 900 ºC depict the presence 
of thin lamellar crystals typical for Di intermixed with needle like FA crystals (Figure 
4.1.8e). The results obtained in the present study are different from those obtained by 
Kamitakahara et al. [103] in their study related with synthesis of glass-ceramics in Di-TCP 
binary system and also from the results of Magallanes-Perdomo et al. [152] where they 
investigated the devitrification behaviour of a eutectic glass-ceramic composition in 
wollastonite-TCP binary system as in both the earlier studies, TCP crystallized in glass-
ceramics the form of -TCP [152]  or b-TCP [103] along with other crystalline phases. 
However, in the present study, no trace of crystallization of TCP has been observed as its 
growth seems to be masked by FA. 
 
4.1.2.6 Cellular response to sintered glass powder compacts 
The cell proliferation on the sintered glass powder compacts and control during 
culture for 3, 7 and 14 days is shown in Figure 4.1.10. For the control, cells proliferated 
actively for up to 7 days and showed a plateau with prolonged culture for 14 days. 
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Figure 4.1.10 Proliferation behaviour of the MSCs cultured on the glass compacts 
(TCP-10 and TCP-20) and the tissue culture plastic used as a control during the periods 
for 3, 7 and 14 days. MSCs derived from rat bone marrow were used for the assay. 
Statistically significance difference was noticed between the groups; control vs. TCP-10 
at day 3; control vs. TCP-10 or TCP-20 at day 7 (p < 0.05, ANOVA, n = 3) 
 
On the other hand, the cell proliferation appeared to be relatively slower for 
investigated glass compositions in the culture for up to 7 days. However, cells continued to 
grow with prolonged culture period reaching to the proliferation level of the control at 14 
days, featuring good proliferative potential of cells upon the glass disc substrates. The 
morphologies of cells grown on the glass disks for 7 days are shown in Figure 4.1.11. 
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Figure 4.1.11 SEM images of the MSCs grown on the sintered glass powder compacts 
(TCP-10 and TCP-20) during culture for 7 days. Cells spread well on both glass 
samples in intimate contacts with the underlying substrates and have active cytoskeleton 
processes with highly elongated filopodia. Some surface cracks associated with the 
sample treatment for SEM are observed. 
 
 As is evident from the images, cells spread well on both the glass compositions in 
intimate contacts with the underlying substrates and have active cytoskeleton processes with 
highly elongated filopodia. The results on cell proliferation and growth morphology suggest 
that the developed glasses provide suitable substrate conditions for the MSCs to adhere and 
proliferate.  
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Figure 4.1.12 Alkaline phosphatase activity of the MSCs during culture for 7 and 14 
days on the glass compacts (TCP-10 and TCP-20) and tissue culture plastic control. 
Statistically significant higher level was noticed on the glass samples with respect to 
control at both periods; *p < 0.05, ANOVA, n = 3.  
 
The effect of the osteogenic differentiation was further investigated by the ALP 
activity of cells grown on the glass disks for 7 and 14 days. The data plotted in Figure 4.1.12 
shows that ALP activity level was significantly higher on both types of glass compositions 
with respect to that on the control at all culture periods. In particular, the increase in the ALP 
level from 7 to 14 days was much higher in the glasses than in the control. ALP is known as 
one of the essential osteogenic markers of cells including MSCs, particularly at an early stage 
of osteogenic differentiation. Therefore, the significantly stimulated ALP level observed in 
the MSCs cultured on the glass-ceramics samples indicates that the materials developed 
herein are effective in modulating the functions of MSCs into the lineage of bone cells, 
consequently highlighting their potential usefulness for bone regeneration.  
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4.2.2 Conclusions 
We have tried to shed some light e influence of varying Di/TCP ratio on the structure, 
biodegradation, and sintering-crystallization behaviour of glasses in the Di-FA-TCP system 
has been presented. The as obtained results depict the potential of investigated glass 
compositions for their application in human biomedicine. The structure of the investigated 
glasses is dominated by Q2 (Si) units while phosphorus is predominantly in orthophosphate 
type environment. Some of the investigated glasses exhibited higher rate of bioactivity in 
vitro in comparison to 45S5 Bioglass® during initial 12 h of immersion in SBF solution. The 
glass with nominal composition Di50 – FA10 – TCP40 (wt%) (Labelled as TCP-40) 
exhibited hydroxyapatite formation on its surface within 1 h of its immersion in SBF while 
glass TCP-20 with composition Di70 – FA10 – TCP20 (wt%) exhibited apatite formation 
after 12 h of its immersion in SBF. All the glasses exhibited considerably lower weight loss 
in comparison to 45S5 Bioglass® in Tris-HCl. Sintering preceded crystallization in glass 
composition with TCP content varying between 10 – 30 wt.%. Further increase in TCP 
content in glasses deteriorated the sintering ability of glass powders considerably. The glass 
composition TCP-20 exhibited superior sintering ability in comparison to other investigated 
glasses. The resultant glass powder compacts were completely amorphous after sintering at 
800 ºC with a three-point flexural strength of ~85 MPa. Di crystallized as primary crystalline 
phase in compositions with TCP content 10 and 20 wt.%, respectively after sintering at 850 
ºC, while further increase in TCP content in glasses suppressed the formation of Di with FA 
being crystallized as the major phase. The sintered (but amorphous) glass powder compacts 
(TCP-10 and TCP-20) significantly increased the osteogenic differentiation of MSCs with 
respect to the culture plastic control, as assessed by the alkaline phosphatase activity. 
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4.2 Structural role of zinc in biodegradation of alkali-free bioactive glasses 
4.2.1. Introduction 
Zinc is an important element that plays a vital role in bone formation and resorption, 
which should be considered in the design of bone graft compositions aimed at bone 
regeneration and TE applications. Owing to the above-mentioned beneficial aspects of zinc in 
human metabolism in section 2.5.3, and considering the ion releasing ability of glasses in 
aqueous medium, bioactive glasses incorporated with zinc have gained considerable attention 
in the recent years for various TE applications. The increasing interest in Zn-containing 
bioactive glasses has resulted in a multiple-fold increase in the number of scientific 
publications in this area during last decade [82, 125, 153-160].  
Despite the interesting studies, there exists a significant disparity among the results 
reported in literature with respect to influence of Zn
2+
 and its content on biodegradation, 
apatite forming ability, osteoblast activity, anti-inflammatory response and angiogenic 
behaviour in bioactive glasses [25, 161]. All these issues have been recently reviewed by 
Hoppe et al. [44] and therefore, will not be discussed in the present section. Apart from that, 
another major concern with most of the zinc-containing bioactive glass compositions studied 
until now is that they are either based on- or inspired by 45S5 Bioglass
®
 [82, 120, 157, 162, 
163] which contain significant amounts of alkali content.  
In the light of above mentioned facts, it becomes necessary to investigate the 
influence of Zn
2+
 on different properties of bioactive glasses but with their chemical 
compositions completely different from that of 45S5 Bioglass
®
 in order to obtain a 
comprehensive database highlighting the precise function and mechanism of zinc in 
regulating various biological processes in human body. Such an attempt has been made by 
Bini et al. [164] and Saino et al. [165] but on alkali-free sol-gel derived glass in the system 
SiO2P2O5CaO. It is usually difficult to compare the results obtained on sol-gel glasses with 
those from melt-quenched glasses due to the high specific surface area and moisture content 
of the former along with the heterogeneous chemical environment of network modifier 
species in comparison to melt-quenched glasses [166]. 
The very promising glass composition TCP-20 discussed in section 4.1 was adopted 
as the starting point for synthesis new series of glasses and was developed by partial 
substitution ZnO for MgO in the same composition with the aim to study the effect of zinc on 
structure and biodegradation of melt-quenched alkali-free glasses designed in 
CaOMgOSiO2P2O5CaF2 glass system. 
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4.2.2 Results and discussion 
4.2.2.1 Glass forming ability 
For all the investigated glass compositions (mol%): 36.07 CaO – (19.24 – x) MgO – x 
ZnO – 5.61 P2O5 – 38.49 SiO2 – 0.59 CaF2, (x = 2–10) (Table 4.2.1), melting at 1570 ºC for 1 
h was sufficient to obtain bubble-free, transparent and XRD-amorphous glasses (Figure 
4.2.1). 
 
Table 4.2.1 Nominal composition of the as-designed glasses (mol%). 
 
 
Figure 4.2.1 X-ray diffractograms of as-quenched glasses. 
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Zn-2 
Zn-4 
Zn-6 
Zn-8 
Zn-10 
Glass CaO MgO SiO2 P2O5 ZnO CaF2 
Zn–0 36.07 19.24 38.49 5.61   0.00 0.59 
Zn–2 36.07 17.24 38.49 5.61   2.00 0.59 
Zn–4 36.07 15.24 38.49 5.61   4.00 0.59 
Zn–6 36.07 13.24 38.49 5.61   6.00 0.59 
Zn–8 36.07 11.24 38.49 5.61   8.00 0.59 
Zn–10 36.07 9.24 38.49 5.61 10.00 0.59 
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4.2.2.2 Glass structure 
The MAS-NMR spectrum (Figure 4.2.2) shows that ZnO substitution for MgO does 
not affect the silicate network connectivity of these glasses. The 
29
Si MAS-NMR results of all 
the glasses as presented in Figure 4.2.2a depict the dominance of Q
2
 (Si) structural units in 
the glasses. Further, only slight shift in the peak positions of spectra could be observed and 
all the spectra are centred between –81 ppm and –82 ppm, thus depicting no significant 
changes in the silicon coordination in glass structure. The findings are further supported by 
the MD simulation studies performed on the glasses which show a predominance of Q
2
 units 
ranging from 47 to 51 % from Zn-0 to Zn-10 [42]. 
  
Figure 4.2.2 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
The 
31
P MAS-NMR spectra of all the glasses show a predominance of an 
orthophosphate-type environment (Figure 4.2.2b), again in agreement with the MD results 
[42]. In fact, the observed chemical shifts, 1–3 ppm, are close to that of the calcium 
orthophosphate (3.1 ppm) and that of the amorphous magnesium orthophosphate (ca. 0.5 
ppm) [137]. The phosphate environment is therefore similar to that of 45S5 Bioglass
®
 [127, 
167].  
-200-150-100-50050
Zn-2 
Zn-4 
Zn-6 
Zn-8 
Zn-10 
29Si Chemical Shift (ppm) 
-81.9  
-81.51  
-81.6  
-81.5  
-80.9 
-50-30-10103050
Zn-2 
Zn-4 
Zn-6 
Zn-8 
Zn-10 
-2.0 
31P Chemical shift (ppm) 
Alkali-free bioactive glasses for bone regeneration  
Page 60 
 
 
4.2.2.3 Apatite forming ability of glasses 
 The X-ray diffractograms of investigated glasses after soaking in SBF solution for 
time durations varying between 1 h  7 days (Figure 4.2.3) showed considerable differences 
in comparison to the diffractograms of their respective parent glasses. A phase reflection at 
2q = 31.77º corresponding to the formation of crystalline hydroxyapatite [HA; 
(Ca5(PO4)3OH; ICDD: 00-09-0432] is evident in the X-ray diffractograms of glasses with 
ZnO concentration varying between 4 – 10 mol% after their immersion in SBF for 1 h 
(Figure 4.2.3a). It should be noted that the HA formed in such experiments in carbonated HA 
and not stoichiometric crystalline HA. With further prolonging the immersion time, the 
intensity of the main XRD peak of HA increased particularly for the Zn-6 composition, while 
showed a fading trend for the other bioactive glasses (Figure 4.2.3b – 4.2.3d). Interestingly, at 
the conclusion of 7 days, HA formation was observed only for parent glass Zn-0 while no Zn-
containing glass exhibited clear evidences for the formation of HA. Various reasons may be 
cited for such a trend observed from XRD data for bioactive glass dissolution and HA 
formation in SBF solution. The two main plausible factors behind this behaviour may 
include:  
1. Influence of ZnO/MgO ratio on HA formation in bioactive glasses: Magnesium is 
known to delay the HA formation in vitro as well as in vivo. According to Pariente et 
al. [148], during in vitro SBF tests, magnesium tends to associate with phosphorus on 
the glass surface due to which apatite-like calcium phosphate domains are barely 
detected in magnesium containing glasses. Further, both Mg
2+
 and Zn
2+
 when present 
together also inhibit HA crystal growth. 
2. Solution pH and degree of saturation: The pH of the SBF solution and its degree of 
saturation play crucial roles in deciding the nature of crystalline products as has been 
discussed in our study [23]. In the present study, the initial pH of SBF solution was 
7.28 while the pH of SBF solution after 24 h of glass powder immersion varied 
between 7.7 – 7.95, irrespective of the ZnO concentration in glasses. It is now 
generally agreed that, both in vitro and in vivo, precipitation reactions at sufficiently 
high supersaturation and pH result in the initial formation of ACP with molar 
calcium/phosphate ratio of about 1.18 – 2.50 [168, 169]. The chemical composition of 
ACP is strongly dependent on the solution pH: ACP phases with Ca/P ratios in the 
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range of 1.18:1 precipitated at pH 6.6 to 1.53:1 at pH 11.7 and even as high as 2.5:1 
[170].   
  
  
Figure 4.2.3 X-ray diffractograms of glass powders before and after immersion in SBF 
solution for (a) as quenched glasses (b) 1 h (c) 6 h (d) 3 days and (e) 7 days. HA refers to 
hydroxyapatite. 
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The FTIR spectra of glasses after immersion in SBF solution for 1 h (Figure 4.2.4a) 
depicts several changes in the glass structure that occurred due to the reaction between glass 
powder and SBF. The strong low frequency band in the region 350 – 650 cm−1 has been split 
into small bands at ~480 cm
−1
, ~570 cm
−1
 and ~620 cm
−1
 as is evident from Figure 4.2.4a. 
The band centred at 480 cm
−1
 can be ascribed to a deformation mode of silica layer that 
develops on the dissolving glass particles while small broad bands at 570 cm
−1
 and 620 cm
−1
 
are characteristic for apatite and other phosphates as it corresponds to P–O bending vibrations 
in a PO4
3−
 tetrahedron. A single peak in this region (570 cm
−1
) suggests the presence of non-
apatitic or ACP, which is usually taken as an indication of presence of precursors to HA. It is 
noteworthy that apatitic PO4
3−
 groups have characteristic split bands at ~560 and 600 cm
−1
, 
with a third signal at ~575 cm
−1
 observed for crystallites of small size [83, 87].  
Figure 4.2.4 FTIR spectra of glass powders after immersion in SBF solution for (a) 1 h and 
(b) 24 h. 
 
Further, a small band at ~1440 cm
−1
 along with a broad but intense band at ~850 cm
−1
 
present in all glasses corresponds to incorporation of carbonate into the apatite, resulting in 
hydroxy carbonated apatite, rather than stoichiometric HA [83]. The most interesting feature 
of the FTIR data on zinc-containing glasses obtained after 1 h of immersion in SBF solution 
is the complete absence of the SiOSi vibration band in the region 12001270 cm−1 which 
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corresponds to the formation of silica gel layer, as postulated in Hench’s inorganic reaction 
set [20]. It is interesting due to the fact that this band is highly evident in the FTIR spectra of 
zinc-free parent glass, Zn-0. An increase in SBF immersion time to 24 h did lead to the 
appearance of an absorption band at ~1220 cm
−1
 in glasses with lower ZnO content (26 
mol%) but this band was still absent in glasses with ZnO content varying between 8 and 10 
mol% as shown in Figure 4.2.4b. Consequently, the increase in immersion time resulted in 
either sporadic or minimal apatite formation on glass surface during 7 days of immersion in 
SBF solution (Figure 4.2.3c – 4.2.3e). Similar observations regarding the absence of silica gel 
layer in bioactive glasses have been reported in zinc containing glasses by Oudadesse et al. 
[162], Kamitakahara et al. [158], Lusvardi et al. [82] and Ebisawa et al. [171].  
 
4.2.2.4 Chemical degradation of glasses in Tris-HCl 
The variation in pH of Tris–HCl with respect to ZnO content in glasses is presented in 
Figure 4.2.5. A slight decrease in pH from 7.4 to 7.2 was observed with increasing ZnO 
content in glasses. It is noteworthy that pH value of 9.7 has been reported for Tris-HCl during 
chemical degradation of 45S5 Bioglass
®
 as reported in the section 4.1, thus exhibiting higher 
dissolution than the investigated glasses. The pH results are in good agreement with the 
weight loss data obtained for the investigated glasses as incorporation of ZnO in glasses 
reduced their dissolution which is evident from their weight loss (Figure 4.2.5). 
All the glasses were amorphous after immersion in Tris-HCl for 120 h as shown in 
Figure 4.2.6, thus negating the possibility of any chemical reaction between the dissolution 
products 
 
Figure 4.2.5 Graphs depicting the change in solution pH and weight loss of glass powders 
after immersion in Tris–HCl.  
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The decrease in pH value of Tris-HCl with incorporation of ZnO is due to the low 
leaching of Mg and Ca ions from glasses as shown in Figure 4.2.7. The slower Ca release 
from the bioactive glasses with increasing ZnO content may be one of the reasons for slow 
HA formation on bioactive glass surface. The concentration of zinc ions leached out from 
glasses after 120 h of immersion in Tris-HCl increased with increase in ZnO content in 
glasses and varied between 0.06 ppm (for Zn-0) to 8 ppm (Zn-8). The zinc release profile of 
glasses is important from the fact that the role of major functional ions (Ca, Mg, Si, P) in 
bone regeneration and soft TE has been well established and documented [28, 104, 125, 172]. 
However, the influence of different functional ions which although present in trace quantities 
in human body are essential for good metabolism is still ambiguous. In particular case of 
zinc, its role in human metabolism has been shown to depend on its ionic release profile in 
body fluids and is therefore dose dependent [120, 157]. 
 
 
Figure 4.2.6 X-ray diffractograms of glass powder after 120 days of immersion in TRIS-HCL 
 
Zn-2 
Zn-4 
Zn-8 
Zn-10 
Zn-0 
Zn-6 
20 25 30 35 40
In
te
n
si
ty
 (
a.
u
.)
 
2q (degrees) 
Scale: 2000 cps 
Alkali-free bioactive glasses for bone regeneration  
Page 65 
 
 
Figure 4.2.7 ICP-AES plots of elemental concentrations of Ca, Mg, P, Si and Zn in Tris–HCl 
after 120 h of immersion of glass powder. It should be noted that Si refers to SiO4
4
 and P 
refers to PO4
3
 species. 
 
4.2.2.5 Discussion  
  The role of zinc on structure and bioactivity of glasses has been extensively studied 
in literature. For example, Aina et al. [120, 173] studied the influence of zinc on surface 
reactivity and cytotoxicity of 45S5-based glasses while Courthéoux et al. [174] investigated 
the influence of Zn
2+
 on alkali-free glasses in the CaOP2O5SiO2 and CaOSiO2 systems, 
respectively. However, all the above mentioned studies have been focused upon sol-gel 
derived glass compositions which have high surface area due to inherent porosity, different 
surface chemistry in comparison to melt-quenched glasses. Therefore, a comparison between 
the results obtained on sol-gel derived and melt-quenched glasses is not plausible.  
Some studies have also been reported on the influence of Zn
2+
 on the surface 
reactivity and biological activity of melt-quenched glasses. However, most of the results 
obtained in these studies are in contradiction with each other. For example: according to Aina 
et al. [120] and Lusvardi et al. [82], the incorporation of ZnO in 45S5 glass reduces its 
solubility but still apatite formation (when immersed in simulated body fluids) takes place 
within few hours to few days of time span. Also, they reported that ZnO enhances the 
biological activity of glasses in vitro as well as in vivo. On the other hand, according to Haimi 
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et al. [175], zinc addition in bioactive glasses has no significant effect on the DNA content, 
ALP activity and osteopontin concentration of human adipose stem cells. Similar results have 
also been reported by Popp et al. [176], who studied the influence of soluble zinc from ACP’s 
on the proliferation of rat bone marrow stromal cells. 
Despite the significant disparity in the results related with the biological behaviour of 
zinc, one result that is coherent among almost all the glass compositions reported in literature 
irrespective of their synthesis route is their decreasing solubility with increasing zinc content. 
A similar behaviour has been observed in the present investigation, as chemical degradation 
of glasses in Tris-HCl decreases with their increasing Zn
2+
 concentration. The implications of 
decreasing solubility with increasing zinc content in glasses may be interpreted on the basis 
of the solubility of parent glass, for example, according to Aina et al. [120], incorporation of 
Zn
2+
 in 45S5 glass is beneficial owing to the high solubility of the latter which leads to a 
significant increase in the pH of physiological fluid, thus affecting the proliferation of 
endothelial cells. However, the precise reason for decreasing solubility with zinc 
incorporation in glasses is still ambiguous as some studies explain it on the basis of influence 
of zinc on glass structure [162, 173] while others discuss it as a function of chemical 
composition and surface chemistry of glasses [177]. According to Aina et al. [173], the zinc 
species in alkali-free bioactive glasses are found in a tetrahedral environment, and can 
enhance the glass reticulation by forming SiOZn inter-tetrahedral links. Similar results on 
the role of Zn in bioactive glasses irrespective of its concentration have also been reported by 
Linati et al. [110] on zinc-doped 45S5 Bioglass
®
. For the present compositions, the MD 
simulations studies [42] have shown that both Zn
2+
 and Mg
2+
 are primarily present in five-
fold coordination, which appears reasonable considering the similar ionic radii of Mg
2+
 (0.65 
Å) and Zn
2+
 (0.74 Å) [178]. The intermediate role of zinc is well documented in literature, 
and therefore depending on the glass composition and its local environment, Zn
2+
 can be a 
four-coordinated weak network former as has been suggested for traditional bioactive glasses 
or five-coordinated as has been observed in the present study [179]. In general, zinc has been 
shown to exhibit a marked preference for tetrahedral coordination in simple alkali silicate 
glasses [180] which has been the case with most of the studies based on Zn-doped 45S5 
Bioglass
®
 or its alkali-containing derivatives. However, with increasing Zn/modifier ratio, the 
ratio of six – to fourfold coordinate Zn species is reported to increase due to the availability 
of charge compensating modifier cations [180, 181]. Further lack of any significant changes 
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in the silicate network connectivity glass by varying the Zn
2+
/Mg
2+
 ratio indicates towards the 
similar co-ordination of Zinc to magnesium.  
The decreasing glass degradation and reduced HA formation in the present case may 
be attributed to the ability of zinc to promote enhanced inter-tetrahedral cross-links as 
observed in MD simulations [42] which in combination with constant silicate network 
connectivity enhances the chemical durability of the glasses. The way in which a modifier or 
intermediate cation involved in inter-tetrahedral cross-links between adjacent silicate 
fragments can result in a more stable glass network (with a higher resistance to dissolution) 
even without actual changes in the silicate network connectivity has been recently discussed 
[110].  
The importance of the silica-rich gel layer is usually attributed to the fact that its 
presence on the glass surface in SBF helps in inducing apatite formation while no apatite 
formation can be induced by silica glass or quartz crystal [182]. However, although 
carbonated-HA formation on glass surface during their immersion in biological fluids is 
considered to be a marker of bioactivity, recent evidence has indicated that formation of this 
HA layer is not critical for bone generation. The ionic dissolution products from bioactive 
glasses appear to stimulate the growth and differentiation of cells at the genetic level, an 
effect which has been considered to be dose dependent [28]. For example: Zn concentrations 
in the range of 2 – 8 ppm have been reported to cause damage to human osteoblasts via 
oxidative stress [157]. Similar results have been reported for endothelial cells where decrease 
in cell proliferation was observed due to toxic Zn concentration of 2.7 ppm released in the 
culture medium from a Zn-doped bioactive glass [120]. Therefore, special consideration 
should be given to the ZnO content in bioactive glasses and their release profile in body 
fluids while designing the compositions. 
 
4.2.3 Conclusions 
The effects of zinc in the biodegradation of alkali-free phosphosilicate glasses have 
been studied through a combination of MAS-NMR, FTIR, XRD and chemical degradation 
experiments An increase in the Zn
2+
/Mg
2+ 
ratio did not induce any significant change in Q
n
 
speciation and network connectivity, as revealed by MAS-NMR; however it did improve the 
chemical durability of investigated glasses (as observed from Tris-HCl studies) which 
consequently suppressed the apatite (carbonated) forming ability of glasses in simulated body 
fluid. The influence of zinc on suppressing the apatite forming ability of glasses has been 
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explained on the basis of the constant silicate network connectivity of the combined with the 
previously suggested ability of Zn to strengthen the glass network through non-covalent 
SiO---Zn---O-Si links. This results in a glass structure more resistant to dissolution in a 
biological medium. An additional factor discussed is the potential influence of zinc on the 
surface chemistry of glasses when immersed in physiological fluids.    
Alkali-free bioactive glasses for bone regeneration  
Page 69 
 
4.3 Influence of ZnO/MgO substitution on sintering, crystallization and bio-activity of 
alkali-free glass-ceramics 
4.3.1 Introduction 
 Bioactive glasses and glass-ceramics are used in a wide range of applications: bulk 
implants to replace bones or teeth, coatings to anchor orthopaedic or dental devices, or in the 
form of powders, as bone grafts, to fill various types of bone defects [4, 183, 184]. The 
successful development of bioactive glasses for such applications requires suitable 
densification and crystallization behaviours along the heat treatment step. Such requirements 
are also of paramount importance in other advanced applications of bioactive glasses 
involving heat treatments aiming at obtaining products such as glass fibres.  
The aim of the present section is to elucidate the effect of partial substitution of MgO 
by ZnO on the evolution of the glass structure and of the crystalline phases developed along 
the heat treatments using MAS-NMR and X-ray powder diffraction as complementary 
techniques and to study the sintering and crystallization behaviours of glass powders using 
hot-stage microscopy and differential thermal analysis, respectively. Understanding the 
sintering behaviour of the glass powders and the interactions between the sintering and 
crystallization events is of utmost importance for successfully fabricating porous scaffolds or 
coatings on metallic implants from bioactive glasses. Further, cell-culture tests using 
mesenchymal stem cells from rat bone marrow were used to investigate the in vitro behaviour 
of as designed glass-ceramics. 
 
4.3.2 Results and discussion  
4.3.2.1 Glass-forming ability 
For all the investigated glass compositions presented in Table 4.2.1, melting at 1570 
ºC for 1 h was sufficient to obtain bubble-free, transparent and XRD-amorphous glasses. 
4.3.2.2 Thermal analysis  
The DTA thermographs of fine glass powders with b= 20 K min−1 are shown in 
Figure 4.3.1. All the glass compositions feature a single endothermic dip before the Tc 
corresponding to Tg, which is followed by the exothermic crystallization effect. The 
characteristic parameters obtained from DTA thermographs are summarized in the Table 
4.3.1. In general, addition of ZnO resulted in gradually lowering Tg from 752 ºC to 718 ºC. 
The decrease in Tg can be attributed to the lower bond strength of Zn–O bond in comparison 
to the Mg–O bonds [185], which in turn reduces the rigidity of the glass network at high 
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temperature in comparison to magnesium, even though both possess similarities in size and 
charge. Further, structural rigidity of a glass network also depends on the field strength thus, 
the weak bond strength of ZnO bond than MgO can be attributed to the weaker cation field 
strength of Zn in comparison to Mg [186]. This in turn translates in lowering the viscosity of 
the glasses [187] thus, decreasing their Tc values. Such changes could be observed in glass 
powder compacts sintered at 800 ºC (not shown here) which remained amorphous for the 
lower zinc contents, and visible XRD peaks only appeared in the glasses with higher zinc 
contents. Hence, the results obtained in the present work for zinc-containing glass-ceramics 
are in good agreement with other literature reports [158, 186, 187]. 
  
Figure 4.3.1 DTA thermographs of glasses at a heating rate of 20 K min
−1
. 
 
4.3.2.3 Sintering and Crystallization behaviour  
A comparison between DTA and HSM results under the same heating conditions can 
be useful in investigating the effect of glass composition on sintering and devitrification 
phenomena. Figure 4.3.2 presents variation in the relative area and heat flow with respect to 
temperature as obtained from HSM and DTA, respectively, for all the investigated glasses at 
a similar heating rate of 5 K min
−1
. Table 4.3.2 summarizes the values of the temperature of 
first shrinkage (TFS; log  = 9.1 ± 0.1,  is viscosity in dPa s), temperature for maximum 
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shrinkage (TMS; log = 7.8 ± 0.1) and ratio of the final area/initial area of the glass powder 
compact (A/A0) at TMS1, as obtained from the HSM along with temperature for Tc and Tp, as 
obtained from the DTA of the glasses. 
(i) In general, TFS values show a decreasing tendency with increasing content of ZnO.  
(ii) Two stage sintering was observed in glasses Zn–2, Zn–4 while a gradual shift to single 
stage shrinkage was observed for glasses thereafter (Figure 4.3.2). The conclusion of 
first sintering stage is characterized at TMS1 while end of second sintering stage is 
characterized by TMS2. Interestingly, in all the glass compositions TMS1 was observed at 
temperatures lower than Tc (i.e., TMS1< Tc). Thus sintering precedes crystallization in 
all the glasses. Therefore one can expect well sintered and mechanically strong glass 
powder compacts.  
(iii) The value for TMS2 was higher than Tc in the glasses exhibiting two stage sintering 
behaviour. Thus depicting that shrinkage continued in the glass powders even after 
onset of crystallization, probably due to the existence of residual glassy phase in the 
glass-ceramics.  
(iv) Table 4.3.1 lists the values of sinterability parameter (Sc), where Sc = Tc –TMS. The 
parameter Sc is the measure of ability of sintering vs. crystallization: the greater this 
difference, the more independent are the kinetics of both processes. However, in the 
present study no particular trend could be observed for the variation of Sc. 
Nevertheless, all the investigated glasses show larger values of Sc (greater than 25 ºC) 
(26 ºC – 48 ºC) indicating good sintering behaviour.  
(v) The values of Tp varied between 895 ºC – 861 ºC. As evident from Table 4.3.1, the 
highest Tp value was observed for Zn–0. Adding increasing amounts of ZnO to the 
parent glass at the expanses of MgO resulted in gradual decreases in Tp. 
(vi) Values of A/A0 ranged from 0.63 to 0.67 (Table 4.3.1) for all the glasses implying 
towards good densification levels of 95–98%.  
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Figure 4.3.2 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions: (a) Zn2, (b) Zn4, (c) Zn6, (d) Zn8 and (e) Zn10. 
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Table 4.3.1 Thermal parameters measured from DTA and HSM at 5 K min
1
 *β = 20 K min–
1
. 
 
4.3.2.4 Effect of heat treatment of the structure 
4.3.2.4.1 Crystalline phase evolution by XRD 
The exact nature of the phases produced during the heat treatment is of great interest 
in bioactive glasses as they are intended to be often exposed to high temperature when it is 
sintered for different biomedical application. Based on DTA thermographs, Tc was 
established for all the compositions and used as a criterion for selecting the heat treatment 
temperature to induce crystallization. In agreement with HSM and DTA, well sintered and 
dense glass-ceramics were obtained after heat treating the glass–powder compacts at 850 ºC 
for 1 h. Figure 4.3.3 presents the qualitative crystalline phase analysis of the sintered glass-
ceramics as depicted by XRD data. Thus heat treating at 850 ºC for 1 h resulted in well-
defined XRD phase reflections in all the compositions indicating their crystalline nature 
(Figure 4.3.3). Di (CaMgSi2O6; ICSD: 10223) and FA (Ca5(PO4)3F; ICSD: 163790) were the 
two the primary crystalline phases formed in all the glass-ceramics, followed by rankinite 
(Ca3Si2O7; ICSD: 2282) as secondary phase. Another phase named petedunnite (CaZnSi2O6; 
ICSD: 158143) crystallized in glass-ceramics with ZnO contents > 4 mol%. Consequently, 
with the addition of ZnO for MgO, Zn
2+
 replaced Mg
2+
 in the Di, thus forming the major 
crystalline phase with higher intensity than FA. The presence of FA phase is highly desirable 
as FA is more stable than HA. Therefore, materials containing FA would be recommended 
when coatings having low dissolution rate are required [136]. 
 Zn0 Zn2 Zn4 Zn6 Zn8 Zn10 
TFS  (±5 ºC) 757 753 748 766 747 750 
TMS1 (±5 ºC) 820 809 797 817 797 795 
TMS2 (±5 ºC) – 883 888 – – 850 
Tg
*
 (±2 ºC) 752 737 733 725 722 718 
Tc (±2 ºC) 850 843 852 843 837 822 
Tp (±2 ºC) 895 881 878 870 868 861 
Sc (=Tc–TMS1) 30 48 55 26 41 27 
A/A0 at TMS1 0.66 0.67 0.66 0.63 0.65 0.67 
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Figure 4.3.3 X-ray diffractograms of glass-ceramics heat treated at 850 ºC for 1 h.  
 
Hence, with the addition of ZnO to the parent composition the intensity of XRD peaks 
corresponding to Di increased whereas the intensity of FA peaks remained almost constant 
throughout the series.  
 
4.3.2.4.2 MAS-NMR of glass-ceramics  
The XRD data was further supported by MAS-NMR studies (Figure 4.3.4). The full 
width half maximum has reduced considerably in comparison to the original glasses (Figure 
4.2.1). Further, as shown in Figure 4.3.4a, all the spectra have a sharp peak centred ~ –84.4 
ppm and a small shoulder at –74.5 ppm, which becomes more pronounced with increase of 
zinc content in glasses, where the former is close to the pure Di [188] while the latter 
corresponds to the presence of minor phase rankinite [188]. In our study of XRD, a total of 
two silicate phases pertaining to chain silicates were observed in the glass-ceramics. 
However, discrimination between these phases is difficult due to the similarity in their silica 
connectivity. Therefore the resonance around –84 ppm can be due to the contribution from Di 
and petedunnite (inosilicates).  
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Figure 4.3.4 (a) 
29
Si MAS-NMR and (b) 
31
P MAS-NMR spectra of glass-ceramics heat 
treated at 850 ºC for 1 h. 
 
Figure 4.3.4b shows 
31
P NMR spectra of glass-ceramics heat treated at 850 ºC for 1 h. 
All the spectra have a sharp peak at 3.3 – 3.5 ppm corresponding to an orthophosphate 
environment and a small shoulder at around –5.3 and –14.6 ppm indicating the presence of 
pyrophosphate units. The band at 3.5 ppm is close to that reported for FA [136]. Further, the 
formation of pyrophosphate phase around –5.3 and –14.6 ppm may be due to the reduction in 
the charge balancing cations, which migrated towards their respective crystalline phases upon 
heat treatment. Further, Di being a mechanically strong phase renders high mechanical 
strength to the resultant glass-ceramics. It is worth noting that the presence of petedunnite as 
a minor phase indicates that zinc predominantly remains in the residual glassy phase. 
 
4.3.2.5 Density and molar volume 
The experimental results showed that substitution of MgO by ZnO caused an increase 
in the density (Table 4.3.2) of the glasses due to the higher density of ZnO (5.6 g cm
−3
) in 
respect to MgO (3.6 g cm
−3
). The molar volume of the glasses increased with increase in Zn 
content in glasses. The increase in molar volume can attributed to the small bond strength of 
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Zn–O bond in comparison to Mg–O bond which results in higher bond lengths thus causing 
an expansion in the network. 
 
Table 4.3.2 Density and molar volume of the investigated glasses. 
Glasses Density (g cm
3
) Molar volume (cm
3
 mol
1
) 
Zn0 2.92 20.40 
Zn2 2.95 20.47 
Zn4 2.98 20.51 
Zn6 3.02 20.55 
Zn8 3.05 20.59 
Zn10 3.08 20.66 
 
4.3.2.6 Mechanical Behaviour 
Evaluating the mechanical strength of a biomaterial is very important while judging 
its suitability for a given intended application, such as scaffolds for bone regeneration. It is 
likely that mechanical strength of a given glass-ceramic will be dependent on the mechanical 
properties of the constituting crystalline phases, their volume fractions, the size/shape of the 
crystals formed, and on the interfacial bonding between the amorphous and crystalline 
phases.  The flexural strength was calculated for powder compacts sintered at 850 ºC. High 
flexural strength values were obtained for glass powder compacts, which can be attributed 
the predominance of Di in all glass-ceramics (Figure 4.3.5). In general, an increase in 
mechanical strength with increasing Zn contents in glasses was observed, with the highest 
mechanical strength being measured for the GC Zn–8. As deduced from HSM and DTA 
analysis, this enhancement can be attributed to two complementary reasons: (i) an improved 
sintering ability due to a decrease in the viscosity of glasses translated by decreasing Tg 
values; (ii) a more extensive subsequent crystallization promoted by the enhanced diffusivity 
of ionic species in the glassy matrix.  
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Figure 4.3.5 Flexural strength of the glass-ceramics heat treated at 850 ºC for 1 h 
 
4.3.2.7 Apatite forming ability of glass-ceramics 
The SEM-EDS results of the glass-ceramic samples before and after immersion in 
SBF solution for different time periods are shown in Figure 4.3.6. The surface morphology of 
Zn-0, Zn-4 and Zn-8 samples before immersion in SBF (Figure 4.3.6a) is similar, a situation 
that was altered for the samples immersed in SBF (Figure 4.3.6b). The EDS data was 
gathered over the entire areas shown in the SEM micrographs to assure reliable averaging of 
the signals and the scale of all EDS spectra was always kept constant to enable a direct 
comparison. Although all the spectra reveal the presence of all glass-constituting elements, 
their relative intensities changed significantly after immersing the samples in SBF. It can be 
seen that the EDS spectrum of Zn-0 sample (Figure 4.3.6a) significantly differs from those 
obtained after immersing in SBF (Figure 4.3.6b). Namely, the intensities of Ca and P became 
more and more predominant with increasing immersion time. This constitutes an obvious 
evidence of apatite formation at the surface of the samples.  
The formation of HA at the surface of ZnO-containing glass-ceramics is less obvious. 
Various reasons can be cited for this delayed bio-mineralization process in ZnO-containing 
glass-ceramics: 
1. Presence of ZnO: The delayed formation of HA can be due to inter-tetrahedral 
non-covalent linkages in the residual glassy phase. Similar results have been 
reported in our previous section. Further, the concomitant presence of Mg
2+
 and 
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Zn
2+
 inhibits HA crystal growth. Literature reports suggest a Langmuir-type 
adsorption of these ionic species at active growth sites on the HA crystals [169] 
2. Low residual glassy phase: The enhanced crystallization of ZnO-containing glass-
ceramics (lower Tc values) and the consequent lower amount of residual glassy 
phase is also expected to decrease the apatite forming ability [189]. 
 
  
Zn-0 Zn-4 
 
Zn-8 
 
Figure 4.3.6a SEM/EDS micrographs images of unpolished and non-etched glass-ceramics 
samples before soaking in SBF:  Zn-0, Zn-4,and Zn-8. 
  
 
10 µm 5 µm 
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Figure 4.3.6b SEM/EDS micrographs images of unpolished and non-etched glass-ceramics 
samples after soaking in SBF for 7 and 14 days: (a) Zn0, (b) Zn4, and (c) Zn8. 
 
4.3.2.8 Mesenchymal cell activity and alkaline phosphatase activity 
Figure 4.3.7 shows the cell viability on the glass-ceramics and control during culture 
for up to 7 days, as assessed by a CCK method. Apparently, the growth kinetics of glass-
ceramics with 4 mol.% ZnO was significantly higher with respect to that of tissue culture 
plastic control as well as to that of other investigated glass-ceramics. Interestingly, all other 
zinc containing glass-ceramics showed lower cell viability in comparison to that for tissue 
culture plastic.  
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Figure 4.3.7 Influence of ZnO content in glass-ceramics on cell viability during culture for 
up to 7 days, as assessed by CCK method. Glass-ceramics with 4 mol% ZnO showed highest 
growth with respect to tissue culture plastic control as well as to that of other investigated 
glass-ceramics.  
 
The representative cell growth images at day 3 and day 7 on the glass-ceramics 
samples are presented in Figure 4.3.8. The cells were not readily noticed on the Zn0 glass-
ceramic after 3 days while the cell proliferation was comparatively better on glass-ceramic 
Zn8. On the other hand, when grown on Zn4, the cells were readily observed covering the 
surface almost completely with active cytoskeletal processes and elongated filopodia 
indicating that glass-ceramic Zn4 provides favourable conditions for adherence, spreading 
and proliferation of MSCs. After 7 days, although the cell proliferation on glass-ceramics 
other than Zn4 was better in comparison to that observed after day 3 but still the glass-
ceramic Zn4 exhibited the highest rate of cell proliferation. The lower cell viability in the 
absence of zinc can be explained by the fact that after iron, zinc is the most abundant trace 
metal in human organisms and is essential for various metabolic activities as has been 
discussed above 
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Figure 4.3.8 SEM images of the MSCs grown on the sintered glass powder compacts (Zn0, 
Zn4 and Zn8) during culture for 3 and 7 days. After 7 days, cell proliferation on glass-
ceramics was better in comparison to that observed after 3 days. Glass-ceramic Zn4 
exhibited the highest rate of cell proliferation. 
 
 However, the decreasing cell viability with increasing zinc concentration in glasses 
may be attributed to its dose-dependent effect. Zn
2+
 has been reported to play a dual role in 
affecting the cell death: although zinc seems to be inhibitor of many forms of apoptosis [190], 
exposure to excessive concentrations may contribute to neuronal cell death in acute 
neurological disorders and to apoptosis of human peripheral blood lymphocytes [191]. The 
mechanism by which Zn
2+
 induces cell death and oxidative stress is still unresolved. 
According to the available literature, an increase in Zn
2+
 concentration in cellular medium 
higher than ~2 ppm can lead to cytotoxicity and cell death [44]. Similar results with respect 
to proliferation of endothelial cells and osteoblasts have also been reported by Aina et al. 
[120, 157] where it has been shown that 45S5 Bioglass
®
 doped with 5 wt% ZnO enhanced 
cell proliferation on its surface while increasing zinc concentration led to significant release 
of lactate dehydrogenase (index of cytotoxicity) thus, resulting in cell death. With respect to 
the bioactivity of glass-ceramic Zn4, the cell growth kinetics in this sample is significantly 
higher in comparison to that reported for apatite-wollastonite [192] as well as for diopside-
flouroapatite [105] glass-ceramics, respectively.  
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Figure 4.3.9 Alkaline phosphatase activity of the MSCs during culture for 7 and 14 days on 
the glass compacts (Zn0 to Zn8) and on tissue culture plastic control. For all the 
investigated glass-ceramics, irrespective of their ZnO content, ALP levels were always higher 
in comparison to that of control (p < 0.05, ANOVA, n=3) 
 
The osteogenic differentiation of the MSCs cultured on the glass-ceramic samples 
was investigated in terms of ALP activity (Figure 4.3.9). Under the osteogenic medium used 
herein, rat bone marrow MSCs have been shown to switch to the lineage of osteoblastic cells 
[193]. When cultured on the control dish, MSCs showed an increased ALP level from days 7 
to 14. The ALP levels for all the investigated glass-ceramics were higher in comparison to 
control irrespective of their zinc content. However, among all the investigated glass-ceramics, 
Zn4 exhibited the highest ALP activity of cells during 7 and 14 days of culture. It should be 
noted that ALP is a homodimeric metalloenzyme that catalyses the hydrolysis of almost any 
phosphor monoester with the release of phosphate and alcohol. Its properties have been 
associated with the mineralization process and phosphate homeostasis in bone tissue [194]. 
ALP acts as a nucleation centre for hydroxyapatite as it is able to release phosphate and 
captures calcium ions. In this way, the presence of ALP and a solution rich in Ca
2+
 ions 
induces the deposition of hydroxyapatite (bone forming mineral) crystals and amorphous 
calcium phosphate.  
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4.3.3 Conclusions 
A detailed investigation about the influence of adding increasing amounts of ZnO to 
partially replace MgO in a parent bioactive glass composition (TCP-20) was shown to have 
consequences in terms of sintering and crystallisation behaviours and on the relevant 
properties of the resulting glass-ceramics, including mechanical and biological responses. 
The glass forming ability of the glasses was unaffected by the level of MgO substitution. All 
the glass compositions investigated exhibited good sintering ability upon heat treating at 850 
ºC for 1 h thus, resulting in well sintered and mechanically strong glass-ceramics with 
diopside and fluorapatite as the primary crystalline phases. A minor crystalline phase 
(petedunnite) was also formed for ZnO > 4 mol%. The ZnO content also revealed to play an 
essential role on the in vitro bioactivity. The glass-ceramic composition with ZnO = 4 mol% 
exhibited the highest levels of mesenchymal cell proliferation and alkaline phosphatase 
activity, while further increasing ZnO contents led to a significant decrease in the in vitro 
performance of the investigated glass-ceramics.  
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4.4 Role of glass structure in defining the chemical dissolution behaviour, bioactivity 
and antioxidant properties of zinc- and strontium- co-doped alkali-free phosphosilicate 
glasses 
4.4.1 Introduction 
Since the chemical degradation of multi-component glasses is strictly related to their 
atomic and molecular structure [5]
 
the design of bioactive glasses requires a thorough 
understanding of the relationship between their atomic/molecular structure and dissolution 
behaviour. In fact, it has been well established that the ionic dissolution products are key to 
understand the behaviour of their parent inorganic materials in vitro and in vivo, especially in 
the context of TE applications [195]. This relationship becomes more important when 
functional ions (for example: Sr
2+
, Zn
2+
, F

, etc.) are incorporated in the glasses with an aim 
to enhance their biological efficacy because these ions interact with and modify the phospho-
silicate glass matrix, thus, affecting the dissolution behaviour of resultant glass compositions. 
Therefore, it is of paramount importance to understand the influence of these functional ions 
on the structure and bioactivity of glasses so as to design glass compositions with controlled 
chemical dissolution and ion release rates.  
Zinc and strontium are two such functional ions whose biological importance has been 
well documented in literature [42, 56, 59, 121]. Despite being present in trace amounts, both 
these ions play essential roles in the chemistry of bone [196, 197]. For this reason several 
studies describing the influence of zinc and/or strontium on various aspects of bioactive 
glasses and their properties have been reported in literature during the last few years [42, 58, 
82, 114, 119-122, 198]. Further, most of the work on strontium and zinc co-doped bioactive 
glasses available in literature has been published by Boyd and co-authors [125, 154, 199-203] 
in the CaO–SrO–ZnO–Na2O–SiO2 glass system.  
The present section aims at defining the structure-property relationships in a series of 
alkali-free phosphosilicate glass composition in Di-FA-TCP system co-doped with Zn
2+
 and 
Sr
2+
. An attempt has been made to understand the structural role of Sr
2+
 and Zn
2+
 co-doping 
on the chemical dissolution behaviour of glasses and its impact on their apatite forming 
ability, osteoblast proliferation and antioxidant behaviour. The very promising glass 
composition TCP-20 discussed in section 2.1 was adopted as the starting point for synthesis 
of present series of glasses. The structure of the as-obtained glasses has been 
investigated by MAS-NMR while the biodegradation of glasses has been investigated by their 
immersion in Tris–HCl and SBF. Furthermore, the influence of glass structure and the 
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dissolution behaviour on osteoblast proliferation and oxidative stress levels has been 
discussed. 
 
4.4.2 Results  
4.4.2.1 Glass forming ability 
For all the investigated glass compositions with varying Zn
2+
/Mg
2+
 and Ca
2+
/Sr
2+
 
ratio: (mol%) (36.07–x) CaO – xSrO – (19.24–x) MgO – xZnO – 5.61P2O5 – 38.49SiO2 – 
0.59 CaF2 (x = 0–10), melting at 1570 ºC for 1 h was sufficient to obtain bubble-free, 
transparent and XRD-amorphous glasses (Figure 4.4.1). Table 4.4.1 presents the detailed 
compositions of the as-designed glasses. 
 
 Table 4.4.1 Nominal composition of the as-designed glasses (mol%). 
 
Glass CaO MgO SiO2 P2O5 ZnO SrO CaF2 
ZS-0 36.07 19.24 38.49 5.61 0.00 0.00 0.59 
ZS-2 34.07 17.24 38.49 5.61 2.00 2.00 0.59 
ZS-4 32.07 15.24 38.49 5.61 4.00 4.00 0.59 
ZS-6 30.07 13.24 38.49 5.61 6.00 6.00 0.59 
ZS-8 28.07 11.24 38.49 5.61 8.00 8.00 0.59 
ZS-10 26.07 9.24 38.49 5.61 10.00 10.00 0.59 
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Figure 4.4.1 X-ray diffractograms of glass powders 
 
4.4.2.2 Structure of glasses 
The 
29
Si MAS-NMR results of all the glasses as presented in Figure (4.4.2a, 4.4.3a), 
depict the dominance of Q
2
 (Si) structural units in the glasses. Furthermore, the dominance of 
Q
2
 structural units is confirmed by the quantitative analysis of deconvoluted NMR spectra 
(Table 4.4.2b). The Qn distributions for the three compositions are rather close to each other, 
i.e. the silicate distribution is dominated by Q
2
 chain species, with substantial amounts of 
chain-terminators Q
1
 and branched Q
3
 species. Further, only slight shift in the peak positions 
of spectra could be observed and all the spectra are centred between –81 ppm and –82 ppm, 
thus depicting no significant changes in the silica coordination in glass structure. The 
31
P 
MAS–NMR spectra of all the glasses (Figure 4.4.2b)  and the corresponding de-convolution 
(Table 4.4.3) show a predominance of orthophosphate–type species with chemical shifts 
centred at around 2–2.5 ppm, close to that of the calcium orthophosphate (3.1 ppm) [137]. 
Besides the dominant Q
0
 orthophosphates, Table 4.4.3 also highlights the presence of non-
negligible amounts of non-orthophosphate species, in agreement with the MD models, a 
phosphorus environment thus qualitatively similar to that found for the 45S5 glass [127, 167]. 
Similar results were obtained for alkali-free bioactive glasses doped with ZnO and SrO on 
independent basis where insignificant influence on silicate network connectivity was 
observed by varying SrO/CaO ratio [204] or ZnO/MgO [42] ratio in the glasses while most of 
the phosphorus component was found in orthophosphate environment. 
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Figure 4.4.2 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
Thus NMR results shows that Zn
2+
/Mg
2+
 and Ca
2+
/Sr
2+
 substitutions do not affect the silicate 
network connectivity of these glasses. 
 
Table 4.4.2 Q
n
 (Si) distribution for glasses ZS-4 and ZS-10 obtained by NMR de-
convolution. 
 
  
  
Q
n
 
ZS-4 ZS-10 
peak position 
(ppm) 
% integral 
peak position 
(ppm) 
% integral 
Q
0
 -66.5 0.3 -66.0 0.3 
Q
1
 -75.7 22.7 -75.8 28.8 
Q
2
 -81.7 50.6 -82.6 48.0 
Q
3
 -88.3 24.1 -90.5 22.7 
Q
4
 -96.7 2.2 -107.4 0.1 
ZS-8 
ZS-2 
ZS-4 
ZS-6 
ZS-10 
-200-150-100-50050
-81.5 ppm 
29Si Chemical Shift (ppm) 
(a) 
ZS-2 
ZS-4 
ZS-6 
ZS-8 
ZS-10 
-40-2002040
2.5 ppm 
2.03 
31P Chemical Shift 
(b) 
Alkali-free bioactive glasses for bone regeneration  
Page 89 
 
Table 4.4.3 Q
n
 (P) distribution for glasses ZS-4 and ZS-10 obtained by NMR deconvolution. 
 
 
 
  
  
Figure 4.4.3 (a) 
29
Si MAS NMR spectra and (b) 
31
P MAS NMR spectra after deconvolution 
of investigated glasses. 
  
Q2 
Q1 
ZS-10 
(a) 
Q3 
-130-110-90-70-50-30
ZS-10 
(b) 
Q0 (Mg) 
Q0 (Ca) 
Q1 
-30-101030
ZS-4 
Q3 
Q4 
Q2 
Q1 
-130-110-90-70-50-30
29Si chemical shift (ppm) 
Q0 (Ca) 
ZS-4 
Q0 (Mg) 
Q1 
-30-101030
31P Chemical Shift (ppm) 
Q
n
 
ZS-4 ZS-10 
peak position 
(ppm) 
% integral 
peak position 
(ppm) 
% integral 
Q
0 
(Ca) 3.2 52.3 3.2 67.4 
Q
0
(Mg) 0.5 27.5 0.8 17.3 
Q
1
 -1.0 20.3 -1.9 15.2 
Q
2
 - - - - 
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4.4.2.3 SBF immersion studies 
In the present case, FTIR spectra of all the glass powders before immersion in SBF 
solution are presented in Figure 4.4.4a. All the investigated glasses show three broad bands in 
350–1300 cm–1 region. The broadness clearly shows the disorder in the glass structure with 
uneven distribution of Q
n
 units. The band ranging from 800–1300 cm–1 corresponds to 
presence of two optical modes of Si–O–Si groups: Si–O bending mode identified around 800 
cm
–1
 and the asymmetric stretching mode Si–O (s) in 1000–1300 cm–1 region. The ~500 cm–1 
band can be attributed to Si–O–Si bending modes, while the weak shoulder around ~750 cm–1 
may be due to Si–O–Si symmetric stretching with simultaneous Si cations motion [205]. 
Further, the band centred around 559 cm
–1
 corresponds to P–O bending modes [206].   
The immersion of glass powders in SBF for varying time durations led to a 
considerable change in the glass chemistry which is evident from the FTIR data presented in 
Figure 4.4.4b-4.4.4d. The soaking of glass powders in SBF for 1 h resulted in the appearance 
of a strong low frequency band around ~503 cm
–1
 (Figure 4.4.4b) typical for the deformation 
mode of silica gel–like layer.  In addition to that the main IR band now appeared at 1051 cm–1 
along with a weak shoulder at 1180 cm
–1
 which could be assigned to Si–O–Si stretching 
vibrations [206]. These bands indicate the development of interfacial high-area silica gel 
layer, as postulated in Hench’s inorganic reactions set [20] and can be observed in all the 
glasses. The peaks around ~560, 600, 1035 cm
–1
 present in all the glasses are evidence for the 
formation of crystalline hydroxyapatite and other crystalline phosphate species as these bands 
correspond to P–O bending vibrations in a PO4
–3
 tetrahedron. Further, the bands at 1296 cm
–1
 
and 1461 cm
–1 
corresponding to the formation of complex carbonate species imply towards 
formation of carbonated HA. It is noteworthy that formation of any calcium carbonate 
(CaCO3) polymorphs has been negated considering their absence in the XRD data obtained on 
glasses after immersion in SBF solution as shown in Figure 4.4.5. 
The XRD data obtained on glass powders after immersion in SBF solution for varying 
time durations support the FTIR results as all the glasses exhibit well defined characteristic 
X-ray peak at 2θ = 31.77º corresponding to the formation of crystalline hydroxyapatite [HA; 
(Ca5(PO4)3OH; ICDD: 00–09–0432] after 1 h of immersion (Figure 4.4.5).  
The intensity of the XRD phase reflections for HA increased with increase in SBF 
immersion time, thus, depicting the high apatite forming ability of these glasses. 
Interestingly, the apatite forming ability of same parent glass (ZS–0) was observed to 
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decrease considerably when doped with SrO (at the expense of CaO) or ZnO (at the expense 
of MgO) on individual basis as has been reported in our previous articles [42, 204]. 
  
  
Figure 4.4.4 FTIR spectra of glass powders (a) before, after (b) 1h, (c) 24h, and (d)14 days 
immersion in SBF. 
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Figure 4.4.5 X-ray diffractograms of glass powders after immersing the glass powders in 
SBF solution for (a) 1 h (b) 3 h (c) 6 h (d) 24 h (e) 3 days and (e) 14 days.  
 
 In order to gain a better insight into the glass dissolution process and apatite forming 
ability of the investigated glasses, the elemental release profile of these glasses was studied 
when immersed in SBF solution for initial 24 h. The trends observed for variation in 
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SBF detected during initial 24 h are presented in Figure 4.4.6. The results obtained have been 
summarized below:  
i) The trend of Ca2+ concentration after 1 h of immersion corresponds to an increase for 
all glasses which reaches its maximum within 12 h of immersion in SBF solution 
(Figure 4.4.6a). The increasing Ca
2+
 concentration in SBF during initial immersion for 
all glasses imply towards the initiation of the bio-mineralization process, where 
modifier cations in the glass exchange with hydronium ions in the external solution 
[20]. This increase in the Ca
2+
 concentration may be attributed to the exchange of Ca
2+
 
with the hydronium ion present in the SBF solution due to disruption of the glass 
network. Thereafter, a kind of saturation plateau is reached for all the investigated 
glasses. The similar dissolution behaviour for all the glass compositions may be 
ascribed to the similar network connectivity exhibited by all the glasses. The release of 
Ca
2+
 seems to depend on their actual concentration in parent glasses as increasing 
SrO/CaO ratio in glasses decreased the Ca
2+
 ion release concentration in the SBF 
solution.  
ii) The concentration of PO4
3
 follows steadily decaying profiles, an indication that the 
dissolution rate from glasses is lower than the rate of surface deposition of such species.  
iii) The Mg2+ ion concentration profile is similar to that of Ca2+ in SBF solution and was 
detected to be highest after 12 h of immersion time for all the glass compositions while 
no significant variations were observed after prolonged SBF immersions (Figure 
4.4.6c), possibly due to attainment of equilibrium between the Mg
2+
 concentration in 
glass and SBF. In general, the amount of Mg detected after any particular immersion 
time was highest for ZS–2 and lowest for ZS–8 possibly due to higher magnesium 
content in ZS–2 as compared to ZS–8.  
iv) Sr2+ can accumulate in bone by exchanging with Ca2+ in the hydroxyapatite crystal 
lattice due to the chemical analogy to Ca
2+
. As shown in Figure 4.4.6d, glass 
compositions up to ZS–4 exhibit Sr release profiles that are similar to other alkaline 
earth ions for all compositions with a maximum after 12 h of immersion in SBF 
solution. With further increasing the ZnO and SrO content to ZS–8, the strontium 
release profile was observed to steadily increase beyond 12 h. Although we did not
 
make elemental analysis of the SBF solution obtained after immersion of glass ZS–10 
for varying time durations, a similar behaviour is expected from this glass too.  
v) In general SiO4
4–
 ion concentration increases with increase in immersion time, 
thereafter reaching a saturation plateau after 6–12 h of immersion (Figure 4.4.6e). It is 
worth noting that Si concentrations reached highest values for ZS–2, an indication that 
the chemical resistance of glasses somewhat increased with increasing added amounts 
of doping ions.  
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vi) The Zn ion release profiles for the investigated glasses over 24 h are shown in Figure 
4.4.6f. In all the investigated glasses the Zn ion concentration in SBF increases with 1 h 
of immersion time, thereafter decreases to a saturation value. Zn
2+
 release from these 
glasses appears to be independent from the Zn content in the glasses. Also it is worth 
noting that co-doping of glasses with SrO and ZnO does not prevent the formation of 
HA on the glasses.  
  
  
  
Figure 4.4.6 ICP plots of elemental concentration of (a) Ca, (b) P, (c) Mg, (d) Sr, (e) Si and 
(f) Zn, in SBF solution versus immersion time for the investigated glass powders.  
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4.4.2.4 Chemical degradation of glasses in Tris-HCl 
All the glasses were XRD amorphous after immersion in Tris-HCl for 120 h, thus 
negating the possibility of any phase formation due to chemical reaction between the 
dissolution products (Figure 4.4.7). 
 
Figure 4.4.7 X-ray diffractograms of glass powder after 120 days of immersion in TRIS-
HCL 
 
The variation in pH of Tris–HCl along with weight loss of the glasses with respect to 
SrO and ZnO content in glasses is presented in Figure 4.4.8a. A slight change in pH of Tris–
HCl from 7.54 to 7.24 was observed with increasing SrO and ZnO content in glasses after 
120 h of immersion. This depicts good chemical stability of glasses which in turn should 
support cell viability due to the absence of sudden pH changes in the dissolution medium. A 
steep decrease in the weight loss of glass was observed with increasing equimolar 
concentrations of ZnO and SrO content up to 6 mol%. Further increase in ZnO and SrO 
content in glasses did not lead to any significant change in the weight loss of glasses. 
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Figure 4.4.8 (a) Graphs depicting the change in solution pH and weight loss of glass 
powder samples (with respect to variation in ZnO and SrO content in glasses) after 
immersion in Tris–HCl; (b) ICPAES plots of elemental concentrations of Ca, Mg, P, 
Si, Sr and Zn in Tris–HCl after 120 h of immersion of glass powder. It should be noted 
that Si refers to SiO4
4
 and P refers to PO4
3
 species. 
 
With respect to the ion release profile the ICP–OES analysis revealed that studied 
glasses demonstrated SiO4
4 
ion release in the range of 39–157 ppm (1 ppm = 1 mg l–1). Also 
increasing strontium and zinc content in the glasses decreased the release of SiO4
4
 species in 
Tris–HCl as shown in Figure 4.4.8b, thus explaining the lower chemical degradation of 
glasses. Previous studies have shown that SiO4
4
 release levels in the range 0.1100 ppm 
from bioactive glass and other biomaterials show stimulatory effects on osteoblasts and the 
expression of TGF–b mRNA in human osteoblast–like cells [207]. Furthermore, gradual 
release of soluble silica over time enhances bone bonding due to the increased formation of 
Si–OH (silanol) groups. Therefore, it is apparent that any bioactive glass releasing SiO4
4 
within these ranges will have similar beneficial effects. Hence, all the glasses in the present 
study may possess beneficial properties towards various biological processes.  
Phosphorus being a major component of the inorganic phase of human bone plays an 
important role in bone formation as mentioned in section 2. In the present study, the ionic 
concentration of phosphorus released (8.6–24 ppm; Figure 4.4.8b) from the glasses in Tris–
HCl lies within the above mentioned limit required to promote favourable biological activity. 
Further, Ca
2+
 ion release from experimental glasses in Tris–HCl solution decreased 
from 268–53 ppm (Figure 4.4.8b) probably owing to the decrease in CaO concentration in 
glasses. The significance of calcium in bone mineralization is well established and its gradual 
release over time is bound to enhance therapeutic efficacy of the glasses. Similarly, 
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Magnesium concentration in the extracellular fluid ranges within 1725.5 ppm. In the present 
study the concentration of Mg
2+
 released from the investigated glasses in Tris–HCl solution is 
higher than the concentration vital for favourable biological properties. However, due to 
efficient excretion of Magnesium in the urine, incidences related to hyper–magnesium 
conditions are rare [60].
 
With respect to release of strontium and zinc from the studied 
glasses, all the glasses demonstrated a release of 23–32 ppm of strontium and 0.1–9.8 ppm of 
zinc over 5 days of immersion in Tris–HCl (Figure 4.4.8b). Although, the amount of 
strontium released from glasses is within the limits of its therapeutic efficacy, the amount of 
zinc released from glasses with ZnO content >4 mol% is slightly higher than required for 
biomedical purpose.  
 
4.4.2.5 Cellular response on bioactive glasses  
4.4.2.5.1 In vitro proliferation of MG63 cells  
Figure 4.4.9 depicts the cell viability on glasses under investigation in comparison 
with commercially available culture plates, of ZS–2, ZS–4, and ZS–6 and ZS–8 bioactive 
glasses. MG-63 cells were used for the following reasons firstly, MG-63 cells display suitable 
integrin molecules required for cell adhesion making them a more appropriate model under 
the present study, secondly the response of MG-63 cells to 1,25(OH)2D3 administration has 
been shown to be similar to normal human osteoblast cells [208]. Additionally, human and 
MG63 cells produce cAMP in response to Parathyroid hormone therapy [209, 210]. 
Moreover, MG-63 cells provide an excellent model for studying the antioxidant properties of 
bioactive glasses as they have been used in variety of studies especially for their use in 
capsaicin induced apoptosis via the caspase cascade and the antioxidant enzyme system and 
Okadaic acid induced apoptosis through the PKR, NF-κB and caspase pathway. These 
pathways are similar to the apoptotic death caused by H2O2 used and oxidizing agent in the 
present study which have earlier been used to studying protection of MG63 cells by 
Melatonin and Simvastatin [211, 212]. Apparently, the proliferation of MG63 cells was 
89.0±4.2%, 86.7±3.9%, 80.25±3.6% and 72.8±3.1% on glasses ZS–2, ZS–4, ZS–6 and ZS–8, 
respectively (Figure 4.4.9a).  
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Figure 4.4.9 Plots showing the cell growth kinetics of the glasses (ZS–2, ZS–4, ZS–6, and 
ZS–8) (a) under normal condition during culture after 4 days under normal conditions (b) 
under H2O2 (250 μM) induced oxidative stress in MG63 cell after 3 days. *(C for control) 
 
The antioxidant potential of investigated glasses was examined on H2O2 induced 
oxidative damage in MG63 cell line after 24 h of cell growth. H2O2 is one major contributor 
to the oxidative damage and leaks from mitochondria in the cells. According to Li et al. [213] 
H2O2 stops cells proliferation in MG63 cells by reducing the levels of cycline B1 and 
induction of G2 cell cycle arrest. Although, the cell viability was higher (in comparison to 
control) in the presence of Sr- and Zn-doped bioactive glasses under investigation; 
interestingly, the cell viability decreased for SrO- and ZnO-concentration in glasses beyond 
ZS–4, as is evident from Figure 4.4.9b. Accordingly, the highest cell viability under oxidative 
stress was observed for glass ZS–2 (163%) followed by ZS–4 (151%), ZS–6 (138%) and ZS–
8 (135%) when compared with control cultures at LD50 dose of H2O2 (Figure 4.4.9b).  
 
4.4.3 Discussion 
From MD simulation results [214], the network connectivity (NC) in the investigated 
glasses is ~1.95. Based on the qualitative interpretation of the correlation between solubility 
and NC, an empirical upper limit of NC~3 has been defined separating bioactive (NC <3) 
from bio-inert (NC >3) glasses [39]. According to O´Donnell and Hill [112], melt-quenched 
silicate glasses with NC = 2 are good candidates for bioactive materials as biological 
response and other properties of glasses rapidly change around this value. Invert glasses with 
NC below 2 usually exhibit very high dissolution rates (due to highly depolymerized glass 
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structure), being considered less practical in biological systems [112]. However, this 
empirical interpretation based on NC should be considered only as a qualitative guideline for 
designing bioactive glasses. As a matter of fact, our investigated glasses having a NC <2 
would be expected to exhibit excessive dissolution rates and unsuitable bioactivity, which is 
at odds with their apatite forming ability in SBF (Figure 4.4.5) and very moderate weight loss 
in Tris–HCl shown in Figure 4.4.8a.  
Further, the 
29
Si MAS–NMR data reveal the predominance of Q2 units along with 
considerable fraction of Q
1
(Si) and Q
3
(Si) in all the glasses (Table 4.4.2). The phosphate 
component in the glass is predominantly coordinated in orthophosphate environment thus, not 
contributing to the glass network backbone. This is again a desired feature because the low 
connectivity of phosphorus in the glass structure along with its ability to rip off the network 
modifying cations (mainly Ca
2+
) from the silicate network not only facilitates the release of 
additional soluble phosphate species into the contact fluid which will increase the local super-
saturation but also accelerate the bone bonding ability of glass by enhancing the HA 
deposition on the glass surface.  
The network modifying role of SrO/CaO along with the intermediate role of 
ZnO/MgO seems to play the major role in deciding the biological efficacy of the investigated 
glasses. This is evident from the significant disparity in the leaching behaviour of ZnO and 
SrO from glasses in SBF solution or Tris–HCl despite the fact that both these oxides have 
been incorporated in the glasses in the equimolar concentrations. The slow release of zinc 
(due to its ability to enhance the strength of inter-tetrahedral cross-links) and the 
comparatively faster release of strontium along with other elements help in enhancing the 
osteoblast proliferation and anti-oxidative properties of the studied glass compositions. 
According to literature, strontium when released in concentrations of <10 ppm has the ability 
to inhibit H2O2 induced oxidative stress in osteoblasts (CRL-11372) within a duration of 6–
12 h [215]. For concentrations >87.6 ppm, strontium becomes an apoptotic agent and induces 
the apoptotic effect of H2O2 [215]. The blood active Sr
2+
 concentration in postmenopausal 
osteoporotic patients treated with strontium ranelate (Protelos
®
, Servier Laboratries, Ireland) 
has been measured to be 10.5 ppm [56]. On the other hand, zinc concentrations have been 
observed to follow a strict dose-dependent behaviour with their therapeutic efficacy being 
restricted to the dose limits of <2 ppm. According to Aina et al. [157], when the 
concentration of zinc released from bioactive glasses exceeds 2 ppm, it causes damage to the 
osteoblasts (MG63) via oxidative stress. In a similar study, Bergandi et al. [216] explained 
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the role of fluoride ions released from F-doped 45S5 Bioglass
®
 in inducing the oxidative 
stress when in contact with MG63 human osteoblast cell line due to inhibition of the pentose 
phosphate oxidative pathway and, in particular, through the oxidative inhibition of glucose 6-
phosphate dehydrogenase. A similar observation has been made in the present study as the 
glass ZS–2, which releases <1.5 ppm zinc and ~10 ppm strontium in SBF (Figure 4.4.6) 
exhibits antioxidant behaviour  by enhancing the cell viability and negating the effect of 
oxidative stress induced by H2O2 addition in the cell culture medium. Further increasing the 
ZnO and SrO contents in glasses led to an increase in their released zinc and strontium 
concentrations. However, the decrease of their antioxidant behaviour could only be clearly 
noticed for the glass compositions with their respective ZnO and SrO content ≥6 mol%. 
Interestingly, although our glasses contain equimolar concentrations of ZnO and SrO, the 
release of Sr
2+
 into the SBF or Tris–HCl solutions is significantly higher than that of Zn2+. 
This depicts the importance of the structural coordination of zinc ions as intermediate in the 
glass structure (at variance with the stronger network modifying role of strontium, and its 
higher ionic field strength in comparison to strontium.  
Oxidative stress plays a prominent role in bone healing and regeneration. It arises due 
to the formation of reactive oxygen species (ROS). ROS (•O2
, •OH, H2O2, OCl

, etc.), which 
are generally produced in cellular mechanisms during conversion of oxygen to water (in 
order to produce energy) by mitochondria or during an encounter between white blood cells 
(WBCs) and pathogens in our body [217]. In case of a bone fracture, oxidative stress injury 
may be caused by an ischemia–reperfusion mechanism. In such a scenario, tissue damage is 
caused due to oxidative stress when blood supply returns to the tissue after a period of lack of 
oxygen. These radicals may cause oxidative injury to the fractured bone as has been seen in 
other tissues with reperfusion injury [218, 219]. The protection of MG63 cell line from H2O2 
induced oxidative stress in the present study by alkali–free bioactive glasses (mainly by 
glasses ZS–2 and ZS–4) may be attributed to the anti–apoptotic effect of zinc and strontium 
when released in a controlled manner. It has been recently reported that zinc is involved in 
direct inhibition of H2O2 induced apoptosis by activation of the P13K/Akt and MAPK/ERK 
pathways [220], while in case of strontium, a recent study by Jebahi et al. [221] reports an 
increase in the Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase 
(GPx) in vivo as the prominent features providing antioxidant behaviour to the materials 
doped with these trace elements. In the overall context of bone healing and regeneration, the 
as designed glasses are potential candidates for applications in the treatment of osteoporosis.  
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4.4.4 Conclusions 
The effects of co-doping of zinc and strontium on the structure, chemical dissolution 
behaviour of alkali-free phosphosilicate glasses and its impact on their apatite forming 
ability, osteoblast proliferation and antioxidant behaviour have been studied with NMR, 
FTIR, XRD, chemical degradation and cell culture experiments. An increase in the Zn
2+
/Mg
2+
  
and  Sr
2+
/Ca
2+
 ratio did not induce any significant change in Q
n 
speciation and network 
connectivity, as revealed by MAS–NMR. The chemical durability of investigated glass 
improved (as observed from Tris-HCl studies), however all the glasses exhibit good apatite 
forming ability. The glass ZS–2 which releases < 1.5 ppm zinc and ≤ 10 ppm strontium in 
SBF, is exhibiting good antioxidant behaviour by enhancing the cell viability and negating 
the effect of oxidative stress induced by H2O2 addition in the cell culture medium. However, 
further increase in ZnO and SrO content in glasses led to an increase in their released zinc 
and strontium concentrations, thus, decreasing their antioxidant behaviour. Thus zinc 
concentration < 1.5 ppm has an anti-oxidant effect. The anti-oxidant behaviour may be 
attributed to the anti–apoptotic effect of zinc and strontium when released in a controlled 
manner. Although promising results suggest possible clinical use of bioactive glass, further 
investigations of long-term outcomes are going on for the glass to be used in orthopaedic 
applications. 
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4.5 Thermo-mechanical behaviour of alkali-free bioactive glass-ceramics co-doped with 
strontium and zinc 
4.5.1 Introduction 
TE has emerged as an effective approach in response to the challenges in 
reconstructive and orthopaedic surgeries which involve restoring the diseased or damaged 
tissue by applying a combination of functional cells and scaffolds made of synthetic 
biomaterials. TE offers a feasible solution to the problems associated with the allograft and 
autograft [23]. This approach requires scaffolds with a well-defined architecture which not 
only provide temporary mechanical strength but also act as guiding channels for cell 
proliferation and tissue ingrowths [161]. The ideal scaffold should (i) be biocompatible (non-
toxic) and should promote cell adhesion and proliferation; (ii) exhibit mechanical properties 
that are comparable to those of the tissue to be replaced; (iii) exhibit controlled degradation 
rate and should degrade into nontoxic products that can be easily resorbed or excreted by the 
body; and (iv) be capable of being machined easily into required shapes [161]. All these 
properties are highly dependent on the substrate material properties and it is due to this 
reason that the choice of the material plays an important role in designing a suitable scaffold.  
In today’s scenario, bioactive glass-ceramics are considered to be potential materials 
for bone TE because of a number of salient features not only in relation with their good 
bioactivity but also owing to their good sintering ability, high mechanical strength and 
controlled chemical degradability [141, 189, 206]. The aim of the present section is 
understand the influence of co-doping of Zn
2+
 and Sr
2+
 on the thermal and mechanical 
behaviour of TCP-20. Although, good amount of literature is available on the influence of 
these two ions on various properties of bioactive glasses on individual basis as mention in 
section 4.4, it is rare to find literature describing the influence of both these ions on thermal 
behaviour of glasses.  
 
4.5.2. Results and Discussion 
4.5.2.1 Glass-forming ability 
For all the investigated glass compositions shown in Table 4.4.1, melting at 1570 ºC 
for 1 h was sufficient to obtain bubble-free, transparent and XRD-amorphous glasses. 
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4.5.2.2 Thermal analysis 
The DTA thermographs of fine glass powders with b= 20 K min−1 are shown in 
Figure 4.5.1. All the glass compositions feature a single endothermic dip which corresponds 
to Tg before Tc followed by an exothermic crystallization curve. The characteristic 
parameters obtained from DTA thermographs are summarized in the Table 4.5.1. In general, 
Tg decreases with increase in SrO and ZnO content in glasses. This decrease in Tg can be 
attributed to decrease in oxygen density (o) of glasses with addition of SrO and ZnO as 
shown in Figure 4.5.2. Oxygen density is a measure of compactness of the glass structure 
and can be calculated by using the following relation [114]: 
v
OPSiO
M
xMgOxZnOxCaOxSrOxxOM )52()(
522
o

  
Where, M(O) is the molecular mass of oxygen atom and x corresponds to the molar 
concentration of the respective oxides and Mv corresponds to the molar volume of the 
glasses. In general, the decrease in oxygen density points towards the expansion of glass 
structure resulting in the weakening of the glass network and an associated decrease in Tg. 
 
Figure 4.5.1 DTA thermographs of glasses at a heating rate of 20 K min
−1
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Figure 4.5.2 Oxygen density plotted against percentage zinc and strontium substitution. 
 
Table 4.5.1 Thermal parameters measured from DTA at 20 K min
1
. 
 ZS-2 ZS-4 ZS-6 ZS-8 ZS-10 
Tc(±2 ºC) 885 884 871 866 870 
Tg(±2 ºC) 756 734 725 721 720 
ΔT(=TcTg) 129 150 146 145 150 
 
 
4.5.2.3 Sintering and Crystallization behaviour 
Figure 4.5.3 presents variation in the relative area and heat flow with respect to 
temperature as obtained from HSM and DTA, respectively, for all the investigated glasses at 
a similar heating rate of 5 K min
−1
. Table 4.5.2 summarizes the values of the temperature of 
first shrinkage (TFS; log  = 9.1 ± 0.1,  is viscosity in dPa s), temperature for maximum 
shrinkage (TMS; log = 7.8 ± 0.1) and ratio of the final area/initial area of the glass powder 
compact (A/A0) at TMS1, as obtained from the HSM data along with temperature for Tc and 
Tp, as obtained from the DTA of the glasses.  
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Figure 4.5.3 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions: (a) ZS-2, (b) ZS-4, (c) ZS-6, (d) ZS-8 and (e) ZS-10. 
 
(i) TFS decreased monotonically from 765 to 740 ºC with increasing SrO/CaO and 
ZnO/MgO ratios. 
(ii) Two stage sintering behaviours, with the main shrinkage occurring along the first step, 
were observed for glasses ZS–2, ZS–4 and ZS–6, while a gradual shift to single stage 
shrinkage was registered for glasses ZS–8 and ZS–10 (Figure 4.5.3). The first sintering 
stage is accomplished at TMS1 while the second one at TMS2.  In all the glass 
compositions TMS1 was observed at temperatures lower than Tc (i.e., TMS1<Tc). This 
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feature will ensure the production of well sintered and mechanically strong glass 
powder compacts. The second stage of densification occurred in competition with 
crystallization and ended at temperatures higher than Tc. This depicts that shrinkage 
continued in the glass powders even after onset of crystallization, possibly due to the 
presence of residual glassy phase in the glass-ceramics. 
(iii) The thermal stability parameter, ΔT=Tc – Tg varied from 129 ºC for ZS–2 to ~150 ºC 
for the remaining compositions (ZS–4 to ZS–10), Table 4.5.1. This suggests that 
thermal stability was enhanced with the increasing amounts of ZnO and SrO within the 
composition range, thus favouring densification during sintering. On the other hand, no 
particular trend could be observed for the variation in Sc values reported in Table 4.5.2. 
However, all the glasses exhibited a comfortable Tc-TMS difference which enables 
delaying the nucleation events thus, providing a wide processing window for attaining 
maximum densification [23].  
(iv) The DTA thermographs of glasses (ZS–2 to ZS–8) exhibited single crystallization 
exothermic curves. This signifies that the obtained glass-ceramics are formed either as a 
result of single phase crystallization or of an almost simultaneous precipitation of more 
than one crystalline phase. The two distinct exothermic events observed for ZS-10 
suggests the almost simultaneous precipitation of two crystalline phases 
(v) Values of A/A0 ranged from 0.65 to 0.67 (Table 4.5.3) for all the glasses implying 
towards good densification levels of 95–98%. 
 
Table 4.5.2 Thermal parameters measured from DTA and HSM at 5 K min
1
 
 ZS-2 ZS-4 ZS-6 ZS-8 ZS-10 
TFS  (±5 ºC) 765 752 748 746 740 
TMS1 (±5 ºC) 803 794 790 789 782 
TMS2 (±5 ºC) 862 865 854   
Tc(±2 ºC) 855 856 831 829 855 
Tp(±2 ºC) 892 887 872 869 879 
Sc(=TcTMS1) 52 62 40 41 73 
A/A0 at TMS1 (±0.02) 0.65 0.67 0.65 0.65 0.65 
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4.5.2.4 Structural transformation in glasses during heat treatment: 
4.5.2.4.1 XRD 
In agreement with HSM and DTA data, Figure 4.5.4a shows that amorphous glass 
powder compacts were obtained for the ZS–2 and ZS–4 samples after sintering for 1 h at 800 
ºC, while crystalline peaks corresponding to strontium-containing FA (Sr-fluorapatite) 
(Sr0.59Ca4.41 (PO4)3) (ICDD card: 01-070-3522) with a maximum intensity at 2θ = 31.75º 
were observed for the other compositions (ZS-6 – ZS-10). Further increase in temperature to 
850 and 900 ºC led to the crystallization of strontium containing Di phase (Sr-Diopside), 
(Sr0.15Ca0.75Mg1.1(Si2O6)) (ICDD card: 04-015-0688) in all the glass-ceramics. The XRD data 
revealed that solid solutions involving partial substitution of Ca
2+
 by Sr
2+
 in FA and Di 
crystal structures were formed. Considering the higher ionic radius of Sr
2+ 
(132 Å) in 
comparison to that of Ca
2+
 (114 Å), variations in lattice parameters are likely to occur. As a 
matter of fact, Figure 4.5.4b-c shows slight shifts in the peak positions to lower 2θ angles, 
especially in case of Sr-FA. Concerning the evolution of the XRD peaks with increasing 
contents of SrO and ZnO in the glass-ceramics, Figure 4.5.4b-c also show two opposite 
trends for the two identified crystalline phases. Namely, the intensity of the XRD peaks 
increases for Sr-FA and decreases for Sr-Di. 
 
 
 
 
 
 
 
 
 
 
Figure 4.5.4 X-ray diffractograms of glass-ceramics heat treated for 1 h at: (a) 800 ºC, 
(b) 850 ºC and (c) 900 ºC. 
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Figure 4.5.5 Intensity ratio of the main XRD intensity peaks of Sr-diopside to Sr-fluorapatite 
plotted against percentage of zinc and strontium substitution for glass-ceramics heat treated 
for 1 h at 850 ºC and 900 ºC.  
 
Figure 4.5.5 shows the variation of the ratio between the highest intensity XRD peaks 
of Sr-Di / Sr-FA with respect to the ZnO + SrO content in the glass. Linear decreasing 
intensity trends are observed. The decrease in Sr-Di phase with increasing SrO/CaO and 
ZnO/MgO ratios can be attributed to the decrease in the Mg content in the glass network due 
to ZnO substitution. Along with the two major crystalline phases mentioned above, low-
quartz (SiO2) and willemite (Zn2SiO4) also precipitate out as minor phases in the glass-
ceramics sintered at 850 and 900 ºC. It is worth noting that the presence of willemite as minor 
phase indicates that zinc predominantly remains in the residual glassy phase.  
Representative SEM images and EDS data collected in the areas indicated in the SEM 
micrographs are shown in Figure 4.5.6 for glass-ceramics ZS8 samples sintered for 1 h at 
different temperatures. At 800 ºC, the microstructure is essentially amorphous and the few 
FA crystals are still isometric. With increasing the sintering temperature, the typical 
elongated morphology of FA became evident. Although the results are informative, there are 
significant deviations in the measured atomic percentages of the different elements relatively 
to those planned for the starting glass compositions or relatively to their proportions in the 
crystalline phases. This is not surprising considering that the area being analysed is larger 
than a single crystal and the measured result is influenced by the surrounding area. In 
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contrast, there is a good agreement between the XRD results (Figure 4.5.4) and the SEM 
observations (Figure 4.5.6). 
 
  
  
  
 
Figure 4.5.6 SEM images and EDS results of glass-ceramic ZS–8 sintered for 1 h at: (a) 800 
ºC, (b) 850 ºC, (c) 900 ºC, after a heating rate ramp of 5 K min
−1
.  
 
4.5.2.5 Mechanical Behaviour: 
The flexural strength was calculated for powder compacts sintered at 800, 850 and 
900 ºC (Figure 4.5.7). Despite their highly amorphous nature, the glass powder compacts 
sintered at 800 ºC exhibited flexural strength of ~ 60 – 70 MPa depicting their good sintering 
ability.  
0 1 2 3 4 5
0 1 2 3 4 5
0 1 2 3 4 5
O 
Sr 
Ca Ca 
F 
Mg P 
Zn 
Ca 
O 
Sr 
Ca
Ca 
F 
Mg 
P Zn 
Ca 
O 
Sr Ca
Ca 
F 
Mg 
P Zn 
Ca 
Alkali-free bioactive glasses for bone regeneration  
Page 111 
 
 
Figure 4.5.7 Flexural strength of glass-ceramics heat treated for 1 h at: (a) 800 ºC, (b) 850 ºC 
and (c) 900 ºC, using a heating rate of 5 K min
−1
.  
 
Further, higher values of flexural strength were obtained for glass-ceramics sintered 
at 850 ºC as sintering at 900 ºC led to a decrease in their mechanical strength. The variation 
in mechanical strength with the sintering temperature can be explained on the basis of 
crystalline phase evolution, including the type of predominating phase and, eventually, the 
size of crystals formed in these glass-ceramics. The mechanical strength was firstly enhanced 
with the predominate formation of Di, a mechanically strong crystalline material. Therefore, 
the relatively higher intensity XRD peaks of Di in glass-ceramics sintered at 850 ºC in 
comparison to their counterparts sintered at 800 and 900 ºC suggests an enhanced fraction of 
this phase that confers  to these samples higher mechanical strength. At 900 ºC, FA became 
the dominant crystalline phase in glass-ceramics with higher SrO and ZnO content. This 
resulted in lower mechanical strength owing to the poor mechanical properties of FA in 
comparison to Di [131]. 
 
4.5.3 Discussions 
We have investigated the influence of strontium and zinc oxides on the sintering and 
mechanical behaviour of alkali-free bioactive phosphosilicate glass-ceramics. The increase in 
SrO and ZnO concentration leads to the expansion of the glass structure and to concomitant 
decreases in Tg. all the investigated glasses exhibit good sintering behaviour and good 
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flexural strength with Sr-diopside and Sr-fluorapatite evolved as the major crystalline phases 
in the glass-ceramics along with willemite and quartz as minor phases. Due chemical 
similarity between strontium and calcium increase in concentration of SrO at the expense of 
CaO led to the partial replacement of Ca
2+
 by Sr
2+
 in the FA crystal structure whereas ZnO 
predominantly remained in the glassy phase. 
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4.6 Understanding the influence of composition on structure bioactive and thermal 
behaviour of Diopside – Tricalcium phosphate based glasses 
4.6.1 Introduction 
 The present work aims at gaining an insight about the influence of composition on the 
structure, bioactivity and thermal behaviour in alkali-free bioactive glasses in the 
CaOMgOSiO2P2O5 system designed along DiTCP binary join by varying Di/TCP ratio 
and These glass compositions are derived from the ternary DiFATCP system which has 
been extensively studied in this thesis. Furthermore, the glass compositions derived from 
these binary and ternary systems have been regarded with much of interest to biomaterials 
community for their potential applications in bone regeneration and tissue engineering  [131-
134, 139, 140, 222]. 
 
Table 4.6.1 Nominal composition of the as-designed glasses (mol%).  
 
Glasses CaO MgO SiO2 P2O5 
Di-0 75 – – 25 
Di-10 68.13 3.43 6.87 21.57 
Di-20 61.82 6.59 13.18 18.41 
Di-30 55.99 9.5 19.02 15.49 
Di-40 50.57 12.22 24.42 12.79 
Di-50 45.55 14.73 29.44 10.28 
Di-60 40.88 17.06 34.12 7.94 
Di-70 36.52 19.24 38.48 5.76 
Di-80 32.44 21.28 42.57 3.71 
Di- 90 28.60 23.20 46.40 1.80 
Di-100 25.00 25.00 50.00 – 
 
4.6.2 Results 
4.6.2.1 Glass forming ability 
For all the investigated compositions (Table 4.6.1), we could obtain amorphous 
glasses only from compositions with Di ≥ 50 wt%. The melting of compositions with Di 
content varying between 3050 wt% at 1570 ºC for 1 h resulted in a highly viscous liquid 
which was prone to spontaneous crystallization even after quenching in cold water, thus 
resulting in a white, opaque material. Decreasing further the Di content to 20 wt% led to the 
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formation of highly viscous, non-homogeneous melt under the same experimental conditions. 
Therefore, the present study will be dedicated towards the investigation of structure, 
bioactivity and chemical degradation of glasses with Di content varying between 50 – 100 
wt%. 
 
4.6.2.2 Structure of glasses by MAS-NMR  
The 
29
Si MAS-NMR spectra of the glasses are shown in Figure 4.6.1a. All glasses 
exhibit a broad peak with full width half maximum in the range of 16–17 ppm centred around 
–81 to –82 ppm indicative of dominance of Q2 units silicate species [188] . There is a slight 
change in the peak position towards higher ppm up to Di-90; afterwards the peak shifts 
towards less negative ppm. 
  
Figure 4.6.1 MAS NMR spectra of investigated glasses showing the peak positions of (a) 
29
Si and (b) 
31
P.  
 
Figure 4.6.1b represents the 
31
P spectra of the investigated glass samples. Irrespective 
of the content of the modifiers in the glasses, all the spectra are characterised by a relatively 
symmetric peak with chemical shift within the range of 1–3 ppm with an approximate line 
width of 8–9 ppm. The line width and the chemical shift values correspond to phosphorus in 
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orthophosphate environment (Ca–Mg orthophosphate). A downfield shift from 2.2–1.7 ppm 
was observed with the increments in Di content. 
In general, infrared spectra of all investigated glasses exhibit three broad 
transmittance bands in the region of 300–1300 cm–1 (Figure 4.6.2). This lack of sharp 
features is indicative of the general disorder in the silicate and phosphate network mainly due 
to a wide distribution of Q
n
 units occurring in these glasses. The most intense bands in the 
800–1300 cm–1 region correspond to the stretching vibrations of the SiO4 tetrahedron with a 
different number of BO atoms [205]. In all the glasses this band further split in two 
transmittance bands, a low frequency band at 940 cm
–1
 and a second band in the range 1030–
1038 cm
–1
. The high frequency bands can be assigned to the Si–O asymmetric stretching 
mode of BOs, whereas the ~940 cm
–1
 may be attributed to the Si–O asymmetric stretching 
mode of the NBOs [205, 223]. While the weak 750 cm
–1
 shoulder may be due to Si–O–Si 
symmetric stretching with simultaneous Si cation motions. Further, a weak shoulder ~600 
cm
–1
 corresponds to P–O bending modes [206]. 
 
Figure 4.6.2 FTIR spectra of the investigated glasses 
  
4.6.2.3 SBF immersion studies 
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Di-60 
Di-70 
Di-80 
Di-90 
Di-50 
498 
1030 
561 
503 
750 
563 
1038 
565 
1032 
500 
1030 
498 1024 
1383 
940 
350 650 950 1250
T
ra
n
sm
it
â
n
ce
 (
u
.a
.)
 
Wavenumber(cm˗1) 
Alkali-free bioactive glasses for bone regeneration  
Page 116 
 
and SBF (Figure 4.6.3). The soaking of glass powders in SBF for 1 h resulted in the splitting 
of a strong low frequency band in the region 350–650 cm–1 into two small bands at ~470 cm–1 
and ~563 cm
1 
(Figure 4.6.3a). The band centred around 470 cm
–1
 can be ascribed to a 
deformation mode of the silica gel layer that develops on the dissolution of glass particles 
[83], while small band at ~563 cm
1 
characteristic phosphates as it corresponds to P–O 
bending vibrations in a (PO4)
3–
 tetrahedron. The band now occurring at ~1060 cm
–1
 and a 
nearby shoulder, centred at ~1240 cm
–1
are attributed to Si–O–Si vibration [147]. These bands 
indicate the development of interfacial high–area silica gel layer, as postulated in Hench’s 
inorganic reactions set [20] and can be observed in all the glasses. After 6 h of immersion the 
bands pertaining to the formation of complex carbonates 875, 1430, 1485 cm
1
 and silica gel 
layer (~1235 cm
1
) became more evident (not shown). Further, an increase in immersion time 
up to 24 h (Figure 4.6.3b), resulted in the sporadic appearance of new bands around 798 and 
960 cm
1
, indicating towards silica gel layer, and also, band at ~560 cm
1 
suggests the 
presence of non-apatitic or amorphous calcium phosphate, which is usually taken as an 
indication of the presence of precursors to HA. Immersion of glass powder for 3 days (Figure 
4.6.3c) led to the formation of well-defined bands in all the glasses at ~563 and 604 cm
1
, 
attributed to crystalline apatite. After 14 days of immersion (Figure 4.6.3d), no new bands 
formation could be seen apart from the increase in intensity of the bands corresponding to 
crystalline apatite i.e., at ~563 and 604 cm
1
, indicating an increase in crystallinity. In 
addition, a small band at ~1420 cm
1
 along with a broad but intense band at ~850 cm
1 
present in all glasses. 
 In agreement with the FTIR results, the XRD patterns of the samples immersed in 
SBF for different time periods are displayed in Figure 4.6.4. Although there are a few 
sporadic peaks apparently related to hydroxyapatite (HA) even after 1 h of immersion (see 
Di80), the indubitable formation of crystalline HA at the surface of the samples Di50 – 
Di90 only becomes clearly evident after 3 days of immersion. With the increase in 
immersion time to 14 days, the intensity of XRD peaks increased irrespective of the glass 
composition (Di–50 – Di–90). Further, the formation of any calcium carbonate (CaCO3) 
polymorphs along the entire immersion period was not observed whereas, formation of 
calcite under similar testing conditions has been reported for pure Di glass [105]. 
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Figure 4.6.3 FTIR spectra of glasses powders after immersion in SBF solution for (a) 1 h, (b) 
24 h, (c) 3 days, and (d) 14 h. 
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Figure 4.6.4 X-ray diffractograms of glass powders before and after immersion in SBF 
solution for (a) 1 h (b) 24 h (c) 3 days and (d) 14 days. HA refers to hydroxyapatite. 
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Figure 4.6.5 Variations in pH and weight loss of glass powders upon immersion in Tris-HCl 
solution for 7 days 
 
4.6.2.4 Chemical degradation of glasses in Tris-HCl 
Chemical durability of the glasses is a critically dependent on the pH and the nature of 
the solution. The leaching behaviour depends on the diffusability of the ions which 
determined by the ionic field strength of the ions and structure of the glasses. In the present 
case, a slight in pH of TrisHCl solution from 7.8 to 8.33 was observed with increasing TCP 
content (Figure 4.6.5). The increase in the final pH value with increasing TCP content can be 
attributed to the increase in the CaO content in the glass. However, the weight loss of the 
analysed samples (Figure 4.6.5), does not reflect well the expected mass balance through the 
ion exchange, in particular less weight loss of the sample Di–50 (~0.12%). 
Glasses with TCP content varying between 10 – 40 wt.% did show some stability in 
observed weight loss, thus approaching more the expected trend when one considers that the 
weight losses derived only from the passage of species from the solid to the solution. Further, 
all the glasses were XRD amorphous (Figure 4.6.6) after immersion in Tris-HCl solution for 
7 days.   
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Figure 4.6.6 X-ray diffractograms of glass powder after 120 days of immersion in TRIS-
HCL 
 
Table 4.6.2 Thermal parameters measured from DTA at 20 K min
1
. 
 
Glasses Tg (±2) Tc (±2) DT 
Di–50 747 825 78 
Di–60 748 861 113 
Di–70 748 881 133 
Di–80 749 901 152 
Di–90 736 880 144 
Di–100 744 839 95 
 
4.6.2.5 Thermal analysis 
The DTA thermographs of fine glass powders with b= 20 K min−1 are shown in 
Figure 4.6.7. All the glass compositions feature a single endothermic dip between 748736 
ºC before the Tc, corresponding to Tg,, estimated from the inflection temperature in DTA 
curve where the first derivative is null [224].  This thermal event was then followed by a 
single exothermic crystallization peak/band for glasses Di60 to Di100, whereas two 
crystallization peaks points (Tp1 and Tp2) were observed in glass Di–50. We could not 
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observe any significant differences in the variation of Tg values with varying Di/TCP ratio in 
the glasses. The characteristic thermal parameters, Tg, Tc and thermal stability, defined as 
ΔT(=TcTg) obtained from DTA thermographs are summarized in the Table 4.6.2.  The 
thermal stability parameter, ΔT=TcTg varied from 78 ºC for Di50 to ~152 ºC for Di80.  
Figure 4.6.7 DTA thermographs of glasses at a heating rate of 20 K min
−1
  
 
4.6.2.6 Sintering and crystallization behaviours 
The variations in the relative area and heat flow as functions of the heat treatment 
temperature as obtained from HSM and DTA, respectively, under a similar heating rate of 5 
K min
−1
 are presented in Figure 4.6.8a–f for all the investigated glasses. The DTA 
thermographs of glasses with Di contents varying between 60 and 100 wt.% exhibit single 
crystallization exothermic peaks Figure (4.6.8bf), confirming the crystallization behaviour 
discussed above observed under a higher heating rate of 20 K min
−1
. Table 3 summarizes the 
values of some relevant thermal parameters including the temperature of first shrinkage (TFS; 
log  = 9.1 ± 0.1,  is viscosity in dPa s), temperature for maximum shrinkage (TMS; log = 
7.8 ± 0.1) and ratio of the final area/initial area of the glass powder compact (A/A0) at TMS1, 
as obtained from the HSM data. The temperatures corresponding Tc, and Tp obtained from 
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the DTA of the glasses are also reported. From these DTA and HSM results the following 
observations can be made: 
1. The temperature of first shrinkage (TFS) showed a slight increase with increasing TCP 
contents in the glasses before decreasing abruptly to at Di50; 
2. The first sintering stage is accomplished at TMS1 while the second one at TMS2. In all 
the glass compositions (except the extreme ones Di50 and Di100), TMS1 was lower 
than Tc meaning that maximum shrinkage was reached before onset of crystallization. 
The second stage of densification TMS2 occurred in much smaller extent and in 
competition with crystallization, ending at temperatures around Tc. This general trend 
is more obvious in the intermediate glass compositions from Di60 to Di90.  
3. The sintering parameter, defined as Sc =Tc–TMS, reflects the extent of separation 
between the sintering and crystallization events in the temperature scale. The Sc values 
for all investigated glasses are reported in Table 4.6.3.  Initially the sintering ability 
increased with increase in TCP content until glass Di80, while further TCP 
increments led to its degradation. In case of Di100, TMS coinciding with Tc, Sc (Tc – 
TMS) = 0 as shown in Figure 4.6.8f. 
4. The values of the A/Ao ratio between the area (A) of the sample at TMS to its initial 
area (Ao) decreased from 0.94 in Di50 (the less prone composition for sintering) to 
0.66 in Di90. Except for Di50, all other glass–powder compacts exhibited good 
densification with A/Ao ratios varying within the range of 0.72 –0.66. 
 
Table 4.6.3 Thermal parameters (ºC) and A/Ao ratio derived from DTA and HSM at 5 K 
min
1
. 
 TFS (±5) TMS1 (±5) TMS2 (±5) Tc (±2) Tp (±2) Tp2 (±2) Sc A/Ao 
Di–50 737 786 932 795 845 910 9 0.94 
Di–60 786 826 – 831 881 903 5 0.72 
Di–70 763 850 – 874 905 – 24 0.75 
Di–80 774 812 – 899 955 – 87 0.68 
Di–90 777 824 – 857 895 – 33 0.66 
Di–100 756 823 – 823 853 – 0 0.69 
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Figure 4.6.8 Comparison of DTA and HSM curves under the same heating rate (5 K min
1
) 
for compositions: (a) Di50, (b) Di60 (c) Di70, (d) Di80 (e) Di90 and (f) Di100 
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Figure 4.6.9 X-ray diffractograms of glass-ceramics heat treated at (a) 900 (b) 1000, and (c) 
1200 ºC for 1 h. (Di: Diopside, OAp: oxyapatite, W: Whitlockite, CaS: Calcium Silicate)  
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4.6.2.7 Structural transformations during heat treatment 
Figure 4.6.9 shows the XRD patterns of the glass powder compacts heat treated for 1 
h at 900, 1000 and 1200 ºC. The peak at 2q = 29.83º position appeared in all glasses and 
became more intense as the Di content is increased. The peak around of 2q = 31.74º was 
restricted to the composition with higher TCP contents (Di50 to Di70). In addition, a 
number of low intensity peaks were also present as minor crystalline phase, being more 
prominent in these compositions (Di50 to Di70). The crystalline phase assemblage did not 
change much upon further increasing the heat treatment temperature to 1000 ºC (Figure 
4.6.9b), traces of new peaks at 2q = 31.30º  start appearing at this temperature especially for 
Di50 to Di70 compositions. Further, with the increase in the heat treatment temperature to 
1200 ºC peaks ~2q = 31.74º disappeared along with some minor phases and new peaks with 
maxima at 2q = 31.30º appeared as the prominent phases (Figure 4.6.9c).  
 
4.6.2.8 Density  
The experimental density data measured for bulk glasses and glass-ceramics heat treated at 
different temperatures are reported in Table 2.6.4. The density of glass Di-50 was not 
measured due to its partial crystallization upon casting/slow cooling. It can be seen that 
density of the glass tends to decrease with increasing proportions of Di. All the glass-
ceramics, except Di-50, exhibited good densification ability, achieving densities that are 
superior in comparison to those of bulk glasses. The density values show a general increasing 
trend with temperature increasing followed by its reversion with further augmenting the 
sintering temperature, with small composition dependent variations.  
 
Table 4.6.4 Density (kg m3) of glasses and glass-ceramics. 
Compositions Bulk glass 
Glass ceramics heat treated at 
900 ºC 1000 ºC 1200 ºC 
Di-50* - 2,819±47 2,863±60 2,893±16 
Di-60 2.945 2,951±12 2,972±4 2,964±15 
.Di-70 2.921 2,972±60 2,953±6 2,962±1 
Di-80 2.897 2,933±1 2,973±6 2,924±3 
Di-90 2.871 2,930±7 2,936±6 2,925±11 
Di-100 2.852 2,897±3 2,936±17 2,892±4 
* Partial crystallisation upon casting 
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Figure 4.6.10 Flexural strength of glass-ceramics heat treated for 1 h at (a) 900 ºC (b) 1000 
ºC, and (c) 1200 ºC. 
 
4.6.2.9 Mechanical properties 
 The 3-point bending strength was calculated for glass powder compacts sintered for 1 
h at 900, 1000 and 1200 ºC (Figure 4.6.10). In general, the flexural strength increased form 
Di50 – Di100 in all the glass powder compacts heat treated at 900 and 1000 ºC. 
Interestingly, for the glass-ceramics sintered at 1200 ºC a point of inflection was observed 
after Di70, i.e., at 1200 ºC there was a gradual decrease in the flexural strength of the glass-
ceramics with increasing Di content.  
 
4.6.2.10 Cell culture studies 
hMSCs’ metabolic activity on Di–60, Di–70 and Di–90 and Tissue culture 
polystyrene (TCPS) after 1, 3, 7, 14 and 21 days under both conditions are shown in Figure 
4.6.11. 
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Figure 4.6.11 Metabolic activities of hMSCs on Di–60, Di–70 and Di–90 and TCPS after 1, 
3, 7, 14 and 21 days. 
 
An increase in cells’ metabolic activity was observed under both basal and osteogenic 
conditions for the culture period tested. On day 14 of culture in a basal medium, the 
metabolic activity of cells on Di–60 and Di–70 showed superior and significant statistical 
difference when compared with the control. However, no statistically significant difference 
was found after 21 days. Under osteogenic conditions, by day 14, cells’ metabolic activity 
was inferior and exhibited significant statistical difference with Di–90 in comparison with the 
control. On day 21, cell’s on Di–70 presented a higher metabolic activity than cells on Di–60, 
D–90 and the control. At this time point, it was also possible to notice a potential recovery of 
cells’ metabolic activity on Di–90. 
 
4.6.3 Discussions 
The gradual replacement of Di (CaO●MgO●2SiO2) by TCP (3CaO
●P2O5) changes the 
balance between glass formers and glass modifiers, implying structural variations that will 
influence the properties of glasses. The decreasing contents of Si lead to the formation of an 
increasing number of non–bridging oxygens in the glass structure. Further, no abrupt change 
in the glass structure was observed with increasing amounts of Di. However, the change in 
peak position towards more negative ppm values with increase in content of Di may be 
attributed to addition of silica and removal of phosphate from the glass network. On the 
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contrary, the up field peak shift in case of Di-100 can be attributed to complete removal of 
phosphate ion and simultaneous movement of modifier ions towards SiO2 which were earlier 
attached to P2O5. 
 Figure 4.6.1b shows that 
31
P MAS-NMR continuously shifts for all the glasses lying 
predominantly in the range for calcium orthophosphate (13 ppm), and a small amount of 
magnesium orthophosphate (0.5 ppm) can be expected. This therefore suggests that 
phosphorus is present in mixed calcium and magnesium orthophosphate. The phosphate 
component in the glass is predominantly coordinated in orthophosphate environment thus, not 
contributing to the glass network backbone. This facilitates the release of additional soluble 
phosphate species into the surrounding fluid, increasing their local super-saturation levels and 
accelerating the bone bonding ability of glass by enhancing the HA deposition on the glass 
surface. Further Lockeyer et al. [225] attributed the presence of orthophosphate-like 
environment as a result of phase separation in glasses. All the glasses prepared by Lockeyer 
et al [225] were annealed for 6 h at 450 ºC before slow cooling. However, the compositions 
under investigation were rapidly quenched in water, thus reducing the possibility of phase 
separation. Further, as the cation field strength and electronegativity of the modifiers 
significantly affect the 
31
P chemical shift in glasses. The peak shift observed in the spectra 
with increasing Di contents can be attributed to the increase in the Mg
2+
 (high field strength) 
and the concomitant decrease in the amount of Ca
2+
 content (low field strength). 
In terms of bioactive behaviour ,all the investigated glasses have shown good in vitro 
bio-mineralization activity in terms of the formation ability of an HCA surface layer over 14 
days of soaking in SBF (Figure 4.6.3), except for pure Di (Di100) [104]. The inability of 
Di100 to form a HCA surface layer after 14 days of immersion can be attributed the 
relatively high amount of MgO which retards the formation of apatite-like calcium phosphate 
[148]. However, the presence of ACP could be detected for these glasses after 24 h of 
immersion (Figure 4.6.3). Further, despite the differences in P2O5 content, all the investigated 
alkali-free glasses show similar rate of biomineralisation  in contrast to the results reported by 
O'Donnell et al. [226] and Mneimne et al. [227]. The possible reason behind these different 
behaviours could be attributed to high alkali content (22–29 mol%) of the bioglass 
compositions used by O'Donnell et al [228] and Mneimne et al. [227]. The eventual 
association of P with Na in the form Na-orthophosphate is likely to contribute to faster rates 
of dissolution and release of phosphates species from these glasses into the surrounding fluid 
in comparison to alkali–free counter parts. Interestingly, the presence of varying amounts of 
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magnesium did not apparently affect the rate of apatite formation in our alkali-free bioactive 
glasses, even though a supressing role in apatite formation has been reported in literature for 
Mg [229]. However, the results obtained in this study are in line with findings reported 
elsewhere [99] about the negligible effects of Mg on the apatite forming ability of other 
bioactive glass compositions. Thus, it seems reasonable to conclude that the effects of MgO 
on the properties of bioactive glasses do not exclusively depend on the added amount of MgO 
but also on the presence and relative contents of other oxides in each glass composition [229].  
 The foremost requirement for optimizing the fabrication of glass–ceramics scaffolds 
is to understand the sintering and crystallization behaviours of the glass powder compacts and 
avoid the overlapping of these two thermal events. A thorough understanding of the 
transformations that occur during the thermal treatment of glasses and how they depend on 
the starting compositions is therefore essential for designing biomedical applications/devices 
based on bioactive glasses that have to undergo high temperature treatments. We could not 
observe any significant differences in the variation of Tg values with varying Di/TCP ratio in 
the glasses. Further, the presence of single crystallization exotherm anticipates that the glass–
ceramics are formed as a result of either single phase crystallization (Di100) or an almost 
simultaneous precipitation of different crystalline phases (Di60 – Di90), while the 
appearance of two crystallization peaks points (Tp1 and Tp2) in Di50 glass points towards the 
separate precipitation of two different crystalline phases. Further, good sintering behaviour 
was observed in the glasses as TMS1 was lower than Tc, meaning that maximum shrinkage 
was reached before onset of crystallization. Further, the higher values of the sintering 
parameter, Sc = (Tc – TMS) for intermediate compositions (Table 4.6.3) clearly explain why 
these compositions perform better upon sintering. The observed decrease in the sintering 
ability for the higher added amounts of TCP is attributed to the formation of phosphate rich 
phases that degrade the sintering ability by enhancing the crystallization tendency of the 
glasses. In case of Di100, TMS coinciding with Tc (Tc – TMS) = 0, (Figure 4.6.8f). However, 
well sintered glass powder compacts were obtained as maximum shrinkage was achieved just 
before the onset of crystallization. This is confirmed by the density data reported in Table 
4.6.4. The lowest density of Di50 glass-ceramics is in good agreement with its poorer 
densification ability as deduced from the DTA-HSM results, with TMS2 coinciding with the 
onset of crystallization. Some bubbling was observed upon immersing the Di-50 glass-
ceramics in diethyl phthalate due to the presence of some open pores, a tendency that 
deceased with increasing temperature, but was not completely eliminated. The absence of 
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bubbling for the remaining glass-ceramics samples and their higher sintered density values in 
comparison to the parent bulk glasses attest their good sintering ability, in good agreement 
with the predictions derived from DTA-HSM studies. Density data confirm that the 
compositions within the range of Di60 to Di80 exhibit the higher sintering ability, being 
the most interesting ones for scaffolds fabrication. The general tendency of density to 
decrease with heat treatment increasing can be attributed to the elimination of a few pores left 
at lower temperatures and or to the formation of increasing amounts of denser crystalline 
phases. The reversion of this trend with temperature further increasing might be due to partial 
re-melting of crystalline phases, crystalline phase transformations. Therefore, exact 
information about the nature of crystalline phases formed upon heat treating the bioactive 
glasses is of great interest as they determine the relevant final properties of the glass-ceramic 
materials. Besides being composition dependent, the phase assemblage might be also affected 
in a certain extent by the heat treatment schedule.  
In the present study, Di (CaMgSi2O6) (ICDD: 01-072-1497) and oxyapatite (ICDD: 
65-1659) were the principal crystalline phases formed at 900 ºC (Figure 4.6.9a). The presence 
of oxyapatite was restricted to the composition with higher TCP contents (Di50 to Di70). 
Calcium silicate (Ca2SiO4) (ICDD: 01-086-0401) was also present as minor crystalline phase, 
being more prominent in these compositions (Di50 to Di70) as evident from the X-ray 
diffractograms. The crystalline phase assemblage did not change much upon further 
increasing the heat treatment temperature to 1000 ºC, but traces of whitlockite 
(Ca2.71Mg0.29(PO4)2) (ICDD: 01-070-0682) start appearing at this temperature especially for 
Di50 to Di70 compositions. The absence of calcium silicate and whitlockite phases in the 
glass-ceramics with higher Di contents can be attributed to the gradual depletion in Ca 
required to form those phases and the concomitant increasing amounts of MgO that tend to 
enhance the viscosity of the melts. Further increasing the heat treatment temperature to 1200 
ºC led to the dissolution of oxyapatite and calcium silicate phases, favouring the formation of 
whitlockite along with Di as the prominent phases. The dissolution of oxyapatite and calcium 
silicate at 1200 ºC can be attributed to increase in the amount of Di phase and the associated 
decrement of calcium content in the residual glassy phase available for apatite/Ca2SiO4 
formation. 
 Mechanical strength of the scaffolds is a very important aspect to take into 
consideration when designing glass-ceramics for bone tissue engineering applications. The 
mechanical strength of glass-ceramics is dependent on the mechanical properties of the 
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constituting crystalline phases and the densification ability of glass-powder compacts. In the 
present investigation the mechanical strength of the glass-ceramics (Di–60 – Di–100) exhibit 
good mechanical strength which can be attributed the mechanical properties of the 
constituting crystalline phases and high density obtained by the glass-ceramics (2,890–2,970 
kg m
–3
). In case of Di50, the poor sintering/densification ability and lower mechanical 
strength of the dominant phase can attributed to the lower mechanical strength upon sintering. 
Further glass-ceramics with higher amounts of Di (a mechanically stronger phase) [230] 
exhibit high mechanical strength values when heat treated up to 1000 ºC. Further, the overall 
decrease in the mechanical strength of the resultant glass-ceramics heat treated at 1200 ºC can 
be due to the decline in the densification ability of the glass-ceramics and formation of 
considerable volume fraction of whitlockite (a mechanically weaker phase), explaining the 
overall decrease in the mechanical strength of the resultant glass-ceramics. 
The cell culture studies showed an excellent cellular response to the investigated glass 
compositions, with the exception of the cells tested with osteogenic supplements and Di–90. 
Under these conditions, cells had lower metabolic activity than control, Di–60 and Di–70. 
Since Di–90 has higher amount of silica and MgO than the other compositions, the release of 
the compounds to the culture medium may induce some levels of cytotoxicity towards the 
hMSCs. Previous studies have shown that high Si concentrations can be cytotoxic [231, 232]. 
However this behaviour was more prominent under osteogenic conditions, which might be 
attributed to the inhibition of the stimulatory effect of osteogenic supplements in the presence 
of high Si concentrations [233]. At the end of the culture period, these cells seem to recover 
from the imposed toxic levels as suggested by an increase in their metabolic activity. This 
behaviour has been reported by several authors [231, 234]. On the contrary, Di–60 and Di–70 
promoted a good cell adhesion, metabolic activity into an osteoblastic phenotype, suggesting 
a potential stimulatory effect of these materials on hMSCs by the release of soluble factors or 
by the fastest formation of a CaP layer [235]. It has been reported the Si–, Ca– and Mg–
containing bioactive ceramics can release soluble ionic products to stimulate the proliferation 
and osteogenic differentiation of osteoblasts and human mesenchymal stem cells [236-238]. 
 
4.6.4 Conclusions 
An attempt has been made gain an insight into composition - structure - bioactivity 
relationships of alkali-free bioactive glasses in the CaO–MgO–SiO2–P2O5 system. The 
glasses have been designed in the Di (CaO•MgO•2SiO2) – TCP (3CaO•P2O5) binary join by 
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varying the Di/TCP ratio. We could obtain amorphous glasses only from compositions with 
Di ≥ 50 wt%. The melting of compositions with Di contents varying between 30-50 wt% at 
1570 ºC for 1 h resulted in a highly viscous liquids which were prone to spontaneous 
crystallization even after quenching in cold water, thus resulting in a white, opaque material. 
Further decrease in Di content to 20 wt% led to the formation of highly viscous, non-
homogeneous melts under the experimental conditions. Further, there was no significant 
change in the structure of the glass with decrease in Di content as investigated glasses have 
predominantly Q
2
 (Si) units while phosphorus is mostly in orthophosphate type environment. 
As expected from the structure of the glasses, all other investigated glasses have shown good 
in vitro bio-mineralisation activity in terms of the formation ability of an HCA surface layer 
over 14 days of soaking in SBF. All the glasses exhibited considerably lower weight loss in 
comparison to 45S5 Bioglass
®
 in Tris-HCl with Di–50 exhibiting lowest weight loss. The cell 
culture studies showed an excellent cellular response to the investigated glass compositions, 
with the exception of the Di–90. Further, all the glasses exhibit good thermal stability and 
processing window wide enough for the fabrication of scaffolds. TCP addition resulted in 
slight Tg variations. Good densification was achieved for the glass powder compacts at all 
investigated temperatures, resulting in well sintered and mechanically strong glass-ceramics. 
Diopside, oxyapatite were the major phases present at 900 ºC and 1000 ºC with calcium 
silicate and whitlockite as the minor phases. At 1200 ºC, diopside and whitlockite were the 
major phases present with no other minor phase detected. 
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5. General conclusions 
The present work aimed at developing alkali-free bioactive glasses in the ternary 
system of Di-FA-TCP having high bioactivity, lower dissolution rate and good sintering 
behaviour for bone regeneration and tissue engineering applications. In this pursuit, an 
attempt was made to understand the structure-property relationships in alkali-free bioactive 
glasses. Further, the influence of various functional ions on the structure and their 
implications on the biodegradation, sintering and crystallization behaviour of bioactive 
glasses was studied. In terms of structure, the glasses are almost similar to 45S5 Bioglass®, 
while significantly differing in the properties that are relevant for the intended applications. 
The designed alkali-free bioactive glasses exhibit: (i) higher bioactivity and slower chemical 
degradation in comparison to 45S5 Bioglass®; (ii) enhanced sintering ability resulting in well 
sintered and mechanically strong glass-ceramics with high residual amorphous content; (iii) 
good ability to be dispersed in aqueous media and to fabricate scaffolds for bone regeneration 
and tissue engineering applications with good mechanical properties and high bioactivity; (iv) 
the pH of the media is kept at moderate values owing to the absence of alkali metals in the 
composition, making them non-cytotoxic.  
Further, the addition of zinc to the parent glasses enhanced their chemical durability 
and the sintering ability without causing a substantial change in the structure. The flexural 
strength of 200 MPa achieved for Zn-8 We is comparable to that of the A-W glass-ceramics. 
Glasses doped with equimolar concentrations of ZnO and SrO showed excellent bioactivity 
despite of their very low degradation in comparison to 45S5 Bioglass®. In addition, the glass 
ZS–2 released doses of zinc and strontium into the SBF that are within the considered 
therapeutic ranges (< 1.5 ppm Zn and ≤ 10 ppm Sr), and exhibited good antioxidant 
behaviour by enhancing the cell viability and negating the effect of oxidative stress induced 
by H2O2 addition in the cell culture medium. Thus zinc concentration < 1.5 ppm has an anti-
oxidant effect.  
Moreover, we have elucidated that a straightforward correlation between the glass 
structure as evaluated by the network connectivity (Qn units) and dissolution behaviour of 
alkali-free bioactive glasses is difficult to establish as the bulk molecular structure of glasses 
does not completely control the hydroxyapatite formation on the surface of bioactive glasses. 
The structural coordination of functional ions in the glass plays a crucial role in deciding their 
elemental release profile thus, affecting the bioactivity of glasses. In the investigated alkali-
free bioactive glasses, all the glasses had almost similar molecular structure (Qn and NC). 
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However, the structural coordination of zinc (five-coordinated) and strontium (six 
coordinated) played an important role in deciding their biodegradation and sintering and 
crystallization behaviour. Also, in order to obtain a comprehensive picture about the 
dissolution mechanism and surface reactivity of glasses, it is of utmost importance to explore 
the surface chemistry of bioactive glasses and correlate it with their molecular structure. 
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6. Future works 
During this research work, an attempt has been made to develop diopside based Alkali-
free bioactive glasses for bone regeneration applications. We have succeeded in shedding 
some light on the composition-structure-property relationships in the glasses and the effect of 
various functional ions on the biodegradation, sintering, thermal and in vitro behaviour of 
bioactive glasses, which render them suitable for further experimentation as potential 
candidates in various bone regeneration applications. However, a lot work still needs to be 
accomplished in order to understand the biodegradation behaviour of the glasses. Therefore, 
in our opinion, the future work in this area may be addressed to the following issues: 
1. Surface chemistry of the glasses is highly important aspect to study the bioactive 
phenomenon. It could be interesting to study the relation of surface chemistry of 
glasses with their biodegradation behaviour and compare them with alkali-containing 
counterparts. 
2. In addition, biologically relevant additives (Co, Mn, Cu etc.) can be added to study 
their effect on bio-degradation behaviour in order to enhance the therapeutic efficacy 
of the glasses 
3. Further in depth in vitro tests are required to see the interaction of bioglass with 
variety to cellular environments. 
4. Also, in vivo tests of glasses/glass-ceramics are required to further establish its 
application in human biomedicine. 
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